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Abstract 
Hypoglycaemia is an unavoidable consequence of treatment of Type 1 Diabetes Mellitus 
(T1DM). Symptoms are often embarrassing and distressing and can lead to the 
development of fear of hypoglycaemia (FoH).  This fear can have a negative impact on 
diabetes management and can lead to further medical complications. 
 
210 children and young people (CYP), aged 3-17 years and 190 parents from diabetes 
paediatric clinics across the West Midlands, UK, completed questionnaires exploring the 
prevalence of hypoglycaemia, FoH and links to hypoglycaemia awareness, self-care, quality 
of life and anxiety.  Demographic information and HbA1c data were also collected. 
 
Results indicated that hypoglycaemia and severe hypoglycaemia (SH) are a problem for 
CYP in the UK.  Hypoglycaemia Fear Survey (HFS) scores were higher in parents than in CYP 
(Total HFS 37.1±14.9 vs. 50.2±17.8 vs. 45.2±18.0, CYP vs. mother vs. father, respectively, 
p<0.01). Adolescents with prior experience of severe hypoglycaemia (SH) had higher HFS 
scores compared to those without (t=-3.61, p<0.001). Trait anxiety and SH explained 23% 
of the variance in HFS scores in adolescents. Trait anxiety explained 37% of the variance in 
HFS scores in under 11 year olds, 18% in mothers of under 11 year olds, 6% in mothers of 
adolescent and 10% in fathers of adolescents. There was no correlation between HFS and 
HbA1c.  Qualitative analyses identified ‘Burden’ as an overarching theme from CYP and 
parent interviews.  ‘Negative emotions’ and ‘Living with diabetes’ emerged as the key 
themes of analysis. 
 
This research study adds to existing findings on the prevalence of hypoglycaemia, severe 
hypoglycaemia, FoH and possible related factors, by focusing on the paediatric population 
and their parents, in the UK, for which there is limited research.  Qualitative analyses also 
provided novel reports of the experience of T1DM for CYP and their mothers.  Implications 
of this research could lead to the development of an FoH and anxiety management 
programme for CYP and their parents. The findings of this study also help to raise 
awareness of this very real and current issue in diabetes management. 
  
Chapter 1 Introduction  
This chapter aims to introduce the reader to Type 1 diabetes mellitus (T1DM) and the 
effect that it has on paediatric populations and their parents. Research focusing on 
hypoglycaemia (low blood sugar) and its associated biological and psychological outcomes 
will be discussed with regards to the paediatric population.  Particular focus will be made 
on the concept of fear of hypoglycaemia and its impact on diabetes management.  Studies 
exploring the effects of hypoglycaemia on the parents of children with T1DM will be 
discussed.  In addition, diabetes management in relation to glycaemic control will also be 
explored in both the paediatric and parent population. 
 
This chapter will help to build a picture of existing research in the area of fear of 
hypoglycaemia (FoH) and other aspects of living with diabetes for children and adolescents 
with T1DM and their parents.  The research will go towards informing the current research 
study, which aims to add to the growing body of FoH literature, especially for a UK 
population sample. 
 
1.1 Type 1 Diabetes Mellitus (T1DM) 
Type 1 diabetes mellitus is an autoimmune disease, commonly diagnosed in childhood, 
which impairs the body’s ability to produce insulin (required to regulate blood glucose 
levels). The condition results in pancreatic β cells being destroyed, leading to absolute 
insulin deficiency (1). The causes of T1DM are unknown; however, it seems that a 
combination of factors such as the presence of autoantibodies, environmental triggers (i.e. 
virus or infection) and genetic susceptibility, may all contribute. 
 
T1DM in CYP can present with a number of common symptoms including hyperglycaemia 
(high blood glucose levels), a frequent need to go to the toilet, excessive thirst, excessive 
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hunger, weight loss and diabetic ketoacidosis (DKA, whereby the body breaks down tissue 
to use for fuel in the absence of glucose) (2). 
 
The prevalence of T1DM is high and increasing at a dramatic rate (3, 4).  Taking into 
account the number of new cases of T1DM across Europe between 1989-2003, Patterson 
et al. (4) predicted that new cases of T1DM would double in children younger than 15 
years, between 2005-2020.  This will have serious implications for healthcare providers, 
therefore effective planning of services is needed to ensure these CYP receive appropriate 
care.  There has also been a shift in the type of diabetes diagnosed in childhood.  T1DM 
was historically known as juvenile diabetes, with Type 2 diabetes commonly referred to as 
adult-onset diabetes.  With obesity (a risk factor in the development of Type 2 diabetes) 
increasing in the paediatric population (5) however, this is no longer the case.  Type 2 
diabetes is now diagnosed in an increasing number of paediatric cases (6).  Although the 
focus of this thesis is T1DM it is important to understand that the impact of diabetes is 
even more far reaching.    
 
1.1.1 Treatment  
Treatment of T1DM is aimed at achieving optimal blood glucose levels by using insulin to 
manage this.  Insulin treatments vary.  At the time of carrying out the study intensive 
(multiple daily injections (MDI)) regimens were replacing the twice daily insulin regimen.  
Twice daily regimens, though limit the number of injections a patient has to administer are 
also inflexible and do not allow variations in CYP’s diets. Current practice has moved away 
from twice daily insulin injections and newly diagnosed patients are more likely to start on 
an intensive regimen (7).  Intensive regimens, including multiple daily injections and 
continuous subcutaneous insulin infusion (CSII, also known as pump therapy) are better 
able to mimic the role that insulin plays in healthy CYP (8). MDI allows patients to adjust 
their insulin requirements according to their lifestyle by injecting a long acting insulin 
(basal) once or twice a day, accompanied by faster acting insulin which can be adjusted 
according to each meal they eat.  In order to manage their BG levels patients need to carry 
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out regular BG monitoring to ensure that they adjust their insulin appropriately (9).  
Continuous glucose monitoring (CGM) has been identified as a more accurate indicator of 
BG levels.  This system allows measurement of interstitial fluid around the cells in the body 
via a device worn under the skin (9).  When used in combination with MDI, CGM has been 
found to reduce HbA1c (estimate of BG levels over the preceding few months) (10).  CSII or 
pump therapy is increasingly becoming the preferred method of therapy, especially in CYP 
with suboptimal diabetes control (9).  Technological advances mean that pumps are better 
able to calculate adjustments to insulin and show evidence of improved glucose levels post 
meal (11) and increased satisfaction from CYP using this type of therapy (12, 13).  These 
intensive therapies also reduce the risk of diabetes-related complications, as will be 
discussed in more detail in the next section (14). 
 
1.1.2 Impact of T1DM 
The impact of diabetes is multifaceted.  In addition to the impact on physical health it can 
also impact CYP psychologically.  Sub-optimal management of diabetes can lead to future 
complications; microvascular and macrovascular.  Such developments can have serious 
implications for the health of CYP living with T1DM. 
 
The impact of T1DM on physical health is well documented (15-18).  As well as the more 
immediate impact of diabetes, namely hypoglycaemia (which will be discussed in the next 
section), T1DM can also give rise to long-term problems such as micro- and macrovascular 
complications.  Long-term hyperglycaemia (high blood glucose levels) can lead to damage 
to blood vessels, both large arteries (macrovascular) and smaller capillaries 
(microvascular) (17).  Microvascular complications include nephropathy (kidney disease), 
retinopathy (eye disease) and neuropathy (nerve damage) (16).  Longitudinal studies in 
adolescents have shown that those who are able to achieve optimal BG levels consistently 
are able to decrease the likelihood of microvascular complications (18).  Similarly, 
macrovascular complications are thought to be reduced when BG levels are managed well 
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(19).  The Epidemiology of Diabetes Interventions and Complications Research Group (20) 
examined the presence of cardiovascular disease in a cohort of patients who had 
previously taken part in the Diabetes Control and Complications Trial (DCCT).  Those 
patients who had been in the DCCT intensive treatment group experienced 42% less 
cardiovascular disease events than those in the conventional treatment group.  Some 
studies have also found evidence of the impact of microvascular complications on the 
development of macrovascular problems.  The DCCT follow up study (20) found that 
microvascular diseases, specifically nephropathy and neuropathy, can increase the 
likelihood of developing macrovascular complications.  This highlights the importance of 
managing BG levels long term. 
  
The impact of T1DM goes beyond the effects on physical health.  The constant 
management of blood glucose levels can also have a psychological impact on CYP (21).  
Research on psychological disorders in CYP with T1DM are conflicting, however, it does 
seem that living with diabetes is associated with higher psychological distress (22).  Links 
between anxiety and depression with poor self-care have also been reported (23) although 
the impact of this on glycaemic control is less pronounced (24).   
 
The psychological impact of T1DM extends to parents of CYP with diabetes.  This is 
discussed further in sections 1.7 and 1.8.  Further to the physical and psychological impact 
of T1DM, there is also evidence of its impact on QoL.  This will be discussed in more detail 
in section 1.9.    
 
1.2 Hypoglycaemia 
Hypoglycaemia is an unavoidable but common consequence of treatment of Type 1 
Diabetes Mellitus (T1DM).  The prevalence of hypoglycaemia in patients with T1DM in the 
UK is under reported, however, a number of contemporary studies have specifically looked 
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at the prevalence in the CYP population (25-27). These studies will be discussed after 
explaining hypoglycaemia in more detail.  Incidences of hypoglycaemia occur when a 
person’s blood glucose (BG) level drops and becomes too low.  The brain depends on a 
continuous supply of glucose for fuel.  When blood glucose levels in the body fall, the 
amount of glucose to the brain also decreases (28).  If left untreated, hypoglycaemia can 
have serious implications for the health of those who experience these episodes (29).  The 
biochemical definition of hypoglycaemia is recognised as blood glucose levels of 
3.9mmol/L (30).  Diabetes patients whose blood glucose levels fall to this level should take 
action to increase their BG levels to avoid further complications.  Hypoglycaemia can be 
defined according to the severity of an episode.  Generally mild and moderate episodes of 
hypoglycaemia are grouped together as, in paediatric populations, parents will often 
support their child in treating both mild and moderate episodes of hypoglycaemia (30).  
Mild and moderate episodes of hypoglycaemia are those where BG levels fall to 
3.9mmol/L whether or not associated with symptoms.  Severe episodes of hypoglycaemia 
will often need to be treated with the help of another person. In paediatric cases as this is 
likely to be the norm for any episode of hypoglycaemia, a severe episode is generally 
recognised as an episode associated with severe deprivation of glucose in the brain 
(neuroglycopenia), leading to coma/convulsions (31).  Associated symptoms of 
hypoglycaemia include sweating, shaking, heart pounding and irritability (mild 
hypoglycaemia) and are usually easily treated.  However, in extreme circumstances, where 
a severe episode of hypoglycaemia occurs, this can lead to unconsciousness/convulsions 
and even death (32, 33).  Those suffering from hypoglycaemia can alleviate symptoms by 
taking a fast acting carbohydrate followed by a longer acting carbohydrate, for example 
drinking fruit juice followed by eating a digestive biscuit.  In more extreme circumstances, 
where a person becomes unconscious, they would need to be treated with an injection of 
glucagon, or intravenous glucose to increase BG levels (34).  Symptoms of hypoglycaemia 
can further be categorised as autonomic and neuroglycopenic (29).  Autonomic symptoms 
occur when hypoglycaemia triggers the autonomic nervous system which produces a 
physiological response that is interpreted by the individual as hypoglycaemia, for example, 
shaking, sweating, and anxiety.  Neuroglycopenic symptoms are a response to glucose 
deprivation in the brain and can lead to the more severe symptoms of hypoglycaemia, 
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including seizures, convulsions, coma and death (29, 35). Incidents of severe 
hypoglycaemia (SH), where a patient requires assistance to be treated, have been found to 
increase when patients attempt to maintain tight control of their diabetes (by maintaining 
optimum HbA1c levels of around 48mmol/mol).  HbA1c levels give clinicians an estimate 
of blood glucose levels over the previous few months, to get an overall picture of diabetes 
management (36). Therefore, those individuals who attempt to maintain a tight control of 
their BG levels can be at greater risk of experiencing hypoglycaemia and associated 
symptoms.  Other risk factors for hypoglycaemia include young age, a history of severe 
hypoglycaemia and loss of hypoglycaemia awareness (30).  
 
1.2.1 Frequency of hypoglycaemia  
The frequency of hypoglycaemia is difficult to determine, especially in children and young 
people.  This is due to a number of reasons, which will be discussed.  Documenting the 
frequency of hypoglycaemia often relies on the memory and recall of these events.  In 
young children then, this can be confounded by factors such as an inability to recognise or 
understand that they are experiencing hypoglycaemia, or difficulty verbalising this, 
especially if they experience mild hypoglycaemia.  Parents are often the source of 
information in these cases but again, their reports of hypoglycaemia are not likely to be 
accurate and they will more than likely report the more severe episodes of hypoglycaemia, 
as it is during these episodes that they may notice changes in their child’s behaviour. 
Therefore the prevalence or frequency of hypoglycaemia is likely to be under-reported for 
this age group.  Studies have attempted to use more stringent methods to try to identify 
how frequently hypoglycaemia occurs in younger children.  Tasker et al. (37) tried to 
overcome issues of recall by developing a technology based method of collecting data on 
mild hypoglycaemia.  Interestingly, for this study, mild hypoglycaemia was defined as 
either BG levels indicative of hypoglycaemia or experiencing symptoms of hypoglycaemia.  
Children aged between 7-18 years old were either asked to monitor hypoglycaemia on a 
daily basis using a paper diary, a computer based interview or mobile phone.  Researchers 
concluded that by using the technology based methods of data collection that there was a 
significant increase in reports of mild hypoglycaemia compared to previous reports.  This 
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supports the idea that experience of hypoglycaemia is likely to be higher than reports of 
hypoglycaemia. 
 
The frequency of severe hypoglycaemia is perhaps easier to determine than mild or 
moderate hypoglycaemia.  This is due to the fact that symptoms are more pronounced 
and obvious and often the child or young person will need significant help in treating such 
an episode, which in itself might make the incident more memorable.  Studies reporting 
on the frequency of severe hypoglycaemia in this population suggest that severe 
hypoglycaemia (characterised by a seizure, coma or severe impairment due to 
unconsciousness) is more prevalent in younger children than in adolescents (38).  This is 
not surprising considering older children/adolescents are more likely to recognise and 
treat a milder episode themselves, whereas younger children may rely on their parents or 
caregiver to recognise the symptoms and treat accordingly.  In a recent study, Johansen et 
al. (39) analysed patient records of children and adolescents with diabetes between 1998 
and 2009.  They found that the prevalence per se, of severe hypoglycaemia remained 
unchanged during the study period.  However, more intensive insulin regimens did seem 
to provide some protection from the incidences of severe hypoglycaemia.  These studies 
again reinforce the idea that mild, moderate and severe hypoglycaemia is prevalent 
amongst children and adolescents and therefore is a problem for those managing T1DM, 
further discussion follows below.     
 
1.2.2 The Diabetes Control and Complications Trial (DCCT) 
The Diabetes Control and Complications Trial (14) was a longitudinal trial carried out on a 
very large sample of diabetes patients and explored various aspects of diabetes and 
diabetes management in adults and adolescents.  1441 patients were assigned to either 
intensive (multiple daily injections (MDI/CSII)) or conventional (twice daily injections) 
diabetes therapy and were followed for an average of 6.5 years. The aim was to assess the 
beneficial outcomes of intensive therapy (MDI/CSII) on diabetes, which required patients 
to maintain optimum BG levels.  Long term hyperglycaemia (high BG) can lead to the 
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development of microvascular complications such as retinopathy (eye disease), 
nephropathy (kidney disease) and neuropathy (nerve damage).   These microvascular 
complications can ultimately lead to morbidity/increased risk of morbidity/mortality (14).  
Intensive therapy (MDI/CSII) was found to delay or slow progression of these 
complications, with a study specifically looking at an adolescent sample (18).  Although 
overall results of the DCCT showed that tight glycaemic control reduced microvascular 
complications, it was also reported that 65% of patients in the intensive treatment therapy 
(MDI/CSII) group suffered at least one episode of SH during the study, compared with only 
35% in the conventional (twice daily injections) therapy group (14, 40). Severe 
hypoglycaemia in this trial was defined as an episode which resulted in patients having BG 
levels below 50mg/dL and required assistance in treating their hypoglycaemia or episodes 
which required treatment using glucagon or intravenous glucose (40). Subsequent 
episodes of SH were predicted by previous experience of suffering from SH (40).   
 
In a review of hypoglycaemia in children, Jones and Davis (41) highlighted the effects of 
intensive therapy on the frequency of episodes of severe hypoglycaemia.    They reported 
that increased intensity of therapy in one clinic was linked to an increase from 4.8 
episodes of coma/seizures induced by hypoglycaemia/100 patient-years to 15.8 
episodes/100 patient-years (42, 43).  Allen at al.’s (44) study also investigated these 
effects.  They found that lower HbA1c, intensive insulin therapy and better control were 
linked to more frequent hypoglycaemia.  An association between SH and lower HbA1c was 
also found. 
 
As mentioned previously, the prevalence of hypoglycaemia in the UK CYP population is 
under-reported.  However, studies carried out in other countries also help to give an 
indication of the prevalence of hypoglycaemia for this particular group. One UK based 
study, carried out by Amin et al. (27) measured glucose levels in 28 under 12 year olds, 
over 3 days and 3 nights using the Continuous Glucose Monitoring System (CGMS).  
Hypoglycaemia was defined as glucose <60mg/dl for more than 15 minutes.  Results of the 
study indicated that 10.1% of all readings from participants fell within the study’s defined 
range of hypoglycaemia.  A comparison of conventional (twice daily injections) vs more 
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intensive regimens (not including pump therapy) suggested a high prevalence for those on 
conventional (twice daily injections) insulin regimens especially for nocturnal 
hypoglycaemia.  Those on intensive regimens also presented with high prevalence, 
however, more during the morning hours.  This study collected actual glucose levels for 
participants in order to identify those levels that typically indicate an episode of 
hypoglycaemia, which provides objective measurements of hypoglycaemia.  The sample 
size is small however and age range does not account for all CYP (the youngest patient was 
6.9 years old). Nevertheless, it does give a good indication regarding the problems that 
hypoglycaemia can present for CYP and their families.   
 
Katz et al. (25) carried out an observational study with 255 CYP, aged between 9-15 years. 
They collected prospective data on the incidence of severe hypoglycaemia (incidences 
requiring assistance from another/with seizure/coma) at quarterly time points, over a 
median of 1.2 years.   Overall, the incidence rate for severe hypoglycaemia in this CYP 
sample was reported as 37.6/100 patient-years (severe hypoglycaemia with seizure/coma: 
9.6/100 patient-years).  A limiting factor for this study was its observational design, but in 
order to collect data for a large cohort and over a lengthy period of time such a design was 
appropriate.  In comparison to the study carried out by Amin et al. (27) reports of severe 
hypoglycaemia in Katz et al.’s (25) study are largely subjective and based on severe 
hypoglycaemia being defined as an episode requiring assistance from another or with a 
seizure/coma.  While the latter part of the definition is clear, defining an episode of severe 
hypoglycaemia as an episode requiring assistance might not be as accurate for reporting 
severe hypoglycaemia.  In CYP samples especially, and specifically for pre-adolescent 
participants, parents may regularly provide support for their child suffering from 
hypoglycaemia and this could be whether that episode is severe or not.  Therefore reports 
of severe hypoglycaemia cannot always be trusted as accurate.  This being said, however, 
this is the case for many studies using an observational approach to studying prevalence of 
hypoglycaemia/severe hypoglycaemia and until a more standard definition is agreed there 
will be grey areas in reports. 
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A more recent study of the prevalence of severe hypoglycaemia explored incidence rates 
of severe hypoglycaemia in Western Australia, from 2000-2011.  Cooper et al. (26) used 
patient data collected from 1770 patients aged 0-17.8 years.  Severe hypoglycaemia in this 
study was defined as an episode of coma or convulsion resulting from hypoglycaemia.  
Overall, researchers found that the incidence of severe hypoglycaemia varied over the 12 
years.  The incidence of severe hypoglycaemia peaked in 2002 at 21.8/100 patient-years 
before showing a reduction on a yearly basis and then stabilising in 2006.  There was very 
little change from 2006 to 2011 where the incidence of severe hypoglycaemia was 
reported as 6.2/100 patient-years.  Again this study employed observational methods 
however, it also had access to an extremely large dataset over an extended period of time.   
Of note is the fact almost all children attending the participating hospital took part in the 
study so the results are taken from a representative sample.  Although cause and effect 
could not be determined from this observational study the authors conclude that there 
has been a decrease in the prevalence of hypoglycaemia over the past 12 years and there 
is also a weaker relationship between glycaemic control and risk of severe hypoglycaemia.  
Potential influencing factors are reported as an increase in pump therapy, improved 
education and increased glucose monitoring.  It is as important as it interesting for the 
current study to try to identify the prevalence of hypoglycaemia and severe 
hypoglycaemia for a UK sample, to assess whether this is a problem for the T1DM CYP 
population here.      
 
The long term consequences of hypoglycaemia have been studied widely in children and 
adults with T1DM.  The most commonly reported lasting effects of suffering from 
hypoglycaemia include impaired awareness and cognitive dysfunction.  These are 
discussed in more detail below with reference to relevant research studies. 
 
1.2.3 Impaired awareness 
Awareness of hypoglycaemia alters over time whereby the patient’s symptoms change or 
become weaker (45) due to experiencing frequent episodes of hypoglycaemia.  This can 
also result in an individual being unable to recognise that the physiological changes they 
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are experiencing are due to a fall in blood glucose levels.  Frequent experience of 
hypoglycaemia can eventually lead to hypoglycaemia unawareness meaning that a patient 
can lose the ability to detect the symptoms of low blood sugar.  Losing the ability to detect 
the symptoms of hypoglycaemia can be dangerous.  As well as the fact that the frequency 
of hypoglycaemia will likely increase, more worryingly, if an individual does not recognise 
the early signs of hypoglycaemia then that episode is likely to become more severe hence 
there will be an increased chance of severe hypoglycaemia.  Hepburn et al. (46) 
questioned 302 T1DM patients about awareness of the onset of hypoglycaemia and the 
symptoms of hypoglycaemia.  They found that loss of awareness of hypoglycaemia was 
associated with increased severe hypoglycaemia, suggesting a link between awareness 
and frequency of hypoglycaemia and consequently the occurrence of severe 
hypoglycaemia.   
 
Impaired awareness of hypoglycaemia (IAH) was investigated by Gold et al. (47).  They 
found that patients with IAH demonstrated a 6 fold increase in the frequency of severe 
hypoglycaemia.  Later studies also found that patients with reduced awareness of 
hypoglycaemia suffer from more moderate and severe episodes of hypoglycaemia (48, 
49).  A longer duration of T1DM has also been found to change the symptoms of 
hypoglycaemia (50) with T1DM children and adolescents displaying reduced autonomic 
symptoms (palpitations, anxiety) and increased neuroglycopenic symptoms (fatigue, 
confusion, seizures).  It seems that patients with impaired awareness of hypoglycaemia 
also report earlier onset of diabetes, are younger and have lower HbA1c (48).  Therefore, it 
is important for those with IAH to be taught how to recognise the early warning signs of 
hypoglycaemia, in order to reduce the likelihood of the occurrence of severe 
hypoglycaemia.  It should be noted, however, that where symptoms actually change or 
weaken these effects can be reversed by consistent avoidance of hypoglycaemia over a 
number of weeks (29).   
 
Comparison of patients with and without hypoglycaemia unawareness has also revealed 
differences in cognitive dysfunction.  Gold et al. (51) found those T1DM patients with 
hypoglycaemia unawareness displayed more abnormal cognitive function during an 
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episode of hypoglycaemia and following BG recovery than those without hypoglycaemia 
unawareness.  They recommended that skilled tasks should not be carried out for at least 
30-40 minutes following BG levels returning to normal. One explanation for Gold et al.’s 
(51) findings is that those who with IAH experienced a greater number of episodes of 
hypoglycaemia which therefore impacted on their cognitive functioning.  Such evidence 
goes some way in explaining another long term consequence of hypoglycaemia; cognitive 
dysfunction. 
 
1.2.4 Cognitive dysfunction 
Many studies of T1DM report that hypoglycaemia can have a negative effect on cognitive 
functioning (41, 52-56).  The human brain relies on a source of glucose in order to function 
optimally (52).  Lack of glucose to the brain can lead to cognitive dysfunction, coma and 
seizures, as a result of hypoglycaemia. Reports suggest that the young  are more 
susceptible to the symptoms of hypoglycaemia due the fact that glucose deprivation in the 
brain (neuroglycopenia) may occur at higher glucose levels than in adults (57).  Although 
there are no official reports highlighting what these levels are, studies do report a 
difference between age groups.  Jones et al. (58) compared the glycaemic thresholds of 
hypoglycaemia symptom onset between adolescent T1DM patients and non-diabetic 
adults. Results showed that these glycaemic thresholds were much higher for younger 
participants (4.9mmol.l vs 3.1mmol/l) suggesting that there is a difference in the way that 
glucose deprivation is experienced by these two distinct groups.  Research, however, has 
primarily been conducted with adolescent vs adults and does not explore the difference 
between younger and older children (48). The impact of hypoglycaemia on cognitive 
functioning in children with early onset T1DM can be especially concerning. This group 
inevitably experiences more severe hypoglycaemic events due to their reduced ability at 
recognising or communicating the symptoms of hypoglycaemia in order for swift 
treatment. The fact that those with early onset T1DM have also been diagnosed at an 
early age means that they are likely to have experienced a greater number of episodes of 
hypoglycaemia than those diagnosed later in life.  
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Conversely, the negative effects of hyperglycaemia on cognitive functioning have also 
been reported (53, 59, 60).  Perantie et al. (53) studied the effects of both hypoglycaemia 
and hyperglycaemia on cognition.  Their findings indicate that extreme BG levels (high or 
low) contribute to differing effects on cognitive functioning.  Hyperglycaemia was found to 
affect verbal intelligence of CYP with T1DM whereas hypoglycaemia had an impact on 
spatial analysis and was linked with a delay in recall of learned information.  This study will 
be discussed in more detail below.  For the purposes of this study the focus will remain on 
the effects of hypoglycaemia on cognitive functions of CYP. 
 
As previously mentioned, Perantie et al. (53) compared 117 T1DM children (aged 5-16 
years) to their non-diabetic siblings (N=58) on cognitive performance.  Children who had 
been diagnosed with diabetes before the age of five performed significantly worse on 
spatial relations than any other group.  These children were also found to suffer more 
frequent episodes of hypoglycaemia, which highlighted how tight control can adversely 
affect a child’s cognitive development. The outcomes of this study should be treated 
cautiously, however, as the retrospective nature of the design does not allow any 
conclusions to be drawn regarding cause and effect.  The sample used in this study was 
broken down into smaller sub groups which could have also had an impact on the 
analyses.    
 
Conflicting evidence is reported by Strudwick et al. (61), who investigated the association 
of severe hypoglycaemia in young children with early onset T1DM with cognitive 
abnormalities.  For this study, severe hypoglycaemia was defined as prior hypoglycaemia 
seizure/coma. The study compared three groups of diabetic children and adolescents who 
were diagnosed aged <6 years; one group had a history of severe hypoglycaemia at age<6 
years; another group experienced their first severe hypoglycaemic episode after the age of 
6 years; the last group was the T1DM control with no history of severe hypoglycaemia.  
Interestingly, no significant differences were detected between any of the groups on 
intellectual, memory or behavioural measures. Severe hypoglycaemia, in this study, was 
characterised only by episodes of seizures or coma and didn’t take into account severe 
hypoglycaemia without these events.  Including a wider range of episodes of severe 
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hypoglycaemia might have made a difference to the strength of relationships however, 
researchers would then have had to rely on retrospective and subjective data. 
Additionally, the small sample size may have impacted on this study’s ability to detect any 
significant results, although the researchers of this study stress that similar studies have 
also used comparable sized samples.   
 
Ho et al. (62) used a similarly matched sample of diabetic children (those with a history of 
SH vs those without a history of SH) diagnosed with diabetes <6 years.  Again, severe 
hypoglycaemia here was defined as a seizure/coma resulting from severe hypoglycaemia.  
Magnetic resonance imaging (MRI) was used to compare structural differences in the 
brain, between groups. Although significant differences were not found between the 
groups, the results of this study indicated that early onset T1DM was associated with 
central nervous system (CNS) abnormalities. Specifically, mesial temporal sclerosis (MTS) 
was evident in the entire cohort.  MTS is unusual in those without seizure disorders so its 
presence in itself was an interesting finding.  The implications of MTS on the brain are 
damage to the hippocampus, leading to long term memory deficits and problems with 
cognitive functions. MRI in children can be problematic due to the fact that these tests 
require participants to lie very still, in a confined space, albeit for a short period of time. 
This may have impacted on the quality and usability of the MRI scans (63).  However, the 
study did objectively examine the structural effects of severe hypoglycaemia on the brain 
of this sample of children. 
 
In spite of research which has focused on the link between severe hypoglycaemia and 
cognitive dysfunction, the topic remains controversial.  McNay and Cotero (52) carried out 
a mini-review of research specific to the impact of recurrent hypoglycaemia.   Their review 
looked at both human and animal studies and concluded that recurrent hypoglycaemia 
seemed to induce a positive brain response whereby an increased supply of fuel was 
directed to the brain, so that cognitive functions were supported rather than impaired.  
The authors however, also acknowledged that whilst the brain seemed to protect against 
hypoglycaemia, previous experiences of hypoglycaemia can interfere with the body’s 
ability to deal with further episodes of hypoglycaemia.  Paired with the fact that recurrent 
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hypoglycaemia also impacts on awareness of hypoglycaemia, there are still major 
implications of hypoglycaemia on those who are affected.  
 
1.2.5 Dead in bed 
One of the most worrying consequences of hypoglycaemia, although also the least 
common, is dead in bed syndrome (64).  Before discussing dead in bed further, nocturnal 
hypoglycaemia and associated anxiety will be discussed. 
 
Hypoglycaemia during sleeping hours can be a source of particular stress for both CYP with 
T1DM and also their parents because nocturnal hypoglycaemia can often go undetected 
by patients (32, 65).  Previous studies suggest that the incidence of nocturnal 
hypoglycaemia is in excess of 40% (66, 67).  Research has shown how episodes of 
hypoglycaemia and severe hypoglycaemia can impact on the daily lives of those with 
T1DM.  However, the threat of experiencing hypoglycaemia when asleep and the potential 
implications can be extremely worrying.  Parents and CYP are unlikely to know about the 
many potential contributors of nocturnal hypoglycaemia considering the fact that it is, 
arguably a different construct to hypoglycaemia experienced in the day (32).  In her paper 
on nocturnal hypoglycaemia in children with T1DM, Matyka (32) suggests that daytime 
hypoglycaemia may differ from nocturnal hypoglycaemia due to a number of factors.  
Firstly, the period of sleep reflects the longest period of fasting for CYP, which will 
inevitably impact on their BG levels.  The characteristics of nocturnal glucose homeostasis 
(32), physiological changes accompanying the stages of sleep (68) and changes in counter 
regulatory responses overnight (69), all contribute to how the body reacts to a fall in blood 
sugar and do so differently when we sleep. Paired with the difficulty of managing insulin 
delivery during the night suggests that there are differences between daytime and 
nocturnal hypoglycaemia. Anecdotal evidence suggests that nocturnal hypoglycaemia and 
associated worry of dead in bed syndrome are very real worries for CYP and parents.     
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Tattersall and Gill’s 1991 (64) study analysed the deaths of 50 diabetic patients and 
concluded that 22 out of the 50 had suffered what they coined as ‘dead in bed’ syndrome.  
These patients were found dead, in undisturbed beds having gone to bed feeling well.  
Similar reports have been reported for other unexplained nocturnal deaths of diabetic 
patients.  Koltin and Daneman (70) report a case of a 14 year old girl with T1DM.  This girl 
was relatively well, with fair glycaemic control and blood glucose levels within the target 
range the evening before she died.  Although some brain pattern and glucose levels 
appeared to suggest hypoglycaemia, results were not conclusive and hypoglycaemia could 
not be given as the cause of death.  This suggests that contrary to likely worries about 
nocturnal hypoglycaemia, these patients did not seem to have experienced a nocturnal 
hypoglycaemia related seizure.  A number of contributory factors, other than 
hypoglycaemia have been suggested as possible causes of these unexplained deaths, for 
example, a cardiac event (caused by hypoglycaemia, rises in adrenaline and falls in 
potassium (resulting from hypoglycaemia) and autonomic neuropathy (whether severe or 
not) (71).   It seems unlikely, given the fact that nocturnal hypoglycaemia can occur 
frequently, without a patient even realising, that hypoglycaemia alone is the sole reason 
for dead in bed syndrome.  Incidence rates of dead in bed are not particularly high; 
accounting for between 2-6% of all T1DM deaths (71).  However, this does not preclude 
hypoglycaemia from being a trigger to this unexplained phenomenon.   
 
So, although rare, the ambiguity of the causes of dead in bed syndrome leave parents and 
CYP with a sense of doubt and therefore, fear of experiencing hypoglycaemia in the night.  
This fear however, isn’t confined to only nocturnal hypoglycaemia, as will be discussed 
next.  
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1.3 Fear of hypoglycaemia in children and young people (CYP) 
and parents 
Considering that the symptoms and potential outcomes of hypoglycaemia can be 
extremely distressing, it is no wonder that patients can develop a fear of hypoglycaemia 
(FoH) and try to avoid this state by maintaining higher BG levels (72). Higher BG levels 
seem to have no immediate consequences but in the long term can lead to microvascular 
complications, leading to morbidity or mortality. Nordfelt and Ludvigsson (73) reported 
that SH with unconsciousness causes more fear in patients than does the development of 
possible later complications of diabetes mellitus, which suggests important implications 
for diabetes management.  Despite the apparent need for further research into FoH in the 
paediatric population, studies are limited in number. Although there is some focus on 
research into FoH in adolescents and children (72, 74), much of the research on these age 
groups looks at parental FoH (72, 75-78).  As with studies in adult diabetes patients, 
paediatric studies have shown that FoH is linked with past experiences of hypoglycaemia 
(72, 79, 80) and can have consequences for long term management of the condition.   
 
1.3.1 The Hypoglycaemic Fear Survey 
The Hypoglycaemic Fear Survey (HFS), adapted for use by children and parents (75), is 
commonly used to assess the presence of FoH in the paediatric population.  Green et al. 
(79) evaluated the use of this measure in children and adolescents and reported good 
validity and internal consistency reliability.  Importantly, this longitudinal study also 
identified the transient nature of FoH, which suggests that FoH actually changes over time 
and is not a stable construct.  This significant finding suggests that potentially a number of 
factors could contribute to FoH, and any variation in contributory factors will impact on 
FoH in individuals.  It is therefore important to identify stressors and try to reduce these, 
in order to try to reduce FoH and allow CYP to maintain optimum BG levels. Reviews of 
subsequent studies looking at the HFS as a measure of FoH (74, 81) showed that the 
measure was found to have good internal reliability, good validity and researchers were 
able to evaluate interventions aimed at reducing FoH by comparing HFS scores before and 
after the intervention. 
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The prevalence of FoH is difficult to determine, considering that it is a transient construct.  
However, FoH studies worldwide have been carried out in the paediatric population with a 
view to understand FoH, contributory factors, impact of FoH on CYP’s lives and 
interventions aimed at reducing FoH. 
 
1.4 Predictors of fear of hypoglycaemia 
Diabetes researchers have tried to identify whether or not fear of hypoglycaemia can be 
predicted.  Implications for such findings could help to improve diabetes management in 
those affected. 
 
1.4.1 Severe hypoglycaemia as a predictor of fear of hypoglycaemia 
Irrefutably, the majority of studies investigating FoH regard previous experience of 
hypoglycaemia, specifically severe hypoglycaemia, to be a contributory factor.  Irvine et al. 
(80) studied the impact of hypoglycaemia on fear in adult patients using the HFS. They 
found that scores on the HFS correlated positively with stress and previous experience of 
hypoglycaemia.  This was reflected in similar studies which all highlighted the key 
relationship between FoH and previous experience of hypoglycaemia (82).  Reports from 
studies focusing on the paediatric population also suggest that a history of hypoglycaemia 
is consistent with incidence of FoH (72, 74, 83).  Gonder-Frederick et al. (72) investigated 
predictors of FoH in an adolescent group (and their parents).  Researchers collected data 
on the experience of moderate and severe hypoglycaemia, FoH, anxiety and HbA1c.  
Results indicated that previous experience of severe hypoglycaemia significantly predicted 
higher FoH in this paediatric group, however, there were no significant links found 
between FoH and metabolic control.  This conflicts with studies that suggest higher FoH 
levels can contribute to poor diabetes management (higher BG levels) and consequently 
impact on long-term health outcomes (76, 83, 84).  Parental FoH for this sample was 
predicted by whether parents believed that their child carried emergency glucose with 
them.  Again there was no significant relationship between adolescent HbA1c and parental 
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FoH.  Gonder-Frederick et al’s (72) study was limited in that only 39 parent-child dyads 
took part in the study and only one of these was a father-child pair.  Researchers 
suggested that a larger sample might find stronger relationships between the collected 
data.   
 
As mentioned earlier, fear of hypoglycaemia in paediatric and adolescent diabetes is 
reported by patients’ parents.  Studies show that parental FoH for their child can actually 
be greater than adult patients have for themselves.  This was demonstrated in a study of 
mothers of children with T1DM by Clarke et al. (75) who found that mothers of children 
who had episodes of SH with unconsciousness scored highly on the HFS.  Studies 
examining parental FoH in parents of adolescents have produced contrary results, to those 
in young children.  Gonder-Frederick et al. (72) found that although adolescents with a 
history of SH with unconsciousness had higher HFS scores and higher HbA1c than those 
with no history, this did not translate over to their parents.  The only predictor of parental 
FoH in this study was whether their child carried emergency glucose or not. This suggests 
that parents were less fearful if they believed their child was equipped to treat an episode 
of hypoglycaemia. It also indicates that parents of adolescents might be less fearful than 
parents of younger children because they might believe that their older children are more 
likely to be able to treat hypoglycaemia than younger children.  This is supported by the 
work of Hawkes et al. (84) who reported that FoH was highest amongst parents of 6-11 
year olds. However, Hawkes et al. (84) therefore, also reported that FoH in parents of 6-11 
year olds was higher than younger age groups.  This is surprising, however, with further 
thought it could be that parents of primary age children have a greater fear because they 
feel their child is not old enough to take complete responsibility for managing 
hypoglycaemia, but it is also at this age where parents potentially lose the control that 
they may have had before their child started school (85).  Parents are most likely to be the 
main caretakers of children younger than primary age and therefore might feel less fear 
because their child is with them the majority of the time.     
 
Although Gonder-Frederick et al.’s (72) study aimed to examine parental FoH, only one 
father participated, therefore results can only be applied to maternal FoH.  In studies 
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comparing mother and father reports of FoH, however, mothers reported higher FoH than 
fathers (86).  Overall, higher parental HFS worry scores were associated with higher HbA1c 
levels and a higher frequency of problematic hypoglycaemia.  This illustrates that although 
mothers are likely to be the main caregivers (87) and therefore might report higher FoH 
levels than fathers, fathers also report FoH.  
 
1.4.2 Anxiety as a predictor of fear of hypoglycaemia 
Another variable commonly associated with FoH is anxiety, in both CYP and parents. 
Gonder-Frederick et al. (72) reported trait anxiety to be a predictor of FoH in adolescents, 
however, found no such relationship between parental trait anxiety and FoH.  Herzer et al. 
(88) also reported a significant association between anxiety in adolescents and sub-
optimal management of diabetes, suggesting that anxiety may be linked to 
hypoglycaemia-avoidance behaviours (as measured by the HFS measure).  Jaser et al. (89) 
reported significant links between maternal FoH and maternal state anxiety in mothers of 
children aged less than 8 years old and more recently Pate et al. (87) found significant links 
between maternal and paternal FoH and trait anxiety (in parents of children aged 7-17 
years).  These findings suggest that FoH may be influenced by how anxious an individual is, 
which could have implications for reducing FoH and diabetes management.  However, as 
these studies are cross-sectional in design it is not possible to conclude what the cause 
and effect are. 
 
1.5 Impact of fear of hypoglycaemia   
The impact of FoH on diabetes management has already been mentioned.  This will be 
discussed further.  There are a number of other ways in which FoH can impact on both 
CYPs’ and their parents’ lives. 
 
1.5.1 Fear of hypoglycaemia and diabetes management  
There has already been some discussion of the association between FoH and BG levels 
suggesting that those with higher FoH also report higher BG levels, potentially as a result 
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of trying to avoid hypoglycaemia (83, 84).  Anecdotal reports suggest that patients (or 
parents) will try to avoid hypoglycaemia, as a result of their fear, by maintaining higher 
than optimal BG levels.  In a case study reported by Matyka (90) diabetes management of 
a 12 year old girl with no history of severe hypoglycaemia was managed by her mother, 
who had witnessed severe hypoglycaemia in her ex-partner.  This had led to anxiety and 
fear in the mother who consequently managed her daughter’s diabetes by maintaining 
higher BG levels, eventually resulting in the early stages of diabetic retinopathy.  This case 
study goes some way in illustrating the impact that FoH can have on patients and their 
families.  
 
Marrero et al. (91) wanted to address the impact of parental FoH on children and 
adolescents with diabetes.  They referred to parents’ suboptimal management of their 
child’s diabetes i.e. maintaining high BG levels in order to avoid hypoglycaemia and reduce 
their own FoH, as an example of negative reinforcement (carrying out behaviour in order 
to reduce a particular outcome). This hypothesis was supported by the fact that children of 
parents with greater FoH had a greater percentage of self-monitored blood glucose 
(SMBG) values above the target range.  Young children who had experienced a sudden loss 
of consciousness (SLC) due to a SH had significantly higher BG values than those with no 
SLC history.  This is despite the fact that there were no significant differences in the 
percentage of SMBG results below the specified range.  Results here suggest that parents 
might have been maintaining high BG levels in their children in order to avoid 
hypoglycaemia.  Patton et al.’s (76) research supports this suggestion.  They found that the 
HFS Behaviour scores of parents of young children treated with continuous subcutaneous 
insulin infusion (CSII) correlated positively with HbA1c 3 months after study enrolment.  
They also found a significant positive association between parent Worry scores and child’s 
daily BG control. These results show that higher parental HFS behaviour and worry scores 
indicate higher blood sugar levels, which could suggest that parents with higher FoH are 
those who also maintain higher BG levels in order to avoid hypoglycaemia in their child 
(78). 
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Similar reports were presented in studies looking at the analysis of cohorts of children and 
adolescents together (87, 92). Higher parental HFS worry scores were associated with 
higher HbA1c and higher frequency (≥7) of problematic hypoglycaemia in CYP aged 1-15 
years (86). The perceived impact of FoH on diabetes management suggests there may be 
an impact on self-care behaviours.  However there is a paucity of research looking at 
diabetes self-care and FoH. 
 
Although the above reports indicate a link between FoH and HbA1c, these findings are 
inconsistent.  A number of studies have been unable to find an association between FoH 
and HbA1c (75, 79).  These inconsistencies may be explained by the fact that HbA1c is in 
itself is likely to be impacted by a number of variables such as hormones, puberty (during 
puberty, insulin action can decrease by 30%-50% therefore, an adolescent’s HbA1c may be 
affected by these changes (93) and even the weather (warmer months have been linked to 
lower HbA1c and vice versa (94).  Therefore, it is difficult to conclude that even where 
significant relationships have been reported that there are no other attenuating factors 
impacting on this relationship.  
  
Interestingly, Stallwood (95) found greater perceived diabetes related stress was related 
to better metabolic control.  It seems then for some parents, trying to maintain optimum 
BG levels in their children can trigger stress which worryingly suggests that parents of 
children with T1DM suffer from anxiety and stress whether they are achieving tight control 
of diabetes management or not.  The impact of diabetes on parents will be discussed 
further later in this chapter. 
 
1.6 Detection of hypoglycaemia by parents 
It is important to note that detection of an episode of hypoglycaemia in children, by their 
parents, is not always accurate.  Therefore, parents could either mistakenly correct 
hypoglycaemia or not recognise the symptoms of low BG levels, leading to SH.  Incorrect 
detection could lead to hyperglycaemia or an increased number of episodes of severe 
hypoglycaemia, which is a predictor of FoH.  Bognetti et al. (38) interviewed patients and 
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parents about the occurrence of SH over a 3 year period.  They found that the number of 
episodes of hypoglycaemia decreased significantly with increasing age.  Therefore, it 
seems that the risk of severe hypoglycaemia was higher in young children than in 
adolescents.  One explanation for this is that parents might not always have been 
successful at detecting hypoglycaemia in their younger children and so were unable to 
treat hypoglycaemia appropriately.  In order to detect hypoglycaemia in younger children, 
who may not themselves be able to recognise the symptoms and inform their parents, 
parents need to be aware of physical symptoms of hypoglycaemia e.g. mood changes, 
sweating, shaking.  Gonder-Frederick et al.’s (72) field study found that children aged 6-11 
years failed to correctly identify hypoglycaemia a large proportion of the time.  Such 
findings only add to the burden and stress on parents of CYP with T1DM.   
 
1.7 Parental anxiety and diabetes  
Parental anxiety is especially evident in mothers of young children with T1DM (89, 95).  
Jaser (89) reported that mothers of young children (aged less than 8 years old) with T1DM 
were found to have clinically significant levels of anxiety and depression.  These symptoms 
were typically linked to feelings of being unable to cope with their child’s diagnosis and 
were related to maternal FoH, however, they were not associated with glycaemic control.  
Anxiety experienced by fathers of young children with T1DM does not appear to be as 
common (96). Paternal stress was correlated with fathers’ lower self-efficacy, high FoH 
and higher state anxiety.  This suggests that for fathers there is a link between high FoH 
and high anxiety. 
 
Although much of the research into parental anxiety concerns parents of young children 
with T1DM, maternal anxiety in mothers of adolescents with T1DM is also reported (92).  
Links between maternal trait anxiety and higher HbA1c were reported for mothers of 
younger adolescents.  This suggests an association between high anxiety and CYP HbA1c.   
As stated previously, research looking at the link between parental FoH and CYP HbA1c is 
inconclusive; however, parental anxiety might also play a role in this association and 
should be investigated further.  Moderate levels of anxiety and stress might actually 
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mediate the levels of FoH and be motivating factors in achieving good glycaemic control 
(95), however at some point excessive stress/anxiety might be maladaptive in diabetes 
management.  Recent research supports the idea of FoH, anxiety and glycaemic control 
being related, for parents of CYP with T1DM (87). It will be interesting to investigate this 
relationship further. 
 
1.8 Additional effects of T1DM on parents of CYP with T1DM  
Aside from anxiety and FoH parents seem to suffer from additional psychological effects as 
a result of their CYPs’ diabetes.  The effects of diabetes on parents are apparent from 
diagnosis (97).  There is a huge impact from learning that your child has a chronic illness. 
 
As a result of the often sudden onset of T1DM and resulting threat that the condition 
presents, studies report the presence of post-traumatic stress disorder (PTSD) in parents 
of young children newly diagnosed with T1DM.  A pilot study by Landolt et al. (98) found 
that 24% mothers and 22% fathers met the full diagnostic criteria for current PTSD, using 
self-report measures. Based on the outcomes of the pilot study Landolt et al.’s (99)  
prospective study supported reports of PTSD for mother and fathers.  Results also showed 
that the number and severity of parental PTSD decreased in the 12 months after the 
child’s diagnosis. 
 
However, PTSD diagnoses should be made with caution, especially when using self-report 
measures. Using a structured clinical interview, Stoppelbein and Greening (100) found that 
only seven per cent of their sample of mothers of children diagnosed with T1DM met the 
criteria for PTSD.  Researchers suggested that previous studies may have reflected acute 
stress symptoms rather than PTSD, given that others were assessed a month after their 
child’s diagnosis.  
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Following diagnosis, parents may experience further psychological difficulties in coping 
with their child’s illness.  Considerable research has been conducted on the mothers, 
usually the primary caregivers, of CYP with T1DM and the impact that their child’s 
diagnosis has on them (92, 101-103). The burden of the responsibility of care for their 
child is often overwhelming for mothers and seems to continue from diagnosis and 
beyond (104).  Bowes et al. (105) explored the long-term impact of CYPs’ diabetes 
diagnosis on parents.  They found that even in the long-term mothers had not necessarily 
accepted their child’s diagnosis and still felt the emotions that they had felt when their 
child was first diagnosed, such as, grief and anger.  Fathers too reported these feelings.  
Bowes et al. (105) confirmed the existence of chronic sorrow in parents of children with 
T1DM, an intermittent experience of grief, which highlights the impact of diabetes on 
parents.  Similarly, in another qualitative study with mothers of children with T1DM, 
Sullivan-Bolyai et al. (101) reported that mothers had an overwhelming amount of 
responsibility for the care of their children and there was often no break from the constant 
diabetes care they had to provide. 
 
The constant pressure and burden on parents of children with T1DM will naturally have 
implications for parents’ health and well-being; both physical and mental.  This adds to the 
impact that T1DM can have on the families of children diagnosed with the condition. 
 
1.9 CYP quality of life and diabetes 
It is important to assess quality of life (QoL) and its association with T1DM.  As a chronic 
disease, T1DM is likely to have a big impact on the day to day lives of patients.  Assessing 
how the illness impacts on diabetic CYPs’ QoL may allow us to understand the 
psychological impact of living with diabetes.  It could help to identify the best way of 
managing the illness in a way that QoL is not compromised or if it is then at least to a 
minimum.  
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Kalyva et al. (106) reported that CYP had lower general health-related QoL than matched 
healthy participants.  Later onset, less hyperglycaemic episodes, lower HbA1c, older age 
and male gender were associated with better diabetes-specific health-related QoL.  
Parents reported diabetes had a greater effect on CYPs’ lives than CYP reported 
themselves suggesting that parents potentially worry more about the impact of diabetes 
and consequently attribute more weight to the impact of diabetes on their children.  As 
previously reported, the impact of diabetes on parents is great and so might reflect on 
their impressions of their child’s QOL (101, 104).  
 
The association between QoL and metabolic control has been explored in a number of 
paediatric studies however results have been largely inconclusive.  It was the international, 
multi-centred HvidØre study group (107) who were able to explore this relationship on a 
large scale.  Results indicated that better metabolic control was associated with better QoL 
in adolescents.  Although the study cannot infer cause and effect it does have important 
implications for the management of diabetes for this age group.  The findings were 
unprecedented on such a large scale and further exploration might clarify the role of QoL 
in diabetes management.  Subsequent studies also supported reports of the link between 
QoL and metabolic control (108-110) which suggests that QoL is an important factor in 
living with diabetes.  
 
Johnson et al. (83) explored the relationship between QoL and fear of hypoglycaemia.  
Results suggest that increased FoH relates to a lower QoL in CYP with T1DM.  Interestingly, 
even parents with higher FoH reported lower QoL for their children. This is yet another 
aspect of the impact that diabetes can have on QoL.  However, again cause and effect 
cannot be inferred from cross-sectional data, and largely research in this area is not 
designed to overcome this issue. 
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Interventions aimed at intermittently measuring QoL in CYP and addressing any issues, do 
show improvement in health-related QoL of CYP with diabetes (111).  Similarly, 
adjustments to insulin regimen have also shown an improvement in the reported QoL of 
CYP (13, 112).  Considering the impact that diabetes has on QoL in CYP (and potentially 
vice versa), it is important to acknowledge the ways in which it might be improved. 
 
1.10 CYP self-care and diabetes 
Although CYP self-care behaviours are vital to achieving optimal glycaemic control, there 
seems to be a lack of research in this area.  This is reflected in Hood et al.’s (113) meta-
analysis of studies looking at the association between adherence and glycaemic control in 
CYP with T1DM.  Their findings showed that as adherence to diabetes-related self-care 
behaviours increases, HbA1c levels have been shown to decrease (across studies between 
1950 and 2008). 
 
Given the implications of increased adherence on glycaemic control, improving or 
sustaining adherence to self-care diabetes should be encouraged amongst CYP with T1DM.  
La Greca et al. (114) reported that increased adherence was related to support from 
friends and family for both practical and emotional aspects of diabetes management.  
Although supported by later studies which reported that parental monitoring of self-care 
behaviours also improved glycaemic control in adolescents (115), conflicting results have 
also been reported.  Shroff Pendley et al.’s (116) research suggested that adolescent 
perceived support (from peers) did not correlate positively with metabolic control (as 
measured by HbA1c), suggesting that peer support in adolescence might not be conducive 
to adherence to diabetes-related self-care.  Importantly, in the case of family support, 
increased diabetes conflict (areas of family conflict in diabetes management tasks) is a key 
predictor of poor metabolic control (117).  Therefore, optimal self-care behaviours appear 
to be achieved by increased family/parental support and reduced familial (diabetes-
related) conflict.  
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Links between the fear of hypoglycaemia and poor metabolic control suggest that FoH 
may have an impact on self-care behaviours (83, 84).  A reduction in FoH was reported for 
those CYP who were able to manage their diabetes independently, albeit with social 
support, following repeated attendance at a diabetes camp (118). This suggests that there 
is an association between diabetes self-care and FoH.   
 
1.11 Qualitative research  
Qualitative research allows exploration of data at a deeper level.  It can often provide 
richer information, which otherwise might be difficult to attain. Qualitative data for CYP 
with T1DM is limited however, it is supported by research with parents of CYP with T1DM.  
Often the primary caregivers, parents are able to report on CYPs’ experience of diabetes, 
as well as their own.  Qualitative research for both CYP and parents has concentrated on 
various areas including living with diabetes (119-124), diabetes management (125-127), 
impact of diabetes (101, 104, 105), fear of hypoglycaemia (65) and insulin regimens (128-
130). 
 
Parents’ experiences of their child’s diabetes have been explored to clarify how the 
diagnosis of a chronic condition affects them.  Research highlights the many issues parents 
seem to face as a result of their child’s diagnosis.  Flynn’s paper on parental coping 
highlighted the issues that parents of CYP with T1DM face (104).  A key issue was the 
responsibility parents have for their younger child’s diabetes care, which can often be an 
overwhelming prospect.  As their child approaches adolescence there is then a need for a 
shift in responsibility to the young person so that they can approach their own care 
independently.  This can be a source of anxiety for parents who might struggle in letting go 
of the responsibility of diabetes care for their child.  Parents report feelings of anxiety, 
upset and distress (105) as well as being burdened with the responsibility for their child’s 
health (125).  Bowes et al. (105) conducted in depth interviews with parents of CYP with 
T1DM.  These parents reported feelings of grief and guilt up to 10 years after their child’s 
diagnosis with some parents becoming visibly distressed when recalling this period.  
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Bowes et al’s (105) findings highlight the profound long term effect that T1DM can have 
on parents and support the notion of ‘chronic sorrow’ in this group.  ‘Chronic sorrow’ 
refers to recurring feelings of sadness, resurfacing amongst seemingly ‘normal’ and happy 
periods, with no endpoint.  Triggers at certain timepoints caused parents to experience 
the sadness they had experienced when their child was initially diagnosed.  Although this 
study included both mothers and fathers, researchers reported that fathers were less 
likely to talk about their emotions.  The fundamental learning point was the lack of 
emotional support provided to parents who continue to experience these feelings of grief, 
years after their child is diagnosed.  This highlights the need for ongoing emotional 
support for these mothers and fathers.  
 
Smaldone et al. (125) investigated parental perspectives of a T1DM diagnosis in parents of 
children diagnosed aged 5 years or younger.  Parents reported feeling overwhelmed with 
the responsibility of care as well as feeling isolated from friends and family who did not 
understand what they were going through.  This aspect of feeling overwhelmed and being 
given responsibility for the daily medical care of your child reoccurred throughout many of 
the qualitative studies (101, 105, 128) which again highlights the impact of living with a 
child with T1DM, on their parents. 
 
Studies focusing on parents and children as a family unit report interesting results.  CYP 
and parents were reportedly affected to differing degrees by T1DM, three years after 
diagnosis.  Wennick et al.’s (122) longitudinal study found that at three years post 
diagnosis, children and their parents felt that they had successfully integrated diabetes 
management into their day to day lives.  Parents tried to encourage independent 
behaviour with regards diabetes management in their children, whereas CYP were quite 
happy for their parents to assume responsibility for their care.  Other studies explored the 
conflict between parent and child in terms of autonomy and diabetes management (121, 
123). Ivey et al. (121) found that parents reported worrying about future complications 
and did not want any regrets later in terms of how they or their child had managed their 
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diabetes.  Parents also seemed frustrated with the lack of optimal diabetes control that 
young people displayed whereas young people were similarly frustrated when their 
parents did not notice when they did do things well.  On a similar note, Spencer et al. (123) 
found that when parents tried to ‘let go’ and give their children the responsibility of 
managing their diabetes, that this resulted in poor self-management.  Conflicting priorities 
and feeling self-conscious were often blamed as reasons for less than optimal diabetes 
care. Using qualitative methods, researchers were able to further explore the feelings and 
emotions of CYP who were trying to move towards being more independent but whose 
parents’ diabetes-related fears made this difficult.  Other studies report on the shared 
experiences of diabetes between families at different stages of living with diabetes; the 
fact that the condition has a significant impact on both parents and children (4-17 year 
olds) (124).  For example, there were references to the effects of treatment on both the 
parent and the child.   Both parent and child reported the difficulty associated with the 
painful injections with children reporting the pain they felt receiving them and parents 
reporting the pain they felt administering them.  Although their lives had changed, both 
parents and children tried to make adjustments so that life was ‘normal.’  In their review 
of qualitative studies with adolescents, Spencer et al. (120) systematically evaluated all 
such research conducted between 1988 and 2008.  By integrating the results of 
appropriate studies, four sets were identified.  These indicated the most common findings 
and were made up of (i) independence and autonomy for diabetes management; (ii) living 
with T1DM; (iii) family relationships and (iv) diabetes care.  Bearing in mind that the 
findings of the systematic review were limited to studies published in English and that 
there were gaps in some of the papers, authors concluded that, for adolescents, some of 
the key topics of concern were the struggle for autonomy and taking responsibility for 
diabetes management (120).  These struggles were reduced somewhat through peer 
understanding, parental support and encouragement of autonomy.  Qualitative research 
on the subject of the fear of hypoglycaemia is limited.  Scott’s (65) doctoral thesis explored 
FoH in mothers of children aged 9-10 years.  The clear message from mothers was that 
hypoglycaemia was indeed a large source of worry.  They feared the worst and worried 
that their child would not wake up from an episode of hypoglycaemia.  There were 
references to anxiety at being away from their child as well as feelings of guilt and 
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sadness. Although carried out with only four mothers, this in-depth account of FoH is key 
in qualitative research as it is the first to address FoH in parents and inspires further 
research to understand the true impact of FoH on families and CYP. 
 
1.12 Current research study  
Given that research in the T1DM paediatric population is relatively limited in the UK, this 
study will focus on CYP and their parents in order to understand how living with diabetes 
impacts on them. 
 
The aims of the current study are to establish the prevalence of hypoglycaemia, and 
consequently fear of hypoglycaemia in this UK sample.  This is an exploratory, 
observational, cross sectional study to allow us to further understand hypoglycaemia in a 
paediatric population and explore the implications of this on our sample of diabetes 
patients and their parents.  Although similar studies have been conducted in other 
western countries, namely the USA and Australia, the differences in healthcare provision 
and diabetes management highlights this UK sample to be a distinct and appropriate 
sample for further investigation.   
 
Firstly, it is important to identify the prevalence of hypoglycaemia in this sample.  This will 
be achieved by collecting data on the frequency of hypoglycaemia and the experience of 
episodes of severe hypoglycaemia.  Although this data will be collected retrospectively, 
which is not ideal, it will allow exploration of the prevalence of hypoglycaemia in a large 
sample.  This study appears to be the first UK study to investigate prevalence of 
hypoglycaemia in a large cohort of children and adolescents with Type 1 diabetes.  
Establishing whether hypoglycaemia is a problem for this sample will allow further 
investigation of any links between the prevalence of hypoglycaemia and fear of 
hypoglycaemia.   
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Hypoglycaemia awareness will also be assessed in adolescents in order to confirm whether 
they are experiencing the warning signs of hypoglycaemia.  Lack of awareness of the 
warning signs could lead to adolescents being more likely to suffer from severe episodes of 
hypoglycaemia.  This could be related to the prevalence of FOH.  This is amongst the first 
UK studies to investigate hypoglycaemia awareness in adolescents.   
 
Examining the fear of hypoglycaemia in this cohort of CYP and parents will help us to 
understand how much of a problem FoH is in this UK sample.  Importantly, this study will 
look at how FoH might contribute to glycaemic control, as studies in other countries report 
conflicting data (75, 79, 83, 84).  To my knowledge this will be the first study to examine 
fear of hypoglycaemia as a predictor of glycaemic control in UK children. This information 
will improve our understanding of the impact of FoH on glycaemic control and the possible 
barriers to appropriate diabetes self-care. It is likely that this will be an important factor to 
assess when considering children and families for intensification of insulin therapy. It is 
anticipated that using this information relevant and effective educational interventions 
may be designed to prevent / modify FoH that may become / be maladaptive. As there is 
little T1DM literature/research in the paediatric population the current study will 
contribute to FoH research that has mainly focused on adults. 
 
Further to the prevalence of hypoglycaemia and FoH, this study will also collect data on 
psychosocial factors related to T1DM.  Links between FoH and anxiety in adolescents have 
previously been reported (72).  Therefore, it is sensible to explore anxiety in this sample as 
anxiety traits may underpin FoH. 
 
Experience of hypoglycaemia and FoH is likely to impact on QoL and self-care behaviours 
in this cohort (74, 83).  Investigating the links between these variables will help to 
understand these relationships and potentially understand their impact on diabetes 
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management.  Again, this is an area that has not been extensively researched in UK 
paediatric populations. 
 
Further to studying UK children with T1DM, this study will also investigate parental FoH 
and associated anxiety.  Previous research indicates that parents of CYP with T1DM report 
elevated FoH and anxiety (87) so it is important to establish whether this is true for a UK 
sample.  Most research on parents in this area tends to focus on the mothers (75, 91) so 
this study will aim to collect data from both parents to add to the growing literature (86, 
87) and give an insight into paternal experiences too. 
 
In order to gain a more in depth understanding of the experience of hypoglycaemia and 
FoH in CYP and parents, qualitative interviews will be carried out.  Previous qualitative 
research in this area tends to focus on parental views, although there are limited 
qualitative studies looking at CYP perspectives.  Qualitative interviews specifically looking 
at hypoglycaemia and FoH are minimal.  It appears that only one qualitative study 
focussing on FoH has been published (65).  This particular study used interpretative 
phenomenological analysis techniques so only engaged a small sample (four participants) 
who were all mothers of CYP with T1DM.  The current study will aim to get views from a 
larger sample of CYP as well as parents, specifically on the impact of hypoglycaemia and 
FoH, with a view to adding to published research in this area. 
 
Aims 
To collect data regarding: 
1. The prevalence of episodes of hypoglycaemia in a large group of children and 
young people with diabetes attending the clinical services within the West Midlands; 
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2. The prevalence of FoH among children / adolescents and their parents and the 
relation to glycaemic control, previous experience of severe hypoglycaemia, diabetes 
related quality of life, trait anxiety and self-care; 
 
3. The impact of episodes of hypoglycaemia on the family using qualitative 
interviewing in a subset of subjects from differing age groups: adolescent, primary school 
children. 
 
It is anticipated that the outcomes of this research study will increase knowledge and 
contribute to existing findings into the prevalence of hypoglycaemia, FoH and possible 
related factors, by focusing on the paediatric population and their parents, in the UK, 
where diabetes management is different to that in the US or Europe and for which there is 
limited research.  Implications of this research could lead to the development of a 
hypoglycaemia management programme for children, adolescents and their parents.  
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Chapter 2 Method 
Phase 1: Quantitative research method 
2.1 Design 
A mixed-method cross-sectional design was used for this study.  This is the first UK study, 
to my knowledge, looking at the fear of hypoglycaemia in both children and young people 
and their parents, in conjunction with potentially related biological and psychological 
factors, including frequency of hypoglycaemia.  It is important to initially ascertain the 
prevalence of hypoglycaemia before investigating FoH in this sample.  The study replicates 
aspects of extensive FoH research carried out in the U.S. by Gonder-Frederick et al. (72). 
 
Questionnaires were used to collect quantitative data with regards to the fear of 
hypoglycaemia and living and coping with diabetes.  Subsequently, the data were analysed 
using SPSS and factors needing further exploration were noted. The factors that were 
identified were those that had produced significant findings from the current study and 
previous studies looking at FoH.   These key factors included FoH, knowledge of 
hypoglycaemia, strategies for coping with hypoglycaemia and potential strategies for 
improving support for young people with Type 1 diabetes, frequency of hypoglycaemia, 
and living with diabetes.  They were used as a basis to form topics for discussion and 
subsequently to form questions for the semi-structured interviews.  CYP and parents, who 
had previously completed the questionnaires, were invited to take part in the interviews.   
 
2.2 Sample 
Two hundred and ten children and adolescents (CYP) aged 3-17 years took part in the 
study.  At least one parent was also invited to take part.  Fifty-two fathers and 138 
mothers participated in the research study.  One hundred and sixty children had at least 
one parent complete the questionnaire, of these, 30 children had both parents complete 
questionnaires. 
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Patients were recruited from five Diabetes outpatient clinics in the Midlands, United 
Kingdom; University Hospitals Coventry and Warwickshire (UHCW) NHS Trust Coventry, 
UHCW NHS Trust Rugby, Heartlands Hospital Birmingham, George Eliot Hospital (GEH) 
Nuneaton and Leicester Royal Infirmary (LRI) Leicester. 
 
In order to be eligible to take part in the research study CYP had to meet the following 
inclusion criteria: 
 Be aged between 2-18 years  
 Have had T1DM diabetes for at least 12 months 
 Have no other  co-morbidities that may influence responses i.e. diabetes with 
cystic fibrosis  
  Have no specific conditions/learning disabilities which prevent them from 
understanding/completing the questionnaires i.e. autism.   
 
For those CYP who were eligible to take part, reasons for non-participation included 
unwillingness to take part, language problems, reading difficulties, concerns/anxiety 
around answering some of the questions and the effect that this possibly may have on the 
CYP/parent , family problems, bereavement  in the family.   
 
The reasons for not returning the questionnaires included participants forgetting to return 
the questionnaires, not having the time to complete the questionnaires, and taking part in 
the study was not a priority so packs were not completed or returned.  Reasons for not 
completing questionnaires when waiting in clinic were that participants ran out of time 
and also that they did not want to face  potential parking charges by staying longer to 
complete the questionnaires. 
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Due to ethical reasons it was not possible to collect demographic data on those 
CYP/parents who refused to participate in the current study.  Therefore, it is not possible 
to assess whether there were any significant differences between those who agreed to 
participate and those who declined. 
 
2.3 Overview of recruitment issues 
Between September 2008 to September 2009 data collection was completed at UHCW 
NHS Trust (Coventry) and Rugby Hospital.  During the following months, those patients 
who had taken questionnaires away to complete at home but had not yet returned them 
were approached for a second time in order to identify whether they still wanted to take 
part in the study.  Data collection was carried out at Heartlands Hospital between the end 
of February 2009 and end of October 2009.  Patients at George Eliot Hospital (GEH) were 
invited to participate in the research study from August 2009 until October 2009. Data 
collection continued at GEH in February and March 2011, after I returned from maternity 
leave.   Patients at Warwick Hospital were approached to take part in this study by their 
lead consultant who passed on the details of those who wished to take part.  These 
patients agreed to complete questionnaires via post, in light of my maternity leave.  
Unfortunately as the lead consultant retired during the research study and no permanent 
replacement was identified it was agreed that it was best to exclude data from patients at 
Warwick hospital.  Data collection was completed at Leicester Royal Infirmary between 
September 2010 and March 2011. Quantitative analysis of data commenced in May 2011. 
The majority of the interviews were also transcribed during this time.  I then went on 
maternity leave from September 2012 until August 2013. Quantitative analysis continued 
in December 2013 and qualitative analysis commenced in September 2015. The final write 
up of the thesis was undertaken between December 2014 and September 2016. 
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2.4 Research with CYP 
2.4.1 Conducting research with CYP 
Conducting research with children and young people is not as straight-forward as research 
with adults.  Not surprisingly, merely trying to get access to CYP in order to discuss the 
research comes with its own difficulties.  There are often gatekeepers (e.g. parents, 
clinicians, teachers) whom the researcher will likely have to negotiate with in the first 
place (131).  Once this has been achieved then CYP and their guardians must consent to 
taking part in the research to ensure that a child is not taken advantage of.  The researcher 
must be as certain as possible that the child or adolescent is aware of what is being asked 
of them and fully understands their role in the research. The researcher must also be 
aware of the power difference between a child and adult and how this could influence 
consent to take part in the research (132, 133).  Parents may also take the decision away 
from the child, deeming the research too sensitive or the child too young to take part 
without giving the child the option of participating in the research (133, 134). Once the 
guardian is happy for the researcher to approach the child the researcher must be sure 
that the child/adolescent is also happy to take part in the research before moving to the 
next stage. 
 
2.4.2 Informed consent  
A number of considerations must be taken into account when working with CYP, such as a 
child’s age, literacy and understanding amongst other things.  CYP should be presented 
with information about the research they might potentially be involved in, in a way that 
they will be able to understand their involvement, their role, implications of taking part in 
the research and also their rights as participants (133, 135).  Once CYP feel that they are 
happy with the information they have received and have asked any questions they need to 
they can then give their informed consent.  Researchers need to ensure that CYP are 
happy to participate throughout the study (135).  In addition to the differences between 
children and adults, those conducting research should be aware of the differences 
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between children and adolescents and even between age groups within these categories.   
The age groups targeted for research should inform the type of methods employed for the 
research study, where possible.  Younger children are likely to benefit from a nurturing 
approach, whereby the researcher presents the research topics/questions in an informal 
way to try to reduce any power differences. Similarly, the power difference should also be 
taken into consideration with adolescent groups and the researcher should try to provide 
an inviting and non-judgemental setting for this research.  However, adolescents might be 
more independent and forthcoming with their views, than younger children.  It should be 
noted that not all CYP will fit the assumed level of understanding and autonomy for their 
age group so researchers must be aware of individual differences and adjust their methods 
accordingly.   
 
2.4.3 Confidentiality & the right to withdraw 
All participating parents and CYP should be assured of confidentiality when consenting to 
take part in the research study as well as the fact that confidentiality could be broken if 
the researcher believes the child to be at risk of harm.  These steps were followed for the 
present research study.  No patient identifiable data were present on any of the measures 
completed by participants.  CYP were each assigned a unique code with a linked unique 
code for each associated parent that took part.  Participant codes and associated 
participant details were stored on a password protected file.  Consent forms were kept 
separately from completed measures, in a locked filing cabinet. 
 
All participants were informed of their right to withdraw from the study without any 
impact on their medical care.  I was required to undergo enhanced CRB checks and had 
honorary contracts in place at each of the NHS Trusts I recruited at to ensure the safety of 
participating CYP, especially since they are considered ‘vulnerable’ participants.  Ensuring 
CYP were fully informed about all aspects of the consent process and their role as 
participant, ensured good ethical practice. 
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2.4.4 Research paradigms: mixed method approach  
A mixed-methods approach was taken for this research study.  In terms of research with 
CYP, this approach provided a varied method of data collection (132).  Methods using 
questionnaires as a form of data collection often draw forced responses from CYP, 
whereas interview methods allow further exploration of the topic and allow CYP to 
elaborate, describe feelings and emotions and also give CYP the platform to tell their story.  
Other methods of data collection which can be helpful in research with children and young 
people are free responses to questionnaires (written), drawing pictures to help explain or 
describe opinions and feelings and taking photographs (132).  This two-pronged approach 
gives CYP various mediums though which to express their opinions, in a way that they feel 
most comfortable and in a way that allows broad exploration of topics (136).  For this 
study, starting with a self-report method of data collection was perhaps less daunting and 
gave CYP the opportunity to understand the topic of the research without feeling under 
pressure to provide their own thoughts or opinions.  Those who then wished to talk about 
the topic further were given the chance to do so in a relaxed manner whereby the 
researcher tried to make the CYP feel more comfortable by presenting the interview less 
formally and more like having a chat.  
  
2.5 Measures 
Questionnaires were completed by CYP and their parent(s) whilst they waited to attend 
their regular clinic appointment.  Questionnaire packs took approximately 30 minutes to 
complete.  On occasion the questionnaires were taken home to complete and posted back 
to the researcher.  Some families preferred to complete their questionnaires at home.   
Figure 1 below outlines the content of the questionnaire pack for each age group 
participating in the study.  Questionnaires can be found in Appendices 1-9. 
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Figure 1: Questionnaire packs by age group 
13-18 years 11-12 years 8-10 years 5-7 years 2-4 years 
CHILD: 
PedsQL 13-18 
Frequency of 
hypoglycaemia 
Hypoglycaemia 
Fear Survey  
State-Trait Adult 
Self-care inventory 
Awareness survey 
 
Information sheet 
11-18 
Consent 16-18 
Assent U16 
  
CHILD: 
PedsQL 8-12 
Frequency of 
hypoglycaemia 
Hypoglycaemia 
Fear Survey  
State-Trait Child 
Self-care inventory 
Awareness survey 
 
Information sheet 
11-18 
Assent U16 
CHILD: 
PedsQL 8-12  
Frequency of 
hypoglycaemia 
Hypoglycaemia Fear 
Survey  
State-Trait Child 
 
Information sheet      
6-10 
Assent U16 
 
CHILD: 
PedsQL 5-7  
Hypoglycaemia 
Fear Survey 
 
Information sheet       
6-10 
Assent U16 
CHILD: 
None 
PARENTS: 
Peds 11-18 
Frequency of 
hypoglycaemia 
Hypoglycaemia 
Fear Survey  
State-Trait Adult 
Self-care inventory 
Parent 
demographics 
 
Information sheet 
Parent 11-16 
Parent consent  
Parent consent on 
behalf of child  
PARENTS: 
Peds 8-12  
Frequency of 
hypoglycaemia 
Hypoglycaemia 
Fear Survey  
State-Trait Adult 
Self-care inventory 
Parent 
demographics 
 
Information sheet 
Parent 11-16 
Parent consent  
Parent consent on 
behalf of child 
PARENTS: 
Peds 8-12  
Frequency of 
hypoglycaemia 
Hypoglycaemia Fear 
Survey  
State-Trait Adult 
Self-care inventory 
Parent 
demographics 
 
Information sheet 
Parent 8-10 
Parent consent  
Parent consent on 
behalf of child 
 
PARENTS: 
Peds 5-7  
Frequency of 
hypoglycaemia 
Hypoglycaemia 
Fear Survey  
State-Trait Adult 
Self-care inventory 
Parent 
demographics 
 
Information sheet 
Parent under 8s 
Parent consent  
Parent consent on 
behalf of child 
 
PARENTS: 
Peds 2-4  
Frequency of 
hypoglycaemia 
Hypoglycaemia 
Fear Survey  
State-Trait Adult 
Self-care 
inventory 
Parent 
demographics 
Information sheet 
Parent under 8s 
Parent consent  
Parent consent 
on behalf of child 
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2.5.1 Background information  
The following information was collected from CYP and parents who took part in the study. 
Demographic data (CYP):  This was collected from hospital records but confirmed when 
participants were recruited to take part.  Demographic data included age, date of birth, 
gender, ethnicity. 
 
Disease related information (CYP):  
 Date of diagnosis: taken from medical records but confirmed by patient/parent.  
This was generally given as the year of diagnosis, in some instances the month was 
also given. 
 Duration of diabetes: again, information was obtained from medical records but 
confirmed by patient/parent.  This was generally given as months and years 
(converted into years for analysis). 
 
Insulin regimen: was obtained from medical records and later categorised either as 
conventional insulin therapy or intensive insulin therapy for analysis. Twice a day insulin 
therapy was categorised as conventional therapy and multiple injections and pump 
therapy were categorised as intensive therapy.  
 
HbA1c: CYPs’ glycosylated haemoglobin (HbA1c) data from the past 12 months were 
collected from their medical records.  All children and young people with diabetes have a 
three monthly assessment of HbA1c which is usually performed on capillary sampling. No 
additional tests were taken for the purposes of the study.  Data were collected 
retrospectively from clinical records to document the most recent HbA1c as well as the 
average of the readings from the 12 months prior to the questionnaire assessments.  All 
local laboratories used DCCT standardised assays.  
 
Demographic data (parents): 
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This included height, weight, collar size, ethnicity, age, age when left full time education, 
where they were educated (UK or other), highest level of education received and 
occupation.  This information was captured using the parent demographic document, 
designed specifically for this study.  
 
2.5.2 Description of measures 
Questionnaire data  
The questionnaires used in this study are all validated measures.  
2.5.2.1 Frequency of hypoglycaemia survey  
This questionnaire was used to measure the frequency of hypoglycaemia and severe 
hypoglycaemia (47) (Appendix 1). 
 
A retrospective assessment of frequency of episodes of both severe (needing assistance) 
and mild hypoglycaemia was made. This questionnaire has been produced by the 
Edinburgh group and has been used in a number of studies assessing hypoglycaemia 
frequency in patients with Type 1 diabetes.   The measure includes a definition of 
hypoglycaemia and a severe hypoglycaemia episode to help patients distinguish between 
the two in their responses.  Although retrospective assessment of the frequency of 
hypoglycaemia is generally inaccurate, the Frier group in Edinburgh developed a range of 
possible answers to obtain a measure of the frequency of exposure, which refers to both 
lifetime experience and to a particular time period, such as the preceding year, 2 years. 
For severe hypoglycaemia, the responses range from "never" to "1 - 2 events", "2 - 5 
events", ">5 events" to obtain a measure of the total exposure. Mild hypoglycaemia is 
measured over time e.g. "weekly", "monthly", "annually".  The measure includes both 
forced response (information on the frequency of both severe and non-severe episodes of 
hypoglycaemia) and free response (information on the frequency of episodes of severe 
hypoglycaemia over the past one and two years).  The parent version of this measure is a 
proxy measure and asks parents about the frequency of their child’s hypoglycaemia.   
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2.5.2.2 Hypoglycaemia awareness survey  
This measure was used to identify the presence of impaired awareness of hypoglycaemia 
(IAH) (47, 49) (Appendix 2). 
 
The IAH measure is used to identify the presence of impaired awareness of 
hypoglycaemia.  The Gold and Clarke (Edinburgh) methods were combined to assess IAH, 
as recommended by Geddes et al. (45).  The two validated measures are made up of ten 
items which ask the respondent to identify whether they experience symptoms of 
hypoglycaemia when they have low blood sugar and the frequency of these experiences. 
The Clarke method (49) makes up items one to nine.  Item nine on the measure looks at 
the likelihood of the presence of 17 potential symptoms a patient might experience 
(presented as a list) when having a hypoglycaemic episode, on a scale of one (not present) 
to seven (present a great deal).  The final item, from Gold et al.’s (47) measure is an 
explicit question which asks the patient to rate whether they are aware they are 
experiencing hypoglycaemia. They are required to respond to this on a scale of one 
(always aware) to seven (never aware).  For items one to eight a score of 4+ implies 
impaired awareness (max = 8).  For item ten a score of 4+ implies impaired awareness of 
hypoglycaemia (max = 7). The awareness measure also collects details on insulin regimen, 
including insulin type and timings and amounts of insulin taken.  The IAH is aimed at 
adolescent patients aged 11+ years. There is no parent version of the measure. 
  
2.5.2.3 Self-care inventory (SCI) 
The original SCI (137) was updated (SCI-R) and measures diabetes-related self-care 
behaviours (138) (Appendix 3). 
 
The 15-item version of the self-care inventory revised (SCI-R) is specifically designed to 
assess the extent to which the respondent believes he or she follows diabetes-specific self-
care behaviours, over the past 1-2 months.  This measure is aimed at adolescents; for pre-
adolescent children proxy reports are completed by their parents (139). When scoring the 
items it is advisable to look at categories within the measure rather than the total score.  
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The items can be categorised into the following groups: overall adherence (items 
1,2,5,6,7,14,15), blood glucose regulation (items 1,2,15), insulin and food regulation (items 
5,6,7), exercise (item 14) and emergency precautions (items 11 and 13) (138).   Items are 
scored on a 5-point scale (1= Never, 2= Rarely, 3= Sometimes, 4= Usually, 5= Always).  
Scores were transformed to a 0-100 scale for analysis using the following formula:  
((average raw score-minimum possible score)*100)/(maximum possible score-minimum 
possible score).   Higher scores on the measure indicate better perceived diabetes self-
care. 
  
Reliability and validity for the SCI is evident from previous studies (138, 140, 141) using the 
SCI.  Lewin et al. (141) reported internal consistency for the SCI when used with 
adolescents (α = 0.80) and with parents (α = 0.72).  Similarly, Weinger et al. (138) found 
that their data showed high internal consistency (α = 0.87) for the SCI-R. 
 
2.5.2.4 Quality of life assessment: Pediatric Quality of Life Inventory (PedsQL 3.0 
Diabetes module)  
This measure looks at health-related quality of life (HRQoL) in T1DM patients (Appendix 4). 
 
The PedsQL 3.0 Diabetes Module is part of a larger Pediatric Quality of Life Inventory 
(142), which assesses quality of life (QoL) in children (healthy children and those with 
acute or chronic illnesses). The diabetes module is made up of 28 items looking at 
problems a child might have with his/her diabetes.  The items are split into five groups: 
About my diabetes (diabetes symptoms; 11 items), Treatment I (treatment barriers; 4 
items), Treatment II (treatment adherence; 7 items), Worry (3 items) and Communication 
(3 items).  For this study, the PedsQL Diabetes 3.0 module was used to measure QoL in 
children with Type 1 diabetes aged between 5-18 years.  Age-specific questionnaires were 
available for varying age groups (5-7 years, 8-12, 13-18 years).   
 
For children aged less than 5 years, parent proxy measures were completed (Appendix 5).  
Parents of older children were also asked to complete parental reports in order to identify 
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how parents perceived their child’s QoL.  Items were reverse scored and transformed from 
a 0-5 scale to a 0-100 scale for analysis (0= 100, 1= 75, 2= 50, 3= 25, 4= 0). For the 5-7 year 
group items were scored on a three point scale and reverse scored and transformed to a 
scale of 0-100 (0= 100, 2= 50, 4= 0). The total score for each subscale and for the overall 
scale were calculated as an average score (total score/ number of complete items).  If 
more than 50% of the items were missing the scale/subscale score was not computed.  
Originally only subscale scores for the PedsQL modules were calculated however, later 
research using factor analysis suggests that a total PedsQL score is psychometrically 
appropriate for use (143).  A high score on the PedsQL measure indicates higher quality of 
life.  
 
Some of the items on the PedsQL Diabetes module included ‘US English’ words or terms.  
To ensure the participants of this study would understand the items clearly it was decided, 
with the approval of Mapi (distributors of PedsQL) that we could amend those words to 
‘UK English.’  Details of the translation procedure are provided in section 2.7.2, below. 
 
  
The PedsQL diabetes module has been tested and found to have internal consistency 
reliability and construct validity. The majority of parent and child reports for the diabetes 
module exceeded Cronbach’s alpha co-efficient of 0.70 (144-146).  For the Diabetes 
module, Varni et al. (144) reported Cronbach’s alpha co-efficient of 0.71 for the child-
report and 0.73 for the parent-report. Higher internal consistency for the Diabetes module 
of the PedsQL was reported by Kalyva et al. (106).  For child-reports they found a 
Cronbach’s alpha of 0.81; although Cronbach’s alpha co-efficient did vary across age 
groups (5-7 years: α = 0.81; 8-12 years: α = 0.92 and; 13-18 years: α = 0.93). 
 
2.5.2.5 Hypoglycaemia Fear Survey (HFS)  
 
The HFS survey identifies the presence of the fear of hypoglycaemia.  The current study 
utilised an adapted version of the original Cox et al. (147) HFS measure, which was 
adapted for use by children (CHFS) and parents (PHFS) (72, 74, 77) (Appendix 6 and 7).    
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Child version 
The CHFS is made up of three parts.  The first part of the survey includes 10 items which 
measure the presence of behaviours associated with hypoglycaemia, for example, “eating 
large snacks before bedtime.”  This is also known as the behaviour sub-scale.  The second 
part of the survey looks at 15 items on worries about hypoglycaemia, for example, “no one 
being around to help during a hypo” (worry subscale).  The items on the ‘Worry’ and 
‘Behaviour’ subscales are rated from 0 (never) to 4 (almost always).  Part three of the CHFS 
is made up of yes/no questions about the situations in which a child has had 
hypoglycaemia (e.g. “is low blood sugar a big problem for you”).   
 
Scores for the CHFS are calculated by adding up the ratings given for each item.  Total 
scores are calculated for the Behaviour (max = 50) and Worry (max = 75) sections, with the 
total HFS (max = 125) score calculated by adding the Behaviour and Worry scores. Higher 
scores on the measure indicate higher fear of hypoglycaemia. 
 
Gonder-Frederick et al. (74) report good internal consistency for the CHFS Total scores 
(0.84-0.87).  The subscales also are reported to have reasonable Cronbach’s alpha co-
efficient, with the Behaviour subscale ranging from 0.59-0.78 and the Worry subscale with 
a higher co-efficient ranging from 0.87-0.89. 
 
Parent Version  
The parent version of the HFS also looks at behaviour, worry and experience of 
hypoglycaemia.  Ten items make up the behaviour section (e.g. “keep my child’s sugar 
higher when he/she will be alone for a while”), 15 items make up the worry section (e.g. 
“child having a hypo while asleep”) with an additional two items which ask the parent to 
rate their confidence in identifying and treating their child’s hypoglycaemia.  The two 
additional items are used as independent assessors of parent’s confidence so the ratings 
for these two items should not be included in the scores for worry or the total PHFS score.  
The items on the ‘Worry’ and ‘Behaviour’ subscales are rated from 0 (never) to 4 (almost 
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always).  The behaviour and worry subscales are followed by the third section which 
explores in more detail, the numbers and associated experiences of hypoglycaemia in 
various situations, for instance when asleep or at school (e.g. “has your child ever had a 
hypoglycaemic event at school”) and the availability of emergency glucose (e.g. “does your 
child carry emergency glucose with him at all times”). 
 
Scores for the PHFS are calculated by adding up the ratings given for each item.  Total 
scores are calculated for the Behaviour (max = 50) and Worry (max = 75) sections, with the 
total HFS (max = 125) score calculated by adding the Behaviour and Worry scores. Higher 
scores on the measure indicate higher fear of hypoglycaemia. 
  
Previous reports of internal consistency for the PHFS range from 0.89-0.92 (74).  Good 
internal consistency has also been reported for the Behaviour subscale (0.72-0.76) and the 
Worry subscale (0.88-0.91) (74).  
 
2.5.2.6 State Trait Anxiety Inventory (STAI/STAIC)  
Spielberger’s state trait anxiety inventory (STAI) is a well-validated measure used to 
identify the degree of a person’s state and trait anxiety.  There are separate measures for 
children and older children/adults (148, 149) (Appendix 8).  
 
The state trait anxiety inventory for children (148) (STAIC) (Appendix 9) is suitable for 
children aged 9-12 years old, although it can be used with younger children with at least 
average reading ability, and is made up of 40 items.  The first 20 items ask how a child is 
feeling at this moment and measures state anxiety (e.g. ‘I feel very calm/calm/not calm’).  
Half of the questions in the state anxiety subscale reflect the presence of anxiety whilst 
the other half reflects the absence of anxiety (these items are reverse scored during 
scoring).  The last 20 items ask the child about how they usually feel and measures trait 
anxiety (e.g. ‘I worry too much’).  Each item has three possible responses which are scored 
from 1-3.  The scores are totalled separately for trait and state anxiety with a highest total 
of 60 for each. 
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The internal consistency of the STAIC is good.  For the state subscale, Cronbach’s alpha co-
efficient is reported to be between 0.82 and 0.87 and for the trait subscale between 0.78 
and 0.81 (148).   
 
The Spielberger trait personality Inventory (150) (STPI) was originally used in this study to 
identify trait anxiety scores (based on similar previous research carried out in FoH (72)) 
however, once data collection was underway, using the STPI, it was decided that the 
STAI/STAIC was actually a better and shorter measure of anxiety.  As a result, the 
assessments were altered to include the STAI/STAIC instead of the STPI.  As the STAI also 
offered a child version of the anxiety measure, this measure seemed to be more 
appropriate to use in this study. The anxiety measure was amended and ethics approval of 
this substantial amendment was given (Appendix 13).  Although some of the items on the 
STPI corresponded with those on the STAI, it was decided that the completed STPI 
measures would be disregarded for ease, considering only a small number had been 
collected by the time the change of assessment was decided.  This is reflected in the 
differing number of parents who completed the STAI in comparison with the rest of the 
battery of measures.  
 
The state trait anxiety inventory for adults (149) (STAI) (revised version) is suitable for 
13+year olds to adults and is made up of 40 items.  As with the child version, 20 items 
measure trait anxiety (e.g. ‘I make decisions easily’) and 20 items measure state anxiety 
(e.g. ‘I feel at ease’).  Each item is scored on a scale of 1-4 (not at all, somewhat, 
moderately so, very much so) with a total possible score of 80 for each subscale.   
 
The STAI is a widely used measure of both state and trait anxiety (149).  Cronbach’s alpha 
co-efficients are reported as 0.92 for the state subscale and 0.90 for the trait subscale 
(149), indicating high internal reliability for this measure.    
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A higher score on both the adult and child measure indicates higher anxiety.  As the items 
on the child and adult STAI differ the scores were converted to z-scores before analysis, to 
allow comparison between the two groups. 
 
Reliability of measures 
Cronbach’s alpha (151) is used to provide a method of measuring the internal reliability of 
a scale, that is, the degree to which the items within a scale are inter-related, and 
therefore, measuring the same thing.  Acceptable levels of alpha range from 0.70 to 0.95 
(152).  Cronbach’s alpha co-efficient has already been reported in the descriptions of each 
of the measures used in this study.  However, here Cronbach’s alpha will determine the 
internal reliability of the measures used, based on the current study data (Table 1).   
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Table 1: Cronbach’s alpha co-efficient 
Measure Total CYP U11 Adolescents Mother Father 
HFS Behaviour 0.68 0.71 0.68 0.76 0.75 
HFS Worry 0.9 0.91 0.9 0.92 0.92 
HFS Total 0.86 0.85 0.86 0.91 0.91 
State Anxiety N/A 0.89+ 0.81- 0.90 0.93 
Trait Anxiety N/A 0.87+ 0.91- 0.92 0.94 
 
PedsQL 
Diabetes 
Module 
total 
score 
13-18 
years 
0.9 N/A N/A 0.93 0.93 
8-12 
years 
0.86 N/A N/A 0.91 0.87 
5-7 
years 
0.88 N/A N/A 0.88 N/A 
2-4 
years 
N/A N/A N/A 0.91 N/A 
Self-care N/A N/A 0.8 0.83 0.90 
- 13-18 years  
+ Under 13 years  
 
Table 1 presents Cronbach’s alpha co-efficient for each of the measures used in the study 
and groups this data by respondent.  The data indicate that internal consistency for the 
measures, across groups, is good.  Cronbach’s alpha co-efficient only drops below 0.70 for 
CYP and adolescents reporting on the CHFS behaviour subscale (α = 0.68 for both).   
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2.6 Advantages of using questionnaires 
This study used a collection of validated structured questionnaires which participants were 
required to respond to during their clinic appointments.  One of the advantages of using 
this method of data collection is that it allows large samples of participants to take part 
with little difficulty.  This method also allows data to be analysed easily.  Where 
questionnaires have been tested for validity and reliability researchers can feel confident 
in their data.  Structured questionnaires, however, also have disadvantages.  Respondents 
are not free to give their own views and are ‘forced’ to choose one of the pre-coded 
responses.  This means that some of the data collected using this method may not be a 
true reflection of the respondent’s thoughts.  Structured questionnaires can also be open 
to biases such as social desirability whereby the respondent will answer questions in a way 
that they think will show them in a positive light.  This method also relies on the same 
questions and responses being presented to a wide sample with varying levels of 
knowledge.  The assumption being that all respondents will understand the intended 
meaning of the questions in the same way.  In this study we were able to overcome the 
shortcomings of using structured questionnaires by carrying out structured interviews.    
 
2.7 Procedure 
Prior to starting the study the following tasks were undertaken: 
2.7.1 Ethics approval 
The ethics application was completed using the NHS IRAS tool.  Ethics approval for this 
multi-centre study was obtained from Oxfordshire Research Ethics Committee on 30th 
November 2007 (Appendix 10). 
 
All substantial amendments during the study were reported to the Ethics committee and 
approved (Appendix 11-14).  The substantial amendments were in relation to minor 
amendments to the parent demographic form; amended letter of invitation; change from 
STPI to STAI as a measure of anxiety (discussed in more detail later in this chapter).  
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2.7.2 PedsQL translation of some items 
A translation from US English to UK English on the PedsQL for Young Children, Parent 
report for Young Children and Parent report for toddlers was carried out.  As there has 
already been a translation to UK English for the Teen, Parent report for Teens, Child and 
Parent report for Child it was agreed by Mapi Research that researchers could use the 
previously translated questionnaires as a guide to translating the remaining US English 
versions of the questionnaire.  Researchers also felt that if two independent translators 
were used to carry out the forward and backward translations, the two new translators 
might translate the questionnaires differently to the way that they have been translated 
previously.  Therefore, the translation might not be consistent across the age groups.  
 
 A comparison of the US and UK English questionnaires was carried out for the 
Teen, Parent report for Teen, Child and Parent report for Child.  Differences 
between the US and UK versions were noted and highlighted.  
 Using the Teen/Child/Parent U.K. versions of the PedsQL questionnaire as a guide 
those areas that had been translated were highlighted on the U.S. versions of the 
Young Child/Toddler/Parent questionnaires. 
 Next, the highlighted sections in the US English version of the questionnaires 
were translated into UK English using the translated UK English versions of the 
questionnaires  
 For the PedsQL for Young Children questionnaire the cover page was vastly 
different to the cover pages for the other age groups as this included an example, 
for children, of how to complete the questionnaire.  The example refers to 
whether the young child can ’snap’ his/her fingers.  In UK English ‘snapping 
fingers’ is known as ‘clicking fingers’ so the researcher decided to make this 
amendment without having a similarly translated questionnaire to refer to.  
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 Figure 2 (below) highlights the phrases that were translated from US English to UK 
English can be found below.  Although the Young Child, Parent of Young Child and 
Parent of Toddler reports differ slightly they all include the translations. 
 
 
Figure 2: Translation of phrases from US to UK English for the PedsQL 
measure 
US English UK English 
Having to go to the bathroom too often Having to go to the toilet too often 
Going “low” Going “low” or “hypo” 
Feeling tired or fatigued Feeling tired 
Having trouble sleeping Having trouble sleeping at night 
Getting irritable Getting grumpy or annoyed 
Needle sticks (i.e. injections/blood tests) 
causing him/her pain 
Injections/blood tests causing him/her pain 
Arguing with me or my spouse about 
diabetes care 
Arguing with me or my partner about 
diabetes care 
Sticking to his/her diabetes care plan Sticking to his/her diabetes routine 
It is hard for my child to take insulin shots It is hard for my child to give himself insulin 
injections 
It is hard for my child to track 
carbohydrates or exchanges 
It is hard for my child to follow a healthy 
diet 
It is hard for my child to wear his/her id 
bracelet 
It is hard for my child to wear his/her id 
bracelet/necklace or carry a card 
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It is hard for my child to child eat snacks It is hard for my child to eat snacks between 
meals when they should 
Worrying about “going low” Worrying about “going low” or “hypo” 
Worrying about long-term complications of 
diabetes 
Worrying about long-term problems of 
diabetes 
Is it hard for you to snap your fingers* Is it hard for you to click your fingers* 
Ask the child to demonstrate snapping his 
or her fingers* 
Ask the child to demonstrate clicking his or 
her fingers* 
*Statement is only present in the Young Child Report 
 
2.7.3 Hypoglycaemia Fear Survey (measurement of FoH) 
translation  
A translation from US English to UK English on the Hypoglycaemia Fear Survey for the 
Children and Parent report was carried out.  One phrase in the questionnaire was 
amended; ‘Insulin reaction’ to ‘hypo’ because in the UK the term ‘insulin reaction’ is 
generally referred to as ‘hypo.’    The translation of this term was agreed to by developers 
of Hypoglycaemia Fear Survey without the need for testing and forward and backward 
translations. 
 
2.8 Procedure in clinic 
 Patient details (name, address, date of birth) and upcoming clinic lists were 
obtained from either the medical secretary (Heartlands, GEH, LRI) or hospital 
booking system (UHCW). 
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 Patients at LRI and UHCW were screened prior to being invited to take part in the 
study.  This was not possible for patients at GEH or Heartlands Hospital so all CYP 
attending the Diabetes clinics here were invited to take part via an invitation letter 
by post. 
 
 A letter of invitation was sent to parents and CYP two weeks prior to their 
upcoming clinic appointment with age appropriate information sheets for both 
parent and patient. Examples of these information sheets can be found in 
Appendix 15 and 16). 
 
 Age-appropriate questionnaire packs (consisting of age-appropriate 
questionnaires and consent forms), extra questionnaire packs, crib sheet, extra 
information sheets and pens were taken to each clinic.  
 
 At each clinic CYP and parents were approached to see if they had received and 
read the information sheets and whether they were interested in taking part in 
the study.  Parents could not take part if CYP did not want to participate in the 
study.  If only one parent was present they were given a set of questionnaires for 
the 2nd parent to complete at home and send back in the enclosed stamped 
addressed envelope, if they were happy to do so. 
 
 Inclusion/exclusion criteria were confirmed by CYP and parent to ensure that the 
CYP had, had T1DM for at least 12 months, whether CYP had any co-morbidities 
and whether they had any conditions/learning disabilities preventing them from 
understanding/completing the questionnaires i.e. autism. 
 
 Consent forms were completed by CYP aged 16+ years (Appendix 17).  Assent 
forms were completed by all CYP aged under 16 years, to indicate their willingness 
to take part in the study (Appendix 18).  For all those CYP aged under 16 years, 
parents (as the children’s guardians) also had to complete a consent form ‘on 
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behalf of child’ (Appendix 19) to document that they agreed to their child 
participating. 
 
 All parents who agreed to take part in the study were required to sign consent 
forms for themselves (Appendix 20) 
 
 Even though 2-4 year olds were not required to complete questionnaires their 
parents still needed to sign an ‘on behalf of child’ consent form.  This was to 
ensure that the researcher had permission to access to the child’s HbA1c data. 
 
 Boxes on the consent forms had to have the participants’ initials, not a tick, to 
indicate they agreed to the each of the statements. 
 
 CYP and parents were encouraged to complete the questionnaires during clinic 
waiting times.  Younger children received assistance in completing the 
questionnaires by their parent or the researcher, if they wanted it.  The researcher 
was also available to answer any questions or clarify any ambiguities whilst the 
questionnaires were completed. 
 
 Consent forms were signed and retained by researcher, one copy for participants, 
one copy for the researcher (the participant to sign two copies of the same form). 
 
 Each questionnaire was given a unique reference number (URN) which was 
written on the front of the questionnaire packs and on the crib sheet (a record of 
child URN, name, age, duration of diabetes/date of diagnosis).  For the first parent 
who was present P1 was added to the code, for the second parent P2 was added 
to the code.  
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 HbA1c data were collected for those patients who consented to take part. These 
were obtained from hospital records or via the Diabetes Specialist Nurses. 
 
All completed questionnaires were scored and a secure Microsoft ACCESS database was 
developed to store responses to items on all questionnaires. 
 
2.9 Statistical analyses 
Measures were scored by hand and the quantitative data were entered and analysed using 
SPSS version 19.0 (IBM Corp. Released 2010. IBM SPSS Statistics for Windows, Version 
19.0. Armonk, NY: IBM Corp.). Missing data was minimal and steps to eliminate the impact 
were taken depending on the measure; guidelines for dealing with missing data were 
provided in scoring guidelines for each measure. The main outcome of this study was the 
prevalence hypoglycaemia and the prevalence of fear of hypoglycaemia (FoH) among CYP 
and parents, and its relation to glycaemic control, previous experience of severe 
hypoglycaemia, diabetes related quality of life, trait anxiety, and self-care as determined 
by the questionnaire data. Data were analysed according to CYP age-specific groups and 
parents.  
 
Each measure was assessed to determine whether data were normally distributed.  Non-
parametric tests were used where data were concluded not to be normally distributed.  
Cronbach’s alpha co-efficient was calculated for all measures for which it was appropriate, 
in order to report the internal reliability of these measures for the current study sample. 
 
The characteristics of the CYP and parents were described using basic descriptive statistics 
reporting frequencies, mean scores, standard deviation scores.  Differences between 
groups were analysed using t-tests and chi-square analyses were used to explore 
associations between groups.  Basic descriptive statistics were used to describe the 
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prevalence of the frequency of hypoglycaemia.  Bar charts illustrated the differences in 
reports of hypoglycaemia and severe hypoglycaemia by age group.  Chi-square analysis 
was conducted to identify any differences between groups in the frequency of 
hypoglycaemia and severe hypoglycaemia.  Group differences in age, gender and insulin 
regimen were explored.  Chi-square tests were also used to compare parents’ reports of 
hypoglycaemia and severe hypoglycaemia.  Comparison between parents of children and 
parents of adolescents were also made.  Correlation analyses were carried out between 
CYP and parental reports to assess the agreement on reports of the number of episodes of 
severe hypoglycaemia.  Finally, the difference in HbA1c across the categories of frequency 
of hypoglycaemia and severe hypoglycaemia was explored using ANOVA and Mann 
Whitney.  Frequency data was not normally distributed; however, there is no suitable non-
parametric counterpart for ANOVA.  Correlations between free response reports of severe 
hypoglycaemia in the past year and year before with HbA1c were also explored. 
 
Continuing the analysis of the frequency of hypoglycaemia data it was also important to 
explore awareness of hypoglycaemia and its prevalence in this sample.  Descriptive 
statistics are presented for awareness in the adolescent group only.  Mann-Whitney tests 
were used to identify any differences in the frequency of hypoglycaemia and severe 
hypoglycaemia between adolescents with normal vs impaired awareness.  Correlational 
analyses were used to identify any relationships between awareness and reports of 
hypoglycaemia and severe hypoglycaemia.  Chi square analysis was then carried out to test 
the association between awareness of hypoglycaemia and the number of episodes of 
hypoglycaemia and severe hypoglycaemia experienced in an adolescent’s life.  
 
Basic descriptive statistics were used to describe the FoH data for CYP and their parents, 
overall and by age-group.  The prevalence of FoH was difficult to determine as the scale 
does not have a cut-off point indicating FoH in a person.  Therefore, descriptive statistics 
were studied in relation to the minimum and maximum scores on the HFS scale and 
comparisons between groups were made to identify how group scores compared.  T-tests 
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were used to examine any differences in HFS scores between age groups, insulin regimen 
and gender.  T-test analyses were also used to compare HFS scores between CYP and their 
parents, to identify any differences in HFS scores between these groups.  In order to 
compare CHFS scores based on CYP experience of severe hypoglycaemia, t-tests were 
carried out, by age group.  Comparison of PHFS scores and SH was also carried out by age 
group.  Correlation analyses were carried out to identify any relationship between HFS 
scores and HbA1c for both CYP and their parents.      
 
Basic descriptive analyses were calculated for additional measures: anxiety, quality of life 
and self-care.  Anxiety scores were converted to z-scores to allow comparison between 
adult and child anxiety measures.  Mann-Whitney and t-test analyses were used to 
examine any differences in scores between groups.  Correlational analyses were used to 
look at any relationship between the additional measures and HFS and HbA1c data. 
 
Stepwise multiple regression analyses were used to examine the independent correlates 
of fear of hypoglycaemia.  Emerging themes from the quantitative data informed the 
topics presented in the interviews.   
 
2.10 CYP and parent participation: variations in completion of 
measures  
The number of participants for each group varies from the total number of CYP and 
parents who completed the measures, for a number of reasons.  The first reason is that 
the measures were distributed among varying age groups.  So, for example although 210 
CYP took part in the study only 203 CYP completed the HFS scale.  This is due to the fact 
that younger CYP, aged 2-4 were not asked to complete any measures, however their 
demographic details and HbA1c data were recorded.  For this young age group parents 
completed proxy measures on the children’s behalf. Some participants did not complete 
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measures fully, therefore where there were too many missing data for the measure these 
scores were not recorded.  Following the scoring guidelines for each measure, I had to 
decide whether the amount of missing data constituted a decision to include or disregard 
that participant’s data.  For the anxiety measure there was a difference in the number of 
parents that completed this measure in comparison to the total N=number of parents 
taking part in the study.  The reason for this is that at the start of the study the State Trait 
Personality Inventory (150) was used to collect data regarding state/trait anxiety.  This 
measure was initially used as it had been used in a previous, similar study.  CYP were 
required to complete the State Trait Anxiety Inventory for Children (148), also based on 
previous research carried out in this area.  However, on reflection, it was decided that it 
would be better to use a specific anxiety measure for parents.  The State Trait Anxiety 
Inventory (149) is a shorter measure and as the study was already using the child version 
for CYP it was felt that this would be a better choice for collecting anxiety data.  Having 
looked at the adult and child versions of the anxiety measure it was decided that parents 
and children aged 13+years would complete the adult version, with the younger age 
groups completing the child version.  As a result of this change in measure the earlier 
completed STPI scores were disregarded, hence the difference in the number of parents 
completing the measure.  A substantial amendment highlighting this change was sent to 
the Ethics REC and approved (Appendix 13).   
Table 2 below highlights the issues associated with specific measures and corresponding 
response data. 
 
 
 
 
  
Table 2: Completion issues encountered with specific measures 
Measure Number of CYP and parent 
respondents 
Issue 
Frequency of 
hypoglycaemia 
CYP: 193 
CYP plus proxy reports: 206/210 
Mothers: 133 
Fathers: 51 
Completed by children aged 8+ years.  Parents completed proxy 
reports for younger children  
Hypoglycaemia Fear 
Survey 
CYP: 197 
Mothers: 138 
Fathers: 52 
 
 
  
For some subscales of the measures there was missing data for 
participants, which meant that a total score could not be calculated.  
However, in these instances, where some subscale scores could be 
calculated and missing data only accounted for one subscale, then 
these participants’ data was included in the analysis of the subscales 
even when data could not be used in the analysis of the measure as 
a whole.  The 2-4 years old group did not complete this measure. 
Peds Quality of Life 
Diabetes Module 
CYP (not including 2-4 year old 
reports.  These are included in the 
parent response numbers): 200 
Mothers:  136 
Although children aged 2-4 years did not complete this measure, 
proxy reports were provided by parents. 
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Fathers:  52 
Self-Care Inventory Adolescent:  150 
Mothers: 136 
Fathers: 52 
This measure was completed by the adolescent group and parents 
only. 
State Trait Anxiety 
Inventory (STAI) State 
Trait Anxiety Inventory 
for Children (STAIC) 
CYP:  191 (State) 193 (Trait) 
Under 13 years: 84 (S) 86 (T) 
13+ years: 107 (S) 107 (S) 
Mothers: 116 (S) 116 (T) 
Fathers: 48 (S) 46 (T) 
For the anxiety measure the age groups were slightly different for 
CYP; U11 group included all CYP aged under 13 years. They 
completed the STAIC.  The adolescent group included CYP aged 13 
years and older. They completed the adult version of the measure, 
as recommended by the STAI test administration guide (149). 
The parent N for the anxiety measure differs to the total N for 
parents as initially the study used the Spielberger Trait Personality 
Inventory (150) to collect data on anxiety.  However, it was decided 
that the STAI was a more efficient method of collecting this 
information, therefore, STPI scores collected prior to this change 
were discarded.   
Awareness Survey  Adolescents: 144 Only CYP aged 11 years and above completed this measure as it is 
not intended for younger children. 
  
2.11 Practical issues 
As discussed earlier in the chapter, research with children can be difficult for a number of 
reasons.  Both consent and assent must be taken from child participants.  This means that 
a parent must agree to their child participating in the study and the child themselves must 
fully understand their involvement in the study.  In order to ensure that this was achieved 
the study had to be explained to potential participants in a way that would be understood 
by different age groups.  The information sheets used for this study were aimed at 
different groups (e.g. parents and CYP) and age groups of participants to help ensure that 
the information that they received was clear and coherent to them.   
 
Completing lengthy questionnaires can be difficult for children as it can be tiring and 
difficult for them to concentrate for long periods.  However, in order to include large 
numbers of participants in the study with only one researcher, in quite a short period of 
time a questionnaire based study seemed the best way to proceed and the most efficient 
way to collect data concerning a variety of relevant areas.  For this study the age groups of 
the participants were considered when compiling the questionnaire packs to ensure that 
the packs weren’t too demanding for each group.  Appropriate questionnaire packs were 
aimed at 5-7 year olds, 8-10 year olds and 11+year olds; the younger 2-4 year olds were 
represented through parent by proxy reports.  
 
There were also some issues with recruitment to the study and again this could be related 
to the fact that children were being recruited.  Parents were asked to give consent for 
their children as well as for themselves and then asked to complete the questionnaires 
during waiting times in clinics.  At times there was sufficient time for the questionnaire 
packs to be completed but where parents and children might be required to stay longer 
than the appointment required, questionnaires were not always completed within the 
clinic and were taken home to complete.  Once taken home questionnaires were often 
forgotten or overlooked, even with reminder prompts from the researcher.  Parents and 
children often could not or were not prepared to spend additional time in clinic to 
 65 
 
complete the questionnaires for a number of reasons.  This included car parks charges, 
which were high at some clinics, and having to get back to school and work.  Also some 
children become tired and did not feel like completing the questionnaires if they had had 
lengthy appointments, for example, with the nurse, consultant and perhaps also a 
dietician.  To overcome such issues all potential participants were approached as soon as 
was possible in the clinic waiting area and encouraged to complete questionnaires in clinic 
where possible. Younger children received assistance from the researcher when 
completing questionnaires so that parents could concentrate on their own questionnaire 
packs. 
 
Phase two: Qualitative research method 
The aim of Phase two was to explore CYP’s views of living with diabetes in addition to their 
thoughts on hypoglycaemia.  Parental views were also sought. 
 
2.12 Design  
A semi-structured interview design was used. The interview was designed to discuss living 
with T1DM, experience of hypoglycaemia, diabetes management and impact of diabetes.  
The semi-structured design allowed the process to remain flexible so that CYP and parents 
could talk about other diabetes-related factors. 
 
2.13 Sample  
Participants were recruited from the original group of CYP and parents who participated in 
Phase one of the study.  All those who had taken part in Phase one and who had agreed to 
be approached for the second phase of the study were invited to take part in the 
interviews. 
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In order to address some of the shortcomings of the structured questionnaires in Phase 
one, Phase two of the study focussed on collecting more in depth data on themes arising 
from the quantitative analysis.  Thirteen CYP and thirteen parents took part in semi-
structured interviews to allow participants to talk more in detail about living with diabetes.  
Training in conducting focus groups and interview with young people was undertaken 
prior to Phase Two, at Warwick Medical School, UK.  Semi-structured interviews have the 
advantage of allowing both the participant and the interviewer to discuss a particular topic 
in much more depth than structured questionnaires allow.  A face to face interview also 
allows the interviewer to probe for further information to elicit richer data and enables 
the interviewer to clarify any ambiguities in a participant’s responses.  This method is 
more individualised and can allow questions to be clarified for participants with varying 
levels of understanding.  However, unlike structured questionnaires, the interview method 
is very time consuming and expensive.  This means that only a small number of 
participants are able to take part.  They can also be subject to interviewer bias where 
participants answer in a way they believe the interviewer wants them to respond.  
However, training in interview methods can help to avoid bias.  
 
In terms of this study the data from interviews will add to the limited qualitative data on 
adolescents and children with Type 1 diabetes.  In a systematic review of the qualitative 
studies of this type Spencer et al. (120) found limited studies in the UK and suggested  
measures should be taken to improve validity (i.e. triangulation) in order to provide better 
understanding of what it’s like for CYP to live with diabetes and to help to understand how 
they cope with it.  There will be further focus on the issue of hypoglycaemia and 
overcoming problems associated with hypoglycaemia and living and coping with diabetes 
in general. 
 
2.14 Qualitative measures 
A set of questions relating to living with diabetes and experiencing hypoglycaemia, to be 
used during interviews with patients and their parents, was devised by the researcher.  
Interview questions were based on items from the questionnaires used in Phase one.  The 
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interview schedule began with asking CYP and their parents about living with diabetes and 
the circumstances surrounding diagnosis.  The questions then focussed on the experience 
of hypoglycaemia and feelings/behaviours associated with episodes of hypoglycaemia.  
The interview schedule was designed to allow the researcher to elicit more detailed 
accounts of parent and CYPs’ fear of hypoglycaemia, self-care behaviours and living with 
diabetes in general.  Once the questions were put together the researcher together with 
two supervisors (consultant paediatrician in diabetes and senior lecturer in psychology) 
worked together to modify the questions to ensure that they were suitable for obtaining 
further details about living with diabetes in CYP and their parents.  The interview 
questions for CYP and parents are presented below (Tables 3 and 4). 
 
Table 3: Interview schedule (CYP) 
Interview Questions 
Children/Adolescents 
1. How old were you when you first had diabetes? 
2. How do you find living with diabetes?  What’s it like having diabetes?  Does it 
affect your daily life?  If so, how? 
3. What do you find difficult about having diabetes? (Do you think there’s anything 
good about having diabetes?  Younger children) 
4. Do you know what hypoglycaemia is? /What do you think hypoglycaemia is? 
a. How would you describe hypoglycaemia? 
5. Have you ever experienced hypoglycaemia? 
a. How many times have you had a hypo in the past year? 
b. Were you able to treat all of your hypos or did you need help? 
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c. Are you always aware that you are having a hypo? 
d. What symptoms do you have when experiencing a hypo? 
6. Do you tend to have hypos at specific times?  Example:  when you exercise? 
7. Have you ever had a hypo at school, with friends, away from your parents, during 
the night? 
8. Have you ever had a hypo while you’ve been asleep? 
a. Do you worry about having a hypo while you’re asleep? 
b. What in particular worries you about this? 
c. Does this affect how you sleep at night? 
d. In what way does this have an effect? 
9. Do you think your diabetes or hypos affect your family life? 
a. In what way do they have an effect? 
10.  Do you think your diabetes or hypos affect your school life? 
a. In what way do they have an effect? 
11. Do you worry about having hypos? 
a. What in particular do you worry about? 
b. How does having a hypo make you feel? 
12. How do you cope with hypos? 
a. What do you do when you have a hypo? 
b. Do you try to avoid having hypos? 
i. How do you manage this? 
13. Do you get any support in terms of your experience of hypos?  
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a. From family? 
b. From other sources (e.g. clinics, DSN, etc.)  
14. Would you like support from your Dr or DSNs in terms of dealing with your/your 
child’s diabetes? 
a. What kind of support do you think would be beneficial? 
For example, if they provided some training or teaching would it be better given 
one to one, in a group or maybe online  
Would e-learning be interesting if done in an age appropriate way? 
Would hypo alarms be any use (something that could be worn all the time or just 
at specific times of increased risk)? 
Do you have any ideas of what might be useful to you? 
 
Thank you for taking part, do you have any questions? 
 
Table 4: Interview schedule (parents) 
Interview Questions 
Parents 
1. How old was your son/daughter when they were diagnosed with diabetes? 
a. How do they cope with it generally? 
2. How do they find living with diabetes?  What do you think it is like for them having 
diabetes?  Does it affect their daily life?  If so, how? 
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3. What do you think they find difficult about having diabetes?  
4. Do you know what hypoglycaemia is? /What do you think hypoglycaemia is? 
a. How would you describe hypoglycaemia? 
5. Has your child ever experienced hypoglycaemia? 
a. How many times has your child had a hypo in the past year? 
b. Was your child able to treat all of their hypos or did they need help? 
c. Is your child always aware that they are having a hypo? 
d. What symptoms does your child have when experiencing a hypo? 
6. Has your child ever had a hypo while they’ve been asleep? 
a. Do you worry about your child having a hypo while they are asleep? 
b. What in particular worries you about this? 
c. Does this affect how your child sleeps at night? 
d. In what way does this have an effect? 
 
7. Do you experience any problems with sleeping? 
a. If so, what problems do you have 
b. Why do you think you have problems with sleep 
c. Do you feel that your difficulties with sleep impact on your day to day 
functioning? 
d. If so, in what way?  
8. Do you think your child’s diabetes or hypos affect their/your family life? 
a. In what way do they have an effect? 
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9.  Do you think your child’s diabetes or hypos affect their school life? 
a. In what way do they have an effect? 
 
10. Do you worry about your son/daughter having hypos? 
a. What in particular do you worry about? 
b. How does this make you feel? 
11. How do you cope with your child’s hypos? 
a. What do you do when your child has a hypo? 
b. Do you try to avoid your child having hypos? 
i. How do you manage this? 
12. Do you get any support in terms of your experience of hypos?  
a. From family? 
b. From other sources (e.g. clinics, DSN, etc.)  
13. Would you like support from your Dr or DSNs in terms of dealing with your/your 
child’s diabetes? 
a. What kind of support do you think would be beneficial? 
b. For example, if they provided some training or teaching would it be better 
given one to one, in a group or maybe online  
Would e-learning be interesting if done in an age appropriate way? 
Would hypo alarms be any use (something that could be worn all the time or just 
at specific times of increased risk)? 
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Do you have any ideas of what might be useful to your child? 
 
Thank you for taking part, do you have any questions? 
 
2.15 Procedure 
CYP and parents who took part in Phase One of the study were invited to take part in 
Phase two.  The focus was on collecting qualitative data obtained via interviews with CYP 
and parents.  CYP and their parents were invited to take part in Phase two via a letter 
which was sent to their home address with information sheets included.  An example of 
this letter and information sheet can be found in Appendix 21 and 22. CYP and their 
parents were asked to return an expression of interest form, indicating on the form 
whether or not they wanted to take part in the second phase of the study.  The researcher 
then contacted the parents who had expressed an interest in participating, by telephone, 
to arrange a time and place for the interview and to answer any questions they may have 
had. Phase two of the study involved interviewing children/adolescents and their parents 
attending diabetes clinics at UHCW, Coventry and LRI, Leicester. 
 
The patients and parents who agreed to take part in the interview sessions met with the 
researcher either at their local clinic (UHCW and LRI) or at patients’ homes, where 
interviews were conducted between February 2011 and December 2011. Thirteen CYP and 
13 parents took part in the semi- structured interviews.   
 
CYP and parents were told what the study was about, why the study was being conducted 
and what the interview session would involve.  Written consent was taken from both CYP 
and one parent (example in Appendix 23).  The CYP were aged between 7-17 years and 
were interviewed separately from their parent, unless they requested otherwise.  This was 
the case for two of the younger members of the group.  Interviews were recorded using a 
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Marantz digital recorder and then transcribed.  Interviews were recorded to ensure that 
the full concentration on the interview and without preoccupation with taking notes from 
the interview.  However, some notes were taken when necessary to record any non-verbal 
actions made by participants, such as hesitation, crying.  Recording the interview sessions 
also allowed full transcription of the interview and familiarisation with the exchange, 
which helped to contribute to the qualitative analysis.  Audio recordings were listened to 
at least twice in full.  Interviews were transcribed by listening back to recorded interviews 
and transcribing using Microsoft Word.  No prior training was received in transcribing.  
However, in order to ensure quality control, initial transcriptions were checked by two of 
my PhD supervisors.  This process also allowed both supervisors to monitor the way in 
which the interviews were conducted. 
 
Throughout the interview process CYP and their parents were given the freedom to speak 
as much or as little as they felt comfortable with within a friendly, empathetic and non-
judgmental forum. 
 
2.16 Data analysis 
2.16.1 Thematic analysis 
The qualitative data was analysed using thematic analysis.  The aim was to get richer data 
on the information that had already been collected during the quantitative phase of the 
study.  Braun and Clarke’s (153) paper on thematic analysis was used as a step by step 
guide to analysing the data, as described below.  This was deemed an acceptable method 
of carrying out the thematic analysis. 
 
Step 1: Familiarise yourself with data 
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Transcribing the interviews involved listening to each recording of the interviews a number 
of times.  This allowed familiarisation of the data.  Once each of the interviews had been 
transcribed, a final listen through of the interview was completed in order to check that 
each of the interviews had been transcribed correctly.  Familiarisation with the data 
contributed to data analysis as it allowed initial generation of codes.  During this step 
potential themes and codes emerged but were not formally recorded.   
 
Step 2: Generating initial codes 
Once all interviews had been transcribed, NVivo qualitative data analysis Software (QSR 
International Pty Ltd. Version 10, 2012) was used to help code sections of each of the 
interviews.  The codes were extracts of the interviews which contributed to the research 
question.   
 
Step 3: Searching for themes 
Once each interview had been coded, the coded extracts were analysed to identify how 
they might group together or where in fact they should remain distinct.  Initial analysis led 
to development of the following themes:  Impact, diabetes experience, fears (about 
diabetes), hypoglycaemia, fear of hypoglycaemia, coping with diabetes, diabetes 
management.  
 
Step 4: Reviewing themes 
Initial themes were reviewed and where themes seemed to have extracts that overlapped, 
these initial themes were merged.  For example, ‘diabetes experience’ was made up of 
initial themes including ‘coping with diabetes’ and ‘diabetes management.’  Reviewing the 
themes was an ongoing process whereby themes were merged and emerged through 
revisiting each transcript to see whether any other themes/sub-themes/codes might be 
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identified.  There was some discussion about the initial generation of themes and 
emerging themes with the three PhD supervisors.  This enhanced the thematic analysis as I 
was challenged to defend the themes I had initially identified and so reviewed my themes 
a number of times before I felt comfortable that they reflected the essence of the 
interviews.  
   
Step 5: Defining and naming themes 
During this stage all the themes and sub-themes were reviewed.  Where themes or sub-
themes were similar, these were merged.  Similarly in cases where the themes seemed too 
broad they were split into more distinct themes.  Eventually, three distinct themes were 
identified.  In the process of analysing these themes and writing up the analysis, sub-
themes also emerged where there was a pattern within the extracts from all of the 
interviews.     
 
Step 6: Producing report 
The final step was producing analysis of the interviews with extracts from the data to 
illustrate the themes and sub-themes identified.   
The relationship between the quantitative and qualitative data was examined in order to 
determine whether the data supported each other 
 
2.16.2 Reflexivity 
Inevitably, when conducting qualitative research a researcher’s own experiences and 
feelings might impact on the way the way that they carry out interviews and influence the 
direction of the interview.  Being a mother of two young children and also someone who 
has lived with a chronic condition for over a decade, some of the issues that were 
discussed during the interviews did have an impact on me personally.  However, I tried to 
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ensure that I stuck to the topics that needed further exploration and this was helped by 
having a semi-structured interview schedule to follow.  I certainly felt a lot of empathy 
towards mothers and the CYP and also admiration for the way that they coped with T1DM.  
I feel that this enhanced my data collection and also later my analysis.  I could really 
empathise and tried to identify with their situation which helped me recognise the issues 
that really seemed to affect them and to what extent.    
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Chapter 3 Results: Recruitment, participation and 
descriptive statistics 
This chapter will report on the recruitment and participation of eligible CYP and parents.  
Demographic data for the entire cohort of CYP, by age group and parents will also be 
presented.  The chapter ends with a discussion regarding response rates and the 
differences in response rates for specific measures. 
 
3.1 Participant recruitment 
After initial screening of 647 children and young people, 121 were deemed not eligible to 
participate (because they had been diagnosed with diabetes for less than one year).  Of 
the remaining 526 remaining eligible CYP, 117 (22%) did not attend their appointment, 46 
(9%) were missed in clinic, and 70 (13%) declined to take part, giving an overall 
participation rate of 55.7% (293/526).  Of these, 210 (71.7%) completed the study (Figure 
3)  
Figure 3: Participant recruitment 
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3.2 CYP demographics  
Two hundred and ten children and adolescents completed the study.  Table 5 shows the 
mean plus/minus standard deviation and minimum and maximum scores for 
demographics of the entire CYP cohort.   The mean age of the sample was 12.40 ± 3.4 
years with 49% females.  HbA1c scores for the sample overall ranged from 43.5-149.6 
mmol/mol (6.1% - 15.8%), with a mean score of 75.14±14.59.  Both current and previous 
(in brackets) methods of reporting HbA1c are shown.  The majority of the study sample 
was on an intensive (multiple daily injections) insulin regimen, with a small number of 
these using a pump.  Almost equal numbers of males and females took part in the study.  
Adolescents represented almost three quarters of the whole study sample.  
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Table 5: CYP demographics  
Variable All CYP                    
(3-18 years) 
(n= 210) 
Under 11                        
(3-10 years) 
(n= 59) 
Adolescents                  
(11-18 years) 
(n= 151) 
Age (Mean ± SD)                             12.40±3.4         8.15±1.97  14.05±2.06   
Female                      
Number (%) 
102 (49%) 26 (44%) 76 (50%) 
White ^                    
Number (%) 
 172 (82%) 46 (81%) 126 (83%) 
HbA1c mmol/mol      
(HbA1c %)                           
75.14±14.59 
(9.0±1.3) 
43.53-149.55     
(6.1-15.8) 
70.23±10.62    
(8.6±1.07) 
44.26-105.46**         
(6.2-11.8) 
77.06± 15.49      
(9.2±1.4) 
43.53-149.55              
(6.1-15.8) 
Duration of diabetes, in 
years (Mean ± SD)                             
5.14 ± 3.37 
1-17 
3.55± 2.02 
1-8.5 
5.77± 3.58 
1-17  
Insulin 
regimen  
Conventional 38 16 22 
Intensive 
[pumps] 
172 [12]        43 [2]* 129 [10] 
^includes White British, White Irish and Any other White ethnic groups 
* p<0.05 adolescents vs under 11 
** p<0.01 adolescent vs under 11 
Children and adolescents were split into two groups for analysis.  Fifty-nine (28%) under 11 
year olds and 151 (72%) adolescents took part in the research.  The ethnicity of the 
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majority of the study sample was identified as white (82%), whilst the remaining 18% of 
the sample was made up of African, Asian (Indian/Pakistani), Caribbean, mixed and other 
ethnic group.  A similar breakdown of ethnicity was also found for the under 11 year old 
and adolescent groups and both male and female participants.  The National Paediatric 
Diabetes Audit (NPDA) 2013-2014 (154) shows a population make up of 72% Type 1 
Diabetes patients who were White, which suggests, in terms of the wider population, this 
sample is slightly over-representative of white ethnicity. Almost equal numbers of males 
and females took part in the study overall, which is representative of the overall paediatric 
Diabetes population.   
 
3.3 CYP and HbA1c 
The target HbA1c level for patients with diabetes is 48mmol/mol (6.5%) (36).  However, 
this target is a general target and patients are advised of their ideal HbA1c by their local 
healthcare team. 
 
The mean HbA1c value for the overall sample was 75.14 ± 14.59mmol/mol (9.0±1.3), 
which is higher than the recommended level for patients with T1DM. 
 
3.3.1 Differences in HbA1c levels, by demographics. 
Further analysis showed that there was a significant difference in HbA1c between the 
under 11 year old group and adolescents.  Adolescent HbA1c values (M=77.06, SE=1.26) 
were significantly higher than the HbA1c values of under 11 year old children (M=70.23, 
SE=1.38); t=3.65, p= <0.001.  This difference could be explained by the fact that those in 
the younger age group were likely to have had T1DM for a shorter period of time and 
potentially were in the ‘honeymoon’ period of their diagnosis (2) where blood sugar levels 
seem to settle and are relatively easy to manage.  This is due to an increase in insulin 
production, a response to the insulin therapy a child is receiving.  Once this honeymoon 
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period comes to an end blood glucose levels should be monitored and managed more 
diligently. 
 
Males had slightly higher HbA1c levels than females (M=76.69, SE=1.43 v M=73.51, 
SE=1.41) although this did not reach statistical significance (p=0.115). 
 
Although it was be expected that those aiming for tighter blood glucose control (intensive 
regimens) would have a lower HbA1c, comparison of HbA1c levels between those on 
conventional (twice daily injections) vs intensive (multiple daily injections/pump therapy) 
insulin regimens (M=77.21, SE=13.6 vs M=74.69, SE=14.78) did not yield a statistically 
significant result (p=0.335).   
 
3.4 Insulin Regimen 
The mean duration of diabetes for the total population sample was 5.14 ± 3.37 years.  The 
majority of CYP were on an intensive (multiple daily injection/pump therapy) insulin 
regimen: 172 vs 38 on conventional (twice daily injections) insulin regimens. Twenty-seven 
percent of under 11 year olds were on conventional (twice daily injections) insulin 
regimens compared with 15% of adolescents.   
 
There was a significant association between age group and type of insulin regimen (x2 (1) = 
4.51, p=0.034) indicating that the adolescent group was significantly more likely to be on 
an intensive insulin regimen (85.4%) than the under 11 age group (72.9%).  This is to be 
expected as, at the time of the study younger patients were generally started on the 
conventional (twice daily injections) insulin regimen and then transitioned to the more 
intensive regimen as they got older.  This is not the case in current paediatric diabetes 
practice; newly diagnosed patients are more likely to be started on intensive regimens.  
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An equal number of males and females reported being on intensive insulin regimen 
therefore no differences were found between the groups for either treatment regimen (x2 
(1) = 0.78, p=0.38).    
  
3.5 Parent demographics 
One hundred and ninety parents (73% mothers) also took part in the study (Table 6).  
Table 6: Parent demographic data 
Variable Mothers 
(N=138) 
Mothers of  
U11 (N=47) 
Mothers of  
Adolescents 
(N=91) 
Fathers 
(N=52) 
Fathers of  
U11 (N=15) 
Fathers of 
Adolescents 
(N=37) 
Age            
(Mean ± SD) 
40.33±6.78     
(24-58) 
36.19±6.26 
(24-48)  N=43 
42.53±6       
(30-58)  N=81 
43.2±6.84*  
(25-59) 
37.27±6.35 
(25-46)  N=15 
45.74±5.43 
(38-59) N=35 
University 
educated 
32 (28%) 14 (35%) 18 (24%) 19 (41%) 6 (46%) 13 (39%) 
Senior level/ 
Professional 
Occupation 
18 (13%) 6 (15%) 12 (16%) 21 (40%) 5 (36%) 16 (46%) 
CYP HbA1c 
mmol/mol (%) 
(Mean ± SD) 
74.16±14.44 
(8.94±1.32) 
70.37±11.62 
(8.59±1.06) 
76.12±15.39 
(9.12±1.41) 
72.96±10.58 
(8.83±0.97) 
68.00±10.66 
(8.37±0.81) 
74.98±8.85 
(9.01±0.98) 
  
Table to show the mean scores plus/minus standard deviation, in addition to the minimum 
and maximum figures for each variable. 
*Mothers vs Fathers p<0.05 
 
The age range of parents was 24 – 59 years. The majority of mothers and fathers were 
identified as white (89% of mothers and 92% of fathers).  Twenty-eight per cent of 
mothers and 41% of fathers were university educated.  Thirty children and adolescents 
had both parents take part in the study. 
3.6 Breakdown of parental occupation 
The majority of mothers were employed in administrative (18.64%) and caring professions 
(18.64%).  A large number of mothers also identified themselves as housewives (16.95%).  
In comparison, the majority of fathers worked in managerial (24.49%), professional (18.37) 
and associate professional (16.33%) occupations. 
 
3.7 Response Rates 
The number of participants completing each measure varied from the total number of CYP 
and parents who took part in the study, for a number of reasons.  More detailed 
explanations and response rates can be found in the Methods chapter (section 2.10), 
however, in brief, the reasons for variation include the differing age requirements for the 
completion of measures; by proxy reporting by parents for young children; and a change in 
tool for the collection of anxiety data during the course of the study. 
 
3.8 Summary of Chapter 3 
This chapter outlines the demographic data of the children and adolescents who took part 
in the study.  Participants were recruited from a number of paediatric diabetes clinics in in 
the West Midlands, UK. 
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Equal numbers of males and females took part in the study and, as expected, a larger 
proportion of the sample was made up of those aged eleven and over (adolescent group).  
The ethnicity of the sample reflected figures reported by the NPDA 2013-2014 (154), with 
a slightly higher majority identifying themselves as White.  In terms of insulin regimen, the 
majority of CYP were on conventional (twice daily injections) insulin regimens, as was 
generally the norm at the time of the study.  However, paediatric practice in diabetes care 
has changed more recently, with intensive (multiple daily injections/pump therapy) 
regimens preferred at the point of diagnosis (26).  
 
Not surprisingly, the majority of the parent sample was made up of mothers.  This is 
typical of studies with paediatric groups as mothers tend to be the main carers.  It was 
refreshing to see that a number of fathers also participated in the study as paternal data 
tends to be limited. 
 
Response rates for CYP and parents were good, but as is the case in questionnaire-based 
studies, there was some variation due to factors associated with the measures themselves.  
These factors are reported and discussed in Chapter 2, section 2.10.        
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Chapter 4 Results: Self-reported frequency of 
hypoglycaemia and relationship to awareness of 
hypoglycaemia and HbA1c 
Managing diabetes in childhood is extremely important to help ensure that children 
remain healthy and to minimise the long-term complications associated with the 
condition.  Hypoglycaemia is an unavoidable and unpleasant consequence of diabetes 
management however, studies have shown it to be quite common amongst those with 
Type 1 Diabetes Mellitus. 
 
This chapter, therefore, focuses on the prevalence of hypoglycaemia in the study sample.  
The aim is to identify whether hypoglycaemia is evident in this UK sample of children and 
young people.  Descriptive statistics and graphical representations are used to 
demonstrate the incidence of hypoglycaemia and severe hypoglycaemia. 
 
4.1 Self-reported frequency of hypoglycaemia 
4.1.1 Definition of hypoglycaemia: 
Hypoglycaemia is defined as blood sugar levels lower than the normal 4-7mmol/L range 
(36).  Please note HbA1c is measured in mmol/mol and blood glucose levels are measured 
by mmol/L (155). 
 
The frequency of hypoglycaemia survey (47) was used to collected retrospective data on 
the experience of hypoglycaemia and severe hypoglycaemia over recent years and also 
over the course of the CYPs’ diabetes diagnosis. 
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Self-reported, retrospective data collection of the frequency of hypoglycaemia for the 
whole sample showed that only four per cent of the sample had never experienced 
hypoglycaemia.  A large percentage of the population sample reported experiencing an 
episode of hypoglycaemia more than once a month (66% of the entire cohort).  
 
In the following graphs, the under 11 year old responses include proxy reports from 
parents who responded for the under 8 year old participants as the measure is not 
suitable as a self-report measure for children aged under 8 years.  Percentages are 
reported by age group rather than percentages of the whole cohort. 
 
Figure 4: Self-reported and parent proxy reported frequency of 
hypoglycaemia by age group  
 
Figure 4 above shows that a higher percentage of the Under 11 group report more 
frequent episodes of hypoglycaemia than adolescents do (44.6% vs 26% experiencing 
hypoglycaemia more than once a week).  There are a number of factors which could 
explain these data.  Younger children (and their parents) might over-report hypoglycaemia 
as a result of being over cautious and potentially mistaking symptoms for an episode of 
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hypoglycaemia.  Conversely, adolescents might be under-reporting hypoglycaemia due to 
impaired awareness of hypoglycaemia (45).   Impaired awareness refers to a state where 
repeated exposure to hypoglycaemia actually reduces a person’s ability to detect an 
episode of hypoglycaemia, therefore affecting reports of hypoglycaemia history (48, 49).  
This will be discussed in more detail later in the chapter.   
 
Of course, the data could just be an accurate reflection of the experience of 
hypoglycaemia.  It could be that younger children do experience more episodes of 
hypoglycaemia, resulting from an inability to recognise symptoms of low blood sugar or 
potentially due to a newly diagnosed child still getting used to managing his/her diabetes.  
In this case then adolescents may actually experience less hypoglycaemia as they may be 
better at managing their BG levels.  It is also important to note that these data are 
retrospective and rely on participants accurately recalling hypoglycaemic events.  
Inevitably there will be some inaccuracies in the recalled responses. 
 
4.2 Self-reported episodes of Severe Hypoglycaemia 
4.2.1 Definition of severe hypoglycaemia: 
It can be difficult to define severe hypoglycaemia, especially for a paediatric population.  
This is because in adult studies an episode of hypoglycaemia is often defined as severe if 
the patient requires assistance to be treated (156).   
 
In paediatric groups, the likelihood that a child will need assistance in treating an episode 
of hypoglycaemia, is high, because often a parent will take responsibility for this.  Some 
studies (25, 27, 40) use a stricter definition citing the presence of a coma/seizure to define 
an episode of severe hypoglycaemia.  Nevertheless, as the measure for frequency of 
hypoglycaemia (47) defines an episode of SH as an episode requiring assistance for 
treatment, this is the definition that will be used for the present study. 
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Experience of severe hypoglycaemia for the whole sample showed that 48% of the entire 
CYP cohort had experienced more than 5 episodes of severe hypoglycaemia in their lives. 
Figure 5: Self-reported and parent proxy reported episodes of severe 
hypoglycaemia in CYP since diagnosis, by age group 
 
The data in the Figure 5, above, show that the majority of CYP, overall, have experienced 
at least one episode of severe hypoglycaemia, since diagnosis.  Episodes of severe 
hypoglycaemia seem to be similar between under 11 year olds and adolescents.  However, 
a higher percentage of adolescents reported experiencing 3-5 episodes of severe 
hypoglycaemia, whereas more of the younger group reported more than five epiodes of  
severe hypoglycaemia in their lives.  This indicates that, in general, both under 11 year 
olds and adolescents experience a high number of episodes  of severe hypoglycaemia.  
 
Grouping the higher frequency categories together (i.e. ‘3 to 5’ and ‘more than 5’ 
episodes) we can see that adolescents actually experience a greater number of episodes of 
severe hypoglycaemia than the under 11 group.  This could be due to impaired awareness 
of hypoglycaemia (as mentioned earlier, this will be discussed later in the chapter).  Having 
impaired awareness of hypoglycaemia means that a person might not experience or 
recognise the warning signs of hypoglycaemia until the episode becomes more serious and 
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requires assistance from another person.  Having said that, the estimated number of 
episodes  of severe hypoglycaemia is also high for the under 11 group.  This could be 
explained by the fact that parents tend to have to assist their children in treating an 
episode of hypoglycaemia, so in this instance may report these episodes as severe 
hypoglycaemia. Another explanantion is that younger children themselves might not 
recognise the symptoms associated with hypoglycaemia or might be unable to verbalise 
this to their parents, or their parents might not be able to recognise the signs of 
hypoglycaemia in their child (157), thus resulting in a more severe episode of 
hypoglycaemia. 
 
Either way, hypoglycaemia and severe hypoglycaemia both seem a real problem for 
children and young people in this sample.  Further analysis of self-reported frequency of 
hypoglycaemia and episodes of severe hypoglycaemia is reported below. 
 
4.3 Group comparisons of self-reported frequency of 
hypoglycaemia and self-reported episodes of severe 
hypoglycaemia. 
Self-reports of the frequency of hypoglycaemia and episodes of severe hypoglycaemia 
were explored further by age group and also insulin regimen group.  The tables below 
show all CYP responses to the multiple choice options presented in the frequency of 
hypoglycaemia measure (47) (which can be found in Appendix 1). 
 
Responses in the table below are shown for adolescents and 8-10 year olds.  Parents 
completed a proxy report for under 8 year olds, results of which can be found in the 
parent frequency tables (Table 11-16). 
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Table 7:  Self-reported frequency of hypoglycaemia (%) by age group 
 CYP  
N=193 
8-10 ^ 
N=43 
11-18 
N=150 
Frequency of hypoglycaemia   
Never 9 (5) 1 (2) 8 (5) 
Less than once/year  5 (3) 0 (0) 5 (3) 
1-3 times/year 18 (9) 3 (7) 15 (16) 
4-12 times/year 37 (19) 6 (14) 31 (21) 
More than once/month 67 (35) 15 (35) 52 (35) 
More than once/week 57(29) 18 (42) 39 (26) 
The table shows the CYP responses to the frequency measure.  The number in brackets 
indicates the percentage of CYP who responded in each category. 
^ Children aged under 8 did not complete the self-report Frequency of Hypoglycaemia 
measure (however parents completed a proxy report for under 8 year olds, results of 
which can be seen in the parent frequency table, Table 11).   
 
A chi-square test was carried out on the categorical frequency data in order to identify 
whether there were any significant differences in reported frequency of hypoglycaemia.  
There was no significant difference in reports of the frequency of hypoglycaemia and 
between age groups (p=0.288) or across gender (p=0.298).  The categories were 
dichotomised  into ‘less than once a week’ vs ‘more than once a week, to allow 
comparison of episodes of hypoglycaemia that were less disruptive vs extremely 
disruptive.  Chi-square analysis here showed a significant difference between age groups, 
x2(1) = 4.58, p=0.032, with more of the younger age group experiencing hypoglycaemia 
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more frequently than adolescents (42% vs 26%).  This difference in reports of 
hypoglycaemia could be attributed to the fact that younger children are more likely to be 
newly diagnosed or have had T1DM for a shorter period than their adolescent 
counterparts and therefore may not have quite managed to get their blood sugars under 
control.   
 
Table 8:  Self-reported episodes of severe hypoglycaemia (%) by age 
group 
 CYP 
N=193 
8-10 ^ 
N=43 
11-18 
N=150 
Episodes of severe hypoglycaemia           
(in CYP’s life) 
  
None 62 (32) 16 (37) 46 (31) 
1 or 2 65 (34) 16 (37) 48 (32) 
3-5 26 (13) 1 (2) 25 (17) 
More than 5 times 40 (21) 10 (24) 30 (20) 
This table shows the CYP responses to the frequency measure.  The number in brackets 
indicates the percentage of CYP who responded in each category. 
^ Children aged under 8 did not complete the self-report Frequency of Hypoglycaemia 
measure (however parents completed a proxy report for under 8 year olds, results of 
which can be seen in the parent frequency table, Table 11).   
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Chi-square analysis also showed no significant difference in reports of the number of 
episodes of severe hypoglycaemia between age groups (p=0.120) or across gender 
(p=0.509).  
 
Table 9:  Self-reported frequency of hypoglycaemia (%) by insulin 
regimen 
 Conventional  
insulin regimen 
N=37 
Intensive       
insulin regimen 
N=156 
Frequency of hypoglycaemia * 
Never 6 (16) 3 (2) 
Less than once/year  1 (3) 4 (3) 
1-3 times/year 8 (22) 10 (6) 
4-12 times/year 7 (19) 30 (19) 
More than once/month 6 (16) 61 (39) 
More than once/week 9 (24) 48 (31) 
The table shows the CYP responses to the frequency measure.  The number in brackets 
indicates the percentage of CYP who responded in each category. 
*p<0.05 (overall significant difference between conventional and intensive insulin 
regimens).  
 
Chi-square analysis revealed significant differences between the insulin regimen groups 
where, not surprisingly, overall, CYP on intensive insulin regimens reported a higher 
frequency of hypoglycaemia than CYP on the conventional insulin regimen (x2 (5) = 25.46, 
p= <0.001).  Specifically, those on intensive insulin regimens reported a higher frequency 
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of hypoglycaemia (more than once per month) compared to those on conventional insulin 
therapy (70% vs. 40%; p= <0.001). These results were not unexpected.  By trying to 
maintain optimum blood glucose levels, those CYP who managed their diabetes with 
intensive insulin regimes were potentially more likely to experience blood glucose levels 
that fell below the recommended 4-7mmol/L and were therefore more likely to 
experience hypoglycaemia. 
This finding suggests that when CYP intensively manage their T1DM then the frequency of 
hypoglycaemia is likely to be high.  It is important to note the relevance of this finding in 
the management of T1DM today, because recommended diabetes regimens have changed 
since this study was carried out (26) and intensive regimens are more common-place than 
they were previously.  More often than not CYP diagnosed with T1DM will be started on 
an intensive regimen straight away. 
 
Table 10:  Self-reported episodes of severe hypoglycaemia (%) by 
insulin regimen 
 Conventional 
 insulin regimen 
N=37 
Intensive  
insulin regimen 
N=156 
Episodes of severe hypoglycaemia (in 
CYP’s life) 
** 
None 20 (54) 42 (27) 
1 or 2 9 (24) 55 (35) 
3-5 3 (8) 23 (15) 
More than 5 times 5 (14) 35 (23) 
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This table shows the CYP responses to the frequency measure.  The number in brackets 
indicates the percentage of CYP who responded in each category. 
**p<0.01 (overall significant difference between conventional and intensive insulin 
regimens). 
 
Further chi-square analysis revealed significant differences between the insulin regimen 
groups where, again, not surprisingly, overall, CYP on intensive insulin regimens reported a 
higher number of episodes  of severe hypoglycaemia than CYP on the conventional insulin 
regimen x2(3) =10.17, p=0.017. Overall, those on intensive insulin regimens were also 
more likely to experience more episodes (more than 5) of severe hypoglycaemia than 
those on conventional regimens (23% vs. 14%, p=0.017).  Again these results were 
expected.  It seems that CYP who managed their diabetes with intensive insulin regimes 
were more likely to experience blood glucose levels that fell well below the recommended 
4-7mmol/L and were therefore more likely to experience severe hypoglycaemia.  The 
implications of this have already been discussed in relation to the relationship between 
insulin regimen and frequency of hypoglycaemia.  However, it should be noted that in a 
review of data of Danish children with T1DM from 1998-2009, intensive insulin regimens 
(multiple daily injections and pump therapy) significantly reduced the risk of severe 
hypoglycaemia in these patients (39). 
 
4.4 Parental reports of frequency of hypoglycaemia and episodes 
of severe hypoglycaemia 
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Table 11: Parent-reported frequency of hypoglycaemia (%), all CYP. 
 
The table shows parental responses to the frequency measure.  The number in brackets 
indicates the percentage of parents who responded in each category. 
*p<0.05 
 
Overall, there was a significant difference between reports of hypoglycaemia between 
mothers and fathers (x2 (5) = 15.18, p=0.010). Fathers reported a higher frequency (more 
than once a week) of hypoglycaemia for their children than mothers did (47% vs. 34%).  
This could be attributed to fathers potentially perceiving their child to have more episodes 
of hypoglycaemia than mothers (who are most likely to have a better idea of the number 
of episodes) and therefore over-reporting these episodes.   
 
 Parents 
N= 184 
Mother 
N= 133 
Father 
N= 51 
Frequency of hypoglycaemia  * 
Never 7 (4) 6 (5) 1 (2) 
Less than once/year 4 (2) 0 (0) 4 (8) 
1-3 times/year 11 (6) 9 (7) 2 (4) 
4-12 times/year 31 (17) 25 (19) 6 (12) 
More than once/month 62 (34) 48 (36) 14 (27) 
More than once/week 69 (38) 45 (34) 24 (47) 
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Table 12: Parent-reported episodes of severe hypoglycaemia (%), all 
CYP. 
 
Table 12 shows parental responses to the frequency measure.  The number in brackets 
indicates the percentage of parents who responded in each category. 
*p<0.05 
 
As with analysis of frequency of hypoglycaemia, there was a significant difference between 
reports of severe hypoglycaemia between mothers and fathers (x2 (3) = 8.28, p=0.041). 
 
 
 
 Parents 
N= 184 
Mother 
N= 133 
Father 
N= 51 
Episodes of severe 
hypoglycaemia (in CYP’s life) 
 * 
None 60 (32) 44 (33) 16 (31) 
1 or 2 54 (29) 43 (32) 11 (21) 
3-5 23 (12) 11 (8) 12 (23) 
More than 5 times 48 (26) 35 (26) 13 (25) 
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Table 13: Parent-reported frequency of hypoglycaemia (%), under 11 
group. 
 Mother Under 11 
N= 45  
Father Under 11 
N= 15 
Frequency of 
hypoglycaemia 
  
Never 1 (2) 0 (0) 
Less than once/year 0 (0) 0 (0) 
1-3 times/year 4 (9) 0 (0) 
4-12 times/year 2 (4) 1 (7) 
More than once/month 14 (31) 5 (33) 
More than once/week 24 (53) 9 (60) 
Table 13 shows the parental responses to the frequency measure.  The number in brackets 
indicates the percentage of parents who responded in each category. 
 
Looking at the mother and father reports of hypoglycaemia for the two age groups 
separately, results showed no significant differences between mother and father reports 
of hypoglycaemia for children aged under 11 (p=0.76).   A difference might have been 
expected here as with mothers being the primary caregivers they are more likely to have 
an accurate idea of frequency of hypoglycaemia than fathers. 
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Table 14: Parent-reported episodes of severe hypoglycaemia (%), 
under 11 group. 
 Mother Under 11 
N= 45  
Father Under 11 
N= 15 
Episodes of severe 
hypoglycaemia (in 
CYP’s life) 
* 
None 12 (27) 7 (47) 
1 or 2 15 (33) 1 (7) 
3-5 3 (7) 4 (27) 
More than 5 times 15 (33) 3 (20) 
Table 14 shows the parental responses to the frequency measure.  The number in brackets 
indicates the percentage of parents who responded in each category. 
*p<0.05 
 
Looking at the analysis of the parents of the under 11 age group for severe hypoglycaemia, 
chi-square tests showed there was a significant difference in reports of severe 
hypoglycaemia between mother and fathers (x2(3)=8.95, p=0.030), with mothers reporting 
more episodes (more than 5 times) of severe hypoglycaemia for the under 11 group than 
fathers (33% vs 20%). This result may be the result of mothers being the primary 
caregivers and therefore being more aware of actual episodes of severe hypoglycaemia 
than fathers. 
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Table 15: Parent-reported frequency of hypoglycaemia (%), 
adolescent group. 
 
Table 15 shows the parental responses to the frequency measure.  The number in brackets 
indicates the percentage of parents who responded in each category. 
** p<0.01 
 
Analysis of the parents of the adolescent group showed the opposite of the results 
produced for parents of the under 11 group.  A significant difference was evident in 
reports of frequency of hypoglycaemia (x2(5) =16.08, p=0.007) between parents of the 
adolescent group. Mothers reported a higher frequency of hypoglycaemia (more than 
once a month) for the adolescent group than fathers did (63% vs 45%). This could be 
attributed to mothers being around the adolescent group more than fathers and 
 Mother Adolescent 
N= 88 
Father Adolescent 
N= 36  
Frequency of 
hypoglycaemia 
** 
Never 5 (6) 1 (3) 
Less than once/year 0 (0) 4 (11) 
1-3 times/year 5 (6) 2 (6) 
4-12 times/year 23 (26) 5 (14) 
More than once/month 34 (39) 9 (3) 
More than once/week 21 (24) 15 (42) 
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potentially having a better idea of the number of episodes of hypoglycaemia they tend to 
have. 
 
Table 16: Parent-reported episodes of severe hypoglycaemia (%), 
adolescent group. 
 
The table shows the parental responses to the frequency measure.  The number in brackets 
indicates the percentage of parents who responded in each category. 
 
For the parents of the adolescent group there was no significant difference in reports of 
severe hypoglycaemia between mothers and fathers (p=0.192).   
 
 Mother Adolescent 
N= 88 
Father Adolescent 
N= 36 
Episodes of severe 
hypoglycaemia (in CYPs’ 
life) 
 
None 32 (36) 9 (24) 
1 or 2 28 (32) 10 (27) 
3-5 8 (9) 8 (22) 
More than 5 times 20 (23) 10 (27) 
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4.5 Comparison of episodes of reports of SH between CYP and 
parents 
A comparison of CYPs’ and mothers’ and fathers’ free responses of self-reports of severe 
hypoglycaemia in the preceding year revealed a significant relationship between the 
responses of CYP and their mothers (r=0.65, p= <0.001) and fathers (r=0.39, p= <0.001).  
Similarly, responses to the number of episodes of severe hypoglycaemia experienced in 
the year before last also showed a significant relationship between CYP and mothers’ 
(r=0.52, p= <0.001) and fathers’ (r=0.32, p=0.027) responses.  So CYP and parents’ reports 
of hypoglycaemia and severe hypoglycaemia are similar and showed a positive linear 
trend.   
 
As with the overall CYP group, mothers’ and fathers’ responses correlated positively with 
the responses provided by their children (with the exception of the fathers and U11 group) 
at, at least the 0.05 level of significance.  Reports of hypoglycaemia were similar between 
parents and CYP, for both age groups, except for fathers and the under 11 group.  Reasons 
for the difference in fathers’ responses and the response of the younger age group could 
be that fathers don’t tend to be the primary caregivers and so are less aware of the 
frequency with which their child is experiencing severe hypoglycaemia.  Why is this 
different to fathers of adolescents then?  The reason could be that reports of severe of 
hypoglycaemia are actually more likely to be severe in the adolescent group and therefore 
be relayed back to fathers whereas for the under 11 group a severe hypoglycaemia might 
be more likely just an episode which requires assistance from a parent but actually isn’t as 
severe in its nature, so therefore a lot of the time the fathers are unaware that they have 
occurred (because the event isn’t relayed back to them).   
 
Free responses to Q3a and Q3b (Appendix 1) asking recall of the specific number of 
episodes of severe hypoglycaemia in the previous year and year before that, suggest that 
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parents and their children have a similar recollection of CYPs’ experience of severe 
hypoglycaemia.  
 
4.6 The relationship between the frequency of hypoglycaemia 
and hypoglycaemia awareness 
Reports of hypoglycaemia will no doubt be affected by CYPs’ awareness of an episode of 
hypoglycaemia and severe hypoglycaemia.  Awareness of hypoglycaemia can be a factor in 
CYPs’ ability to report the frequency of hypoglycaemia as they may not always be aware 
that they are experiencing hypoglycaemia.  Awareness can also play a part in whether CYP 
are able to respond to an episode of hypoglycaemia before it becomes too severe, again 
because of the delay in being aware of experiencing hypoglycaemia. 
 
Hypoglycaemia awareness was measured using both the Gold (47) and Clarke (49) 
methods, across the adolescent group only, as it is not suitable for use by younger 
children.  Adolescents were assigned to one of two groups (normal awareness and 
impaired awareness) depending on their total score on the measure. A score of 4+ 
indicates an impaired awareness of hypoglycaemia (IAH).  Scores suggest that 25% (N=36) 
of adolescents have IAH.   
 
Differences between adolescents with normal awareness vs impaired awareness were 
explored. The two groups did not differ significantly on age, gender, HbA1c levels or insulin 
regimen.  Mann-Whitney tests showed that adolescents with IAH have a significantly 
longer duration of diabetes (Mdn = 6.5 years) than those with normal awareness (Mdn=5.0 
years), U=1465.0, p=0.027.  This is not unexpected as those with a longer duration of 
diabetes are likely to experience more episodes of hypoglycaemia, which itself is a 
contributor to impaired awareness. 
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Although there were no significant differences in awareness between adolescents on 
conventional vs intensive insulin regimens (p=0.683) here it might have been expected 
that those on intensive insulin regimens may be more likely to show signs of IAH than 
those on the conventional regimen due to those on intensive regimens potentially being 
more likely to experience hypoglycaemia due to tighter blood sugar control (156). 
 
Figure 6 below shows a comparison of adolescent reports of the frequency of 
hypoglycaemia by awareness of hypoglycaemia. 
 
Figure 6: Comparison of frequency of hypoglycaemia between CYP 
with normal vs impaired awareness of hypoglycaemia. 
  
This figure shows that very few adolescents in either group reported hypoglycaemic 
episodes less than once per year.  Those with IAH, however, were less likely to report 
hypoglycaemic episodes more than once a week.  This could be a reflection of their 
impaired ability to detect hypoglycaemia. 
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Correlational analysis was carried out using the raw scores from the awareness measure. 
There was no significant correlation between hypoglycaemia awareness and reported 
frequency of hypoglycaemia (r=-0.081, p=0.333).  When looking at awareness 
dichotomised into normal vs impaired awareness, chi-square analysis to observe the 
association between frequency of hypoglycaemia and hypoglycaemia awareness further, 
showed no significant relationship (x2(5)9.06, p=0.107).  Based on the theoretical link 
between hypoglycaemia and IAH (49), a significant association was expected.  More 
frequent episodes of hypoglycaemia might be expected to be associated with a higher 
incidence of impaired awareness of hypoglycaemia, considering research suggests 
increased exposure to hypoglycaemia can lead to IAH.  It could, however, be that those 
with IAH simply under-reported frequency of hypoglycaemia as they did not recognise the 
symptoms of an episode. 
 
4.7 The relationship between the episodes of severe 
hypoglycaemia and hypoglycaemia awareness. 
Having discussed the relationship between frequency of hypoglycaemia and IAH, it is 
important to also look at any association between severe hypoglycaemia and IAH.   
 
Figure 7 below shows the number of adolescents with normal and impaired awareness of 
hypoglycaemia, reporting on their experience of severe hypoglycaemia. 
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Figure 7: Comparison of episodes of severe hypoglycaemia between 
CYP with normal vs impaired awareness of hypoglycaemia. 
 
For severe hypoglycaemia, the data in Figure 7 show a difference between those 
adolescents with normal awareness and those adolescents with impaired awareness of 
hypoglycaemia.  Figure 7 shows that more adolescents with a normal awareness of 
hypoglycaemia report having had no or 1 or 2 severe hypoglycaemia in their lives whereas 
a higher proportion of those with an impaired awareness of hypoglycaemia (IAH) report a 
higher number of episodes of severe hypoglycaemia.  This follows from the earlier 
observation that those in the impaired group reported a lower number of episodes of 
hypoglycaemia potentially due to the fact that they had IAH.  Therefore the lack of 
awareness of hypoglycaemia could have led these adolescents to be more likely to 
experience severe hypoglycaemia as they might not have noticed or experienced the initial 
symptoms until their blood sugars dropped to extremely low levels.  
 
There was a significant positive correlation between awareness of hypoglycaemia scores 
and the number of episodes of severe hypoglycaemia in an adolescent’s life (r= 0.391, 
p=0.000), indicating that those with IAH experienced more frequent episodes of 
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hypoglycaemia.  Similarly, awareness scores also produced significant positive correlations 
with reports of severe hypoglycaemia in the last year (r=0.357, p= <0.001) and the year 
previous to last year (r=0.287, p= <0.001).  Again this indicates that those adolescents with 
IAH experienced more episodes of severe hypoglycaemia in preceding years, 
notwithstanding the fact that increased experiences of hypoglycaemia might have caused 
IAH in the first place.  Table 17 outlines the reported data for episodes of SH in the last 
year and the year before last.   
Table 17: Self-reported number of episodes of severe hypoglycaemia 
in preceding years (median (range)). 
 CYP U11 Adolescent 
No. of episodes of 
SH in the last year 
0.0 (0-100) 
N=181 
1.0 (0-100) 
N=43 
0.0 (0-30)  
N=138 
No. of episodes of 
SH in the year 
before last 
0.0 (0-100) 
N=178 
0.0 (0-100) 
N=43 
0.0 (0-50) 
N=135 
 
The association between awareness of hypoglycaemia and the number episodes of severe 
hypoglycaemia experienced in an adolescent’s life was explored further using chi-square 
analysis.  A significant association between awareness and experience of severe 
hypoglycaemia was found x2 (3) = 11.32, p=0.010.  Reports of more than 5 episodes of 
severe hypoglycaemia were higher for those with impaired awareness when compared 
with CYP with normal awareness (33.3% vs 16.7%).  This is not surprising considering that 
those with impaired awareness are less likely to experience the early signs of a 
hypoglycaemic episode (if at all), which in turn can become more severe if it hasn’t been 
treated. 
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4.8 Frequency of Hypoglycaemia and HbA1c 
4.8.1 CYP 
Overall, for all CYP there were no significant differences in HbA1c data across frequency of 
hypoglycaemia (F=0.92, p=0.47) and frequency of severe hypoglycaemia (F=0.30, p=0.83).  
No differences in HbA1c were found when comparing those CYP who had suffered from an 
episode of severe hypoglycaemia vs those who had not (U=4013.0, p=0.90).  Correlations 
of free reports of severe hypoglycaemia in the past year and year before with HbA1c also 
returned no significant relationships (p=0.336 and p=0.601, respectively).  This is 
surprising.  It might have been expected that there was some link between frequency of 
hypoglycaemia/severe hypoglycaemia and HbA1c, perhaps a lower HbA1c to reflect more 
frequent episodes of hypoglycaemia.  However, this was not the case.  HbA1c can be 
affected by a number of external (and internal factors) which could have mediated any 
potential relationship. 
 
4.9 Summary of Chapter 4 
The incidence of hypoglycaemia and severe hypoglycaemia is high in both the under 11 
age group and adolescent group.  The data show that 60% of adolescents and 80.3% of 
under 11 year olds report experiencing hypoglycaemia more than once a month.  This is in 
stark contrast to the percentage of under 11 year olds and adolescents reporting never 
having experienced hypoglycaemia (1.8%; 5.3%). 
 
Reports of episodes of severe hypoglycaemia (requiring the assistance of another person 
in order to treat the episode) are also high.  Almost 37% of adolescents report having 
suffered from severe hypoglycaemia more than 3 times in their lives, with almost 30% of 
under 11 year olds also reporting the same thing.  The figures do cause for concern, 
however, they don’t tell us how severe the episodes of hypoglycaemia being reported 
here, are.  Are they episodes leading to coma/seizures or are they just episodes that 
require assistance because the child or adolescent is too young or unprepared to treat the 
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episode themselves?  A limitation of the data here may also impact the reports of severe 
hypoglycaemia.  The interpretation of severe hypoglycaemia might vary across individuals 
in this age group so the data might not give a true reflection of the experience of severe 
hypoglycaemia.  Self-report data also relies on participants being able to accurately recall 
events that may have happened a year or two previously.  
 
Overall, there was no statistically significant difference for the frequency of hypoglycaemia 
or frequency of severe hypoglycaemia, either between age groups or across gender, 
although dichotomising the frequency responses showed otherwise. Significant 
differences were found, however, between the two insulin regimens.  Not surprisingly, 
those on more intensive regimens reported a higher frequency of hypoglycaemia and 
severe hypoglycaemia than CYP on conventional insulin regimens. 
 
Mothers and fathers were found to report significantly different frequencies of 
hypoglycaemia and severe hypoglycaemia.  This could be related to the roles that they 
play in their child’s diabetes management.  Reports of hypoglycaemia were similar, at, at 
least the 0.05 level of significance, between parents and their children across age groups, 
except for fathers and the under 11 year group.   
 
Links between the frequency of hypoglycaemia and impaired awareness of hypoglycaemia 
were explored.  Significant differences in the frequency of severe hypoglycaemia between 
adolescents with impaired vs normal awareness of hypoglycaemia were found.  The results 
were not replicated for the frequency of hypoglycaemia.  
 
Unexpectedly, no significant relationships were found between frequency of 
hypoglycaemia, frequency of severe hypoglycaemia and HbA1c 
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Chapter 5 Results: Fear of Hypoglycaemia 
Fear of hypoglycaemia (FoH) is an emotional/cognitive response to the experience of 
hypoglycaemic episodes. Experience of hypoglycaemia can be upsetting, embarrassing and 
even terrifying for people with diabetes and their carers.  This can lead to a fear of 
experiencing an episode of hypoglycaemia and can lead to sub-optimal care for oneself or 
if caring for another, by keeping blood sugar levels higher (72, 78) than recommended by 
health professionals, in order to avoid the unpleasant symptoms associated with 
hypoglycaemia.  
 
The scale used to measure FoH in the population sample of this study is the 
Hypoglycaemia Fear Survey (HFS) (147).  This measure looks at behaviours and worry 
associated with hypoglycaemia, as well as a Total score, in order to quantify (to an extent) 
the fear of hypoglycaemia in an individual (see 2.5.2.5 for full description of HFS measure).  
The HFS scale has a version suitable for CYP (Child Hypoglycaemia Fear Survey; CHFS) and 
one aimed at parents of CYP with T1DM (Parental Hypoglycaemia Fear Survey; PHFS).  The 
measure does not provide definitive scores or cut off points of whether a person has a fear 
of hypoglycaemia or not, but rather gives indication of FoH on a scale (0 - 125 scores); i.e. 
a higher score indicates a higher fear of hypoglycaemia.    
 
5.1 Fear of hypoglycaemia in CYP 
It is difficult to say conclusively whether CYP in this study have a fear of hypoglycaemia, 
considering there is no cut off score.  However, the scores suggest that children and 
adolescents do experience a level of FoH, given that the scores are above zero.  Table 17 
highlights the mean and standard deviation for scores on the HFS measure for CYP.   
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Table 18: HFS Measure (Mean plus/minus SD and range) 
 Total CYP U11 Adolescents P 
HFS Behaviour 19.68±6.82    
(0-40) N=203 
20.54±7.65     
(4-36) N=52 
19.38±6.51     
(0-40) N=151 
N/S 
HFS Worry 17.49±11.92 
(0-53) N=197 
18.96±13.79    
(0-52) N=50 
16.99±11.21   
(0-53) N=147 
N/S 
HFS Total 37.11±14.94 
(0-82) N=197 
39.7±16.75     
(6-82) N=50 
36.22±14.23   
(0-75) N=147 
N/S 
   
5.2 Difference in fear of hypoglycaemia between age groups 
Figure 8 below illustrates the difference in HFS scores between the under 11 group and 
adolescents. 
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Figure 8: Difference in fear of hypoglycaemia between age groups, 
including standard deviation. 
 
Analysis looking at the differences between the CHFS scores for the age groups of CYP 
showed no significant differences between the under 11 group and adolescents.  The 
under 11 group (M=20.54, SE=1.06) scored higher for HFS Behaviour than the adolescent 
group (M=19.38, SE=0.53).  The difference, however was not statistically significant, t=-
1.05, p=0.293.  For HFS Worry, again the under 11 group (M=18.96, SE=1.95) scored higher 
than the adolescent group (M=16.99, SE=0.93).  There was not a significant difference 
between the scores for the two groups, t=-1.01, p=0.315.  Finally, the two groups’ total 
CHFS scores were compared.  The under 11 group (M=39.7, SE=2.37) scored higher than 
the adolescent group (M=36.22, SE=1.17).  There was no significant difference between 
groups for total CHFS scores, t=-1.43, p=0.156.  Although there were negative correlations 
between CHFS scores and age and diabetes duration, the correlations were not statistically 
significant.  This indicates that FoH does not decrease as age and duration of diabetes, 
increase. 
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5.3 Differences in fear of hypoglycaemia, by demographics  
Figure 9 below shows the difference in HFS scores between those on conventional vs 
intensive insulin regimens. 
 
Figure 9: Differences in fear of hypoglycaemia by insulin regimen  
 
 
5.3.1 Fear of hypoglycaemia and insulin regimen 
Differences in FoH scores between CYP on conventional and intensive insulin regimens 
were explored.  T-test analysis revealed no significant differences in CHFS scores between 
CYP on conventional vs intensive insulin regimens, (M= 36.86, SE = 16.76) vs (M = 37.16, SE 
= 14.54), t=0.11, p=0.913.  The results were surprising; it might be expected that those 
who are on intensive insulin regimens are more likely to experience a higher frequency of 
hypoglycaemia and severe hypoglycaemia.  Therefore a higher frequency of 
hypoglycaemia and SH might be expected to contribute to a fear of hypoglycaemia (due to 
increased exposure to hypoglycaemia).   
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Looking at results for CHFS by insulin regimen, for each of the age groups, there was also 
no significant difference within the under 11 group between conventional vs intensive 
regimens (M=36.0, SE=4.48) vs (M=40.51, SE=2.72), p=0.470.  A similar result is reported 
for differences in CHFS for adolescents between those on conventional vs intensive 
regimes (M=40.19, SE=2.83) vs (M=35.37, SE=1.28), p=0.117). 
 
5.3.2 Fear of hypoglycaemia and gender 
No differences between genders, for CHFS scores were found. Data not presented. 
 
5.3.3 Fear of hypoglycaemia and HbA1c 
Considering one of the key implications of FoH is the impact it may have on HbA1c levels it 
is important to explore whether there is a relationship between HbA1c and CHFS scores 
(Table 19). 
   
Table 19: Relationship between fear of hypoglycaemia (Behaviour (B), 
Worry (W) and Total (T)) scores and HbA1c levels 
 CYP U11 Adolescent 
 CHFS-
B 
CHFS-
W 
CHFS-
T 
CHFS-
B 
CHFS-
W 
CHFS-
T 
CHFS-
B 
CHFS-
W 
CHFS-
T 
CYP 
HbA1c 
-0.095 -0.001 -0.047 -0.122 0.181 0.091 -0.073 -0.030 -0.057 
Table above reports the correlation coefficients, illustrating the relationship between CHFS 
scores and HbA1c.  
Analyses of CHFS scores and HbA1c showed no statistically significant correlations 
between the two variables for all CYP or by age group.  Considering that behaviour 
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associated with FoH might lead to those CYP with T1DM (or their parents) maintaining 
higher blood glucose levels, a positive correlation between CHFS scores and HbA1c might 
be expected.  So as fear of hypoglycaemia increased blood glucose levels and 
consequently HbA1c levels would also increase (to reflect behaviours to avoid 
hypoglycaemia).  However, as HbA1c can be affected by a number of factors (duration of 
diabetes, the weather, physical activity, body mass index) it could be that alone, FoH does 
not have a strong enough link with HbA1c levels.  HbA1c is also a relatively short term 
measure and changes every three months so might not be a reliable indicator, however, 
for this study, where available, the average HbA1c over the past 12 months was recorded 
to counteract this. 
    
Although these results reflect similar reports to other studies looking at HbA1c and FoH 
(72), other studies report an association between high CHFS scores and higher HbA1c 
levels, especially for adolescents (83).  
 
5.4 Parental fear of hypoglycaemia 
As mentioned previously, there is no cut off point to indicate whether or not a person has 
a fear of hypoglycaemia.  Instead, the scores indicate the level of fear on a scale (higher 
scores indicate higher FoH).  For parents of children and adolescents in this study, FoH is 
evident, however, statements cannot be made as to whether this fear is high or not.  
Comparisons of scores between groups however, will allow some conclusions to be drawn.  
Parental scores are shown below in Table 20. 
  
 
Table 20: HFS measure parental scores (Mean plus/minus SD and range) 
 Mother  Father Mother U11 Mother 
Adolescent 
Father U11 Father 
Adolescent 
PHFS 
Behaviour 
22±7.07       
(2-38)  N=138 
21.06±7.17 
(4-38)   N=52 
22.51±5.45 
(8-33) N=47 
21.74±7.79 
(3-38) N=91 
22.53±6.19 
(12-35) N=15 
20.46±7.52 
(4-38) N=37 
PHFS 
Worry 
28.04±13.51 
(0-56)  N=137 
24.02±12.74 
(2-55)   N=52 
27.70±13.53 
(4-51) N=47 
28.21±13.57 
(0-56) N=90 
25.53±13.46 
(9-55) N=15 
23.57±12.71 
(2-53) N=37 
PHFS 
Total 
50.16±17.76 
(3-89)   N=137 
45.15±17.96 
(13-89)   N=52 
50.13±15.36 
(22-77) N=47 
50.18±18.97 
(3-89) N=90 
48.07±16.83 
(21-83) N=15 
44.14±18.60 
(13-89) N=37 
  
  
 
5.4.1 Comparison of parental HFS scores, by age group. 
There were no significant differences between the two groups for CYP overall, although 
mothers’ scores were higher than fathers’ scores.  A comparison of mothers’ and fathers’ 
PHFS scores revealed no significant differences across age groups for each of the 
subscales.   Similarly, no significant differences were found between mothers’ and fathers’ 
PHFS scores, for the under 11 group and the adolescent group, although, mothers scored 
higher than fathers across all PHFS subgroups for adolescents. 
 
PHFS scores of mothers of the two age groups and fathers of the two age groups were 
compared.  No significant differences were found between PHFS scores for mothers of the 
under 11 age group and mothers of the adolescent group.  Similarly, no significant 
differences were found between PHFS scores of fathers of the under 11 group and fathers 
of the adolescent group. 
 
5.4.2 Comparison of parental HFS scores, by CYP’s insulin regimen  
No significant differences in parental PHFS scores were found between mothers of CYP on 
conventional vs intensive insulin regimens.  Similarly no significant differences in PHFS 
scores were found between fathers of CYP on conventional vs intensive insulin regimens. 
Data not shown. 
 
5.5 Relationship between CYP and parental fear of 
hypoglycaemia  
The relationship between CYP FoH and parental FoH was investigated by analysing CHFS 
and PHFS scores. 
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Table 21: Comparison of all CYP and Parent HFS scores (Mean 
plus/minus SD and range) 
**p<0.01 CYP vs Mothers/Fathers 
***p<0.001 CYP vs Mothers 
 
Table 21 shows a comparison of HFS scores between all CYP, mothers and fathers.  T-test 
analyses of mothers’ and CYP HFS scores showed significant differences across all HFS 
categories.  Mothers scored significantly higher than CYP for HFS Behaviour (t=-3.04, 
p=0.003), Worry (t=-7.36, p= <0.001) and Total (t=-7.04, p= <0.001) all at the 0.01 level of 
significance.  These results suggest that mothers of CYP with T1DM actually present a 
higher FoH for their children than CYP do for themselves.  As far as I am aware there have 
been no similar reports of comparisons between mothers’ and CYP HFS scores, however 
this outcome is not surprising.  Clarke et al. (75) found that mothers have higher FoH than 
adult patients have for themselves.  Haugstvedt et al. (86) looked at both mothers’ and 
fathers’ FoH and found that mothers report higher FoH than fathers do, as did Patton et al. 
(158) and more recently Pate et al. (87). These results show that in general, mothers do 
tend to report higher FoH than other groups do.  This presents an important issue that 
could have a number of implications for mothers of children with T1DM in terms of their 
well-being and also their children’s diabetes management.  This will be explored further in 
Discussion Chapter 7 and the qualitative results Chapter 8.   
 
 Total CYP Mother  Father 
HFS Behaviour 19.68±6.82 (0-40) 22±7.07 (2-38) ** 21.06±7.17 (4-38) 
HFS Worry 17.49±11.92 (0-53) 28.04±13.51 (0-56) 
*** 
24.02±12.74(2-55) 
** 
HFS Total 37.11±14.94 (0-82) 50.16±17.76 (3-89) 
*** 
45.15±17.96 (13-89) 
** 
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A comparison of CYP vs fathers’ HFS scores showed that fathers scored higher on all 
subscales for fear of hypoglycaemia than CYP did for themselves.  Although scores were 
not significantly different for the HFS Behaviour subscale (p=0.199), fathers’ scores were 
significantly higher than CYP for the HFS Worry (t=-3.46, p=0.001) and Total (t=-3.31, 
p=0.001) subscales.  Fathers also have a higher FoH than their children but this is more 
linked to worry about hypoglycaemia and not so much the behaviours associated with 
having a fear of hypoglycaemia.  Again, this can have implications for fathers’ well-being. 
 
5.5.1 Under 11 group vs parental HFS scores 
A comparison of HFS scores across the age groups and respective parental age groups was 
also made (Table 22). 
Table 22: Comparison of U11 and parental HFS scores (Mean 
plus/minus SD and range) 
 Under 11 Mother U11 Father U11 
HFS-Behaviour 20.54±7.65 (4-36) 22.51±5.45 (8-33) 
N=47 
22.53±6.19 (12-35) 
N=15 
HFS-Worry 18.96±13.79 (0-52) 27.70±13.53 (4-51) 
N=47 * 
25.53±13.46 (9-55) 
N=15 
HFS-Total 39.7±16.75 (6-82) 50.13±15.36 (22-77) 
N=47 * 
48.07±16.83 (21-83) 
N=15 
*p<0.01 U11 vs Mothers of U11 
 
For the under 11 age group the only significant difference in HFS scores was evident 
between the under 11 group and mothers of under 11 year olds for the HFS Worry (t=-
3.15, p=0.002) and Total (t=-3.19, p=0.002) subscale, with mothers of under 11s, again 
scoring higher.  Although mothers of under 11s were also found to have a higher mean 
score than the under 11 groups for the HFS Behaviour subscale, this difference was not 
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significant (p=0.140). This again shows that mothers reported a higher FoH for their under 
11 year olds, than this group did for themselves.  Although behaviour scores did not 
significantly differ, mothers’ worry about hypoglycaemia exceeded that of their child.  
Again, this is not surprising given that previous research does suggest that mothers tend to 
report higher FoH than other groups (i.e. patients with T1DM, fathers) (75, 86, 87, 158). 
 
Fathers of under 11 year olds also scored higher than the under 11 group across all HFS 
subscales, however, none of these comparisons were significantly different (p>0.05 across 
all HFS subscales).   
 
5.5.2 Adolescent vs parental HFS scores 
Looking at the adolescents’ HFS scores in comparison to the HFS scores of mothers and 
fathers of adolescents’, in the main, parents scored significantly higher than adolescents 
across all subscales (Table 23) 
Table 23: Comparison of Adolescent and parental HFS scores (Mean 
plus/minus SD and range) 
 Adolescents Mother Adolescent Father Adolescent 
HFS Behaviour 19.38±6.51 (0-40) 21.74±7.79 (3-38) 
N=91 * 
20.46±7.52 (4-38) 
N=37 
HFS Worry 16.99±11.21 (0-53) 28.21±13.57 (0-56) 
N=90 *** 
23.57±12.71 (2-53) 
N=37 ** 
HFS Total 36.22±14.23 (0-75) 50.18±18.97 (3-89) 
N=90 *** 
44.14±18.60 (13-89) 
N=37 * 
*p<0.05 Adolescent vs Mother of Adolescent/Father of Adolescent 
**p<0.01 Adolescent vs Mother of Adolescent/Father of Adolescent 
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***p<0.001 Adolescent vs Mother of Adolescent 
 
Mothers of adolescents scored significantly higher than the adolescent group for HFS 
Behaviour (t=-2.53, p=0.012), Worry (t=-6.59, p= <0.001) and Total (t=-6.02, p= <0.001) 
scores.  Similarly, fathers of adolescents scored significantly higher than adolescents on 
the HFS Worry (t=-3.10, p=0.002) and Total (t=-2.42, p=0.020) scores and although fathers 
scored higher than adolescents on the HFS Behaviour subscale, this was not a statistically 
significant difference (p=0.384).  So, it seems that even when broken down by age groups, 
at least for the adolescent group, mothers and fathers actually reported a greater fear of 
hypoglycaemia than their children reported for themselves.  Fathers reported higher 
worry scores whereas mothers reported both higher worry and behaviour scores 
associated with FoH.  These results are unprecedented, at least in UK samples, to my 
knowledge, no studies have found a significant difference between parent and child HFS 
scores.  This could have implications for both the well-being of mothers and fathers of CYP 
with T1DM and also for the management of diabetes for mothers of adolescent age 
groups. 
 
5.6 CYP HbA1c and parental fear of hypoglycaemia  
CYP HbA1c and parental FoH were explored to identify any relationship between the two 
(Table 24). 
 
Table 24: Correlation between CYP HbA1c and parental HFS scores 
Scale Mothers  Fathers 
HFS-T HFS-B HFS-W HFS-T HFS-B HFS-W 
CYP HbA1c -0.0112 -0.049 -0.072 -0.120 -0.011 -0.053 
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Pearson’s correlation was carried out on the data. The table shows that there were no 
significant correlations between parental PHFS score and CYP HbA1c.  This suggests that 
for this study sample, there is no relationship between HbA1c levels and parental HFS 
scores.  This supports research by Johnson et al. (83) who also found no association 
between parental HFS scores and CYP HbA1c levels.  Again a positive relationship might 
have been expected here as higher FoH might lead to behaviours associated with avoiding 
hypoglycaemia such as maintaining higher than recommended blood glucose levels. 
Hawkes et al. (84), report that parents of CYP with HbA1c levels lower than 7.5% had lower 
HFS scores than parents of those CYP with HbA1c levels over 7.5%.  It should be noted 
however, that HbA1c can be affected by more than just blood glucose control so analyses 
of cross-sectional data might not pick up on the full impact of FoH.  
 
5.7 Fear of hypoglycaemia and self-reported frequency of 
hypoglycaemia  
Frequency of hypoglycaemia was not significantly related to either CHFS or PHFS scores in 
any group studied, which was surprising.  A higher frequency might be likely to be linked 
with a higher FoH, since the experience of an episode of hypoglycaemia and accompanying 
symptoms might lead to a person with T1DM carrying out hypoglycaemia-avoidance 
behaviours. 
 
5.8 Fear of hypoglycaemia and self-reported episodes of severe 
hypoglycaemia 
5.8.1 CYP 
Overall, there was a significant positive relationship between episodes of severe 
hypoglycaemia and CHFS-W scores (r=0.16, p=0.025) and CHFS-T (r=0.20, p=0.005).  This 
suggests that those who experience a higher number of episodes of severe hypoglycaemia 
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are also more likely to worry about hypoglycaemia and consequently report higher levels 
of FoH. 
 
CYP CHFS-T scores also seemed to differ between those who had no experience of  severe 
hypoglycaemia vs those who had suffered at least one episode of severe hypoglycaemia  
(M= 32.34, SE=1.68) vs (M=39.14, SE=1.34), t(185)=-3.04, p=0.003).  Again, this shows that 
those with experience of severe hypoglycaemia also presented higher levels of FoH. 
 
5.8.2 Under 11 years 
Further analyses showed no significant correlations between under 11 CHFS scores and 
episodes of severe hypoglycaemia.   
 
There was also no significant difference in CHFS scores between children in the under 11 
year group who have experienced at least one episode of severe hypoglycaemia compared 
to those who have not (p>0.05 across all CHFS subscales).   
 
For this younger age group then, there appears to be no difference in FoH between those 
who have experienced severe hypoglycaemia and those who have not.  This could be 
explained by the fact that severe hypoglycaemia for this age group might represent more 
episodes where an adult has had to help the child to treat their hypoglycaemia, not 
necessarily because their symptoms were severe but more due to the young age of the 
child.  Severe hypoglycaemia for this age group might not therefore, translate to a fear of 
hypoglycaemia.  It will be interesting to look at adolescents’ results in comparison. 
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5.8.3 Adolescents 
In contrast to the younger group, significant positive relationships were found between 
severe hypoglycaemia and all subscales of the HFS measure (HFS-B: r=0.162, p=0.047; HFS-
W: r=0.175, p=0.035; HFS-T: 0.244, p=0.003) for the adolescent group.  Again, this suggests 
a link between FoH and the number of episodes of severe hypoglycaemia.   
 
For the adolescent group then, it is likely that the reports of severe hypoglycaemia are 
based on more severe symptoms of hypoglycaemia rather than just the fact that they 
required assistance to treat their episode of hypoglycaemia.  Therefore, it is not surprising 
that those who have experienced severe hypoglycaemia have higher FoH than those who 
have not. 
 
Adolescents who had never experienced severe hypoglycaemia in the past had 
significantly lower CYP CHFS scores compared to those who had, had at least one episode 
of severe hypoglycaemia in their lives (CHFS-B (M= 17.39, SE=0.86) vs (M= 20.34, SE=0.65), 
t=-2.61, p=0.010; CHFS-W (M= 12.78, SE=1.11) vs (M=18.84, SE=1.21), t=-3.68, p= <0.001; 
CHFS-T (M=30.17, SE=1.7) vs (M=38.99, SE=1.46), t=-3.61, p= <0.001) suggesting that prior 
experience of severe hypoglycaemia is an important contributor to fear of hypoglycaemia 
in this age group.  
 
5.8.4 Parental HFS scores, all CYP  
Differences in parental PHFS scores were evident between those whose CYP had 
experienced severe hypoglycaemia vs those whose CYP had not, for mothers (PHFS-W 
(M=30.15, SE=1.37) vs (M=24.8, SE=2.29), t=-2.11, p=0.037) and fathers (PHFS-T (M=48.94, 
SE=2.95) vs (36.57, SE=4.64), t=-2.24, p=0.300.  This supports the idea that those parents 
whose children have suffered at least one episode of severe hypoglycaemia have a higher 
fear of hypoglycaemia (fathers) or at least worry about hypoglycaemia (mothers) more 
than those parents whose children have never experienced severe hypoglycaemia. 
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5.8.5 Parental HFS scores, under 11 
Mothers of children who had suffered at least one episode of severe hypoglycaemia, in the 
under 11 group, scored higher on PHFS-W scores compared to mothers of under 11 year 
olds who had never experienced severe hypoglycaemia (M= 32.7, SE=2.52) vs (M=23.77, 
SE=3.66), respectively, t=-2.08, p=0.046. This suggests that for mothers, previous 
experience of severe hypoglycaemia for their children (aged less than 11 years) 
contributes to worry about hypoglycaemia, but not necessarily behaviours to avoid 
hypoglycaemia.  
 
5.8.6 Parental HFS scores, adolescents 
There was no relationship between mothers’ PHFS scores and their child’s history of 
severe hypoglycaemia in analysis of adolescents. However, fathers’ PHFS scores differed 
significantly between those fathers with adolescent children who had experienced severe 
hypoglycaemia compared with those that hadn’t (M=48.64, SE=3.57) vs (M=30.11, 
SE=2.57), t=-4.21, p= <0.001.  Interestingly here, it appears that fathers of adolescents 
with a history of severe hypoglycaemia have an increased fear of hypoglycaemia. It could 
be that being the main caretakers, mothers are more aware of and therefore more 
confident in their child’s ability to treat their own hypoglycaemia than fathers are. 
 
5.9 Summary of Chapter 5 
This sample of CYP and their parents do experience a level of fear of hypoglycaemia.  
However, as there is no definitive score to indicate the presence of FoH or not we cannot 
conclusively report whether participants had a high FoH. 
 
There were no statistically significant differences between CHFS scores between under 11 
year olds and adolescents, indicating that the level of FoH does not differ based on age 
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group.  Similarly, no differences were found across gender or insulin regimens.  It might 
have been expected that those on intensive insulin regimens could experience more 
episodes of hypoglycaemia and severe hypoglycaemia and consequently have higher FoH. 
  
Another surprising outcome was that there was no significant link between HbA1c and 
FoH.  It might be expected that those with high FoH might engage in behaviours to avoid 
hypoglycaemia, such as, maintaining high blood glucose levels.  However, this alone did 
not have as much of an effect as was expected. 
 
Looking at parental fear of hypoglycaemia, the key finding was that parents do score 
higher on the HFS scale than CYP do for themselves.  As reported, these findings have 
previously not been reported, to the best of my knowledge.  This suggests that parents 
have a higher FoH than their children have.  The problem of FoH, therefore, could be a 
bigger problem for the parents of CYP with T1DM rather than for the children and 
consequently could have an impact on parental well-being and quality of life.  This will be 
explored further in the qualitative analysis. 
 
Not surprisingly, looking at the whole cohort, parents of CYP who had suffered from at 
least one episode of severe hypoglycaemia had a higher fear of hypoglycaemia.  Mothers 
of children in the under 11 group who had had at least one episode of severe 
hypoglycaemia had a higher FOH than mothers of under 11 year olds who had never 
experienced severe hypoglycaemia (this difference was not evident between fathers of the 
under 11 age group).  However, for adolescents, the opposite result was found.  There was 
no statistically significant relationship between mothers’ PHFS scores and their child’s 
history of severe hypoglycaemia.  For fathers though, those fathers whose adolescent 
children had experienced severe hypoglycaemia at least once, had a higher FoH than those 
fathers of adolescents with no history of hypoglycaemia.  Parental experience of their 
child’s severe hypoglycaemia therefore, is linked to parental fear of hypoglycaemia.    
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Chapter 6 Results: Secondary factors associated with 
fear of hypoglycaemia 
In this results chapter I explore the secondary factors that are potentially associated with 
fear of hypoglycaemia for this population sample.  It is important to look at these factors 
as potential contributors to FoH in CYP and their parents. 
 
The State Trait Anxiety Inventory (STAI for adults) (149) and State Trait Anxiety Inventory 
Child (STAIC for children) (148) is used to identify anxiety levels in respondents at the time 
of completing the measure (state) as well as the levels of anxiety that tend to stay 
relatively stable over time (trait).  High scores on the STAI(C) indicate high state anxiety 
and/or high trait anxiety. 
 
A series of tables showing the mean state and trait anxiety scores of CYP and parents, as 
well as by age group, are presented below.  The age groups for this measure were slightly 
different as the child version of the measure (STAIC) is aimed at those aged under 13 and 
the adult measure (STAI) is suitable for those aged 13 years and above.  To allow for 
comparisons between the groups and to carry out analyses, scores were converted to z-
scores before any analysis was carried out. 
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Table 25:  State and trait anxiety scores for CYP and parents (Mean 
plus/minus SD and range) 
Measure Total CYP Mother Father 
State Anxiety^ N/A 39.16±10.82 (20-65) 
N=116 
37.02±11.42 (20-65) 
N=48 
Trait Anxiety^ N/A 38.77±10.24 (20-62) 
N=116 
38.11±10.24 (20-56) 
N=46 
^ Actual anxiety score are presented here.  For analysis raw scores were converted to z-
scores as the measures for children and older children/adults are different.  
 
Table 26:  State and trait anxiety scores for U11 and parents (Mean 
plus/minus SD and range) 
Measure U11+ Mother U11 Father U11 
State Anxiety^ 28.85±6.42 (20-51) 
N=84 
42.69±10.91 (20-65) 
N=39 
35.77±14.82 (20-65) 
N=13 
Trait Anxiety^ 30.66±6.64 (20-47) 
N=86 
41.13±10.53 (23-59) 
N=39 
35.36±10.83 (23-54) 
N=11 
^ Actual anxiety score are presented here.  For analysis raw scores were converted to z-
scores as the measures for children and older children/adults are different.  
+ Under 13 years  
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Table 27:  State and trait anxiety scores for adolescents and parents 
(Mean plus/minus SD and range) 
Measure AdolescentΔ Mother Adolescent Father Adolescent 
State Anxiety^ 34.36±9.17 (20-62) 
N=107 
37.36±10.39 (20-60) 
N=77 
37.60±10.25 (20-56) 
N=35 
Trait Anxiety^ 36.62±11.32 (20-67) 
N=107 
37.57±9.94 (20-62) 
N=77 
39.17±10.29 (20-56) 
N=37 
^ Actual anxiety score are presented here.  For analysis raw scores were converted to z-
scores as the measures for children and older children/adults are different.  
Δ13-18 years  
 
Trait and state anxiety are both important factors to consider when looking at FoH.  Those 
individuals with evidence of higher trait anxiety, i.e. relatively stable levels of anxiety over 
a period of time, could arguably also be more likely to worry about things in general, 
including episodes of hypoglycaemia, which in turn could produce higher HFS scores. 
 
6.1 CYP anxiety and HbA1c 
HbA1c scores were correlated with state (r=0.107, p=0.142) and trait (r=0.028, p=0.696) 
anxiety scores, however no significant relationships were found.  Therefore, for this 
sample there was no relationship between HbA1c and anxiety.  
 
6.2 CYP anxiety and insulin regimen 
Comparison of state and trait anxiety scores between insulin regimens showed a 
significant difference only for state anxiety scores, only (t=0.23, p=0.021).  Those on 
intensive regimens reported higher state anxiety scores (M=0.76, SE=0.80) than those on 
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conventional regimens (M=-0.36, SE=0.15).  Potentially those CYP on intensive insulin 
regimens might have found the insulin regimen more stressful (due to higher incidences of 
hypoglycaemia linked to intensive insulin regimens) and therefore scored higher on the 
state anxiety scale than those on conventional insulin regimens.  Alternatively, more 
anxious people prefer to be on an intensive insulin regimen which might give them more 
flexibility in diabetes management. 
 
No significant differences in state and trait anxiety scores were found between male and 
female CYP.   
 
6.3 Relationship between anxiety and fear of hypoglycaemia 
6.3.1 CYP (whole cohort) 
State anxiety 
CYP state anxiety scores correlated positively across CHFS-W (r=0.311, p= <0.001) and 
CHFS-T (r=0.263, p= <0.001) scores at the 0.01 level of significance.  These findings suggest 
a relationship between anxiety and fear of hypoglycaemia.  It is possible that one causes 
the other although causality cannot be confirmed.   
Trait anxiety 
CYP trait anxiety scores correlated across all CHFS scales at least the 0.05 level of 
significance (CHFS-B: r=0.144, p=0.045; CHFS-W: r=0.525, p= <0.001; CHFS-T: r=0.486, p= 
<0.001).  Causality may be inferred here as trait anxiety is defined as being relatively stable 
and doesn’t tend to fluctuate.  Therefore, those with higher trait anxiety might be more 
likely to worry in general and therefore could be more likely to worry about 
hypoglycaemia, resulting in higher FoH.  These findings support previous research carried 
out in this area (72, 74). 
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6.3.2 Under 11 
State anxiety 
For state anxiety there was a significant correlation with CHFS-W (r=0.309, p=0.050) and 
CHFS-T (r=0.368, p=0.018).  Again this suggests that as anxiety increases so does FoH, in 
this age group. 
Trait anxiety 
Trait anxiety scores for under 11 year olds significantly correlated (positively) across all 
CHFS scales at, at least the 0.05 level of significance (CHFS-B: r=0.330, p=0.031; CHFS-W: 
r=0.565, p= <0.001; CHFS-T: r=0.582, p= <0.001).  So, higher trait anxiety scores are 
associated with higher FoH. 
 
6.3.3 Adolescents 
State and trait anxiety 
Significant, positive correlations between adolescent anxiety scores (state and trait) and 
CHFS scores were found for CHFS-W (state: r=0.312, p= <0.001; trait: r=0.506, p= <0.001) 
and CHFS-T (state: r=0.223, p=0.007; trait: r=0.445, p= <0.001) scores.  This suggests that 
higher anxiety is linked with higher FoH, in adolescents.  
 
6.3.4 Parents 
Under 11  
A significant positive correlation was observed, between maternal trait anxiety and 
children’s (under 11 years) total CHFS (r=0.455, p=0.009) and CHFS-W (r=0.484, p=0.005) 
scores suggesting an influence of maternal anxiety on child fears, or vice versa. Again, 
considering this relationship is evident for trait (not state) anxiety, it seems appropriate to 
suggest that mothers’ trait anxiety might contribute to the FoH children have for 
themselves.   
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Adolescents 
No significant correlations were found between maternal anxiety and adolescent CHFS 
scores.  In mothers and fathers there was a strong positive correlation between total PHFS 
score and trait anxiety (mothers: r=0.241, p=0.009; fathers: r=0.311, p=0.035), as well as 
between PHFS-W scores and trait anxiety (mothers: r=0.242, p=0.009; fathers: r=0.319, 
p=0.030). It is fair to suggest that those parents who are more anxious have higher levels 
of fear of hypoglycaemia.  Alternatively, fear of hypoglycaemia could lead to persistent 
anxiety (74, 77, 87, 89, 159). 
 
6.4 Quality of life and fear of hypoglycaemia  
The PedsQL Diabetes Module 3.0 (144) was used to measure quality of life (QoL) in CYP 
with type 1 diabetes mellitus.  This is a self-report measure designed to be completed by 
the child themselves and also a parent version where the parent is required to report on 
their child’s quality of life; so CYP’s perceived quality of life as judged by their mother or 
father.  High scores on the PedsQL Diabetes Module 3.0 indicate high health related 
quality of life either for self (reported by CYP) or perceived high quality of life of child 
(reported by mothers/fathers).  A series of tables showing the mean and standard 
deviation scores for CYP and parents, by age group, is presented below. 
 
Table 28:  Health-related quality of life scores for CYP and parents 
(Mean plus/minus SD and range) 
Measure  Total CYP Mothers Fathers 
HRQoL 69.03±14.67       
(29.09-99.54)      
N=200 
57.67±16.30         
(7.48-99.09)        
N=136 
65.46±15.22         
(7.48-92.46)          
N=52 
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Table 29:  Health-related quality of life scores for U11 and parents 
(Mean plus/minus SD and range) 
Measure  U11 Mothers U11 Fathers U11 
HRQoL 67.04±15.80        
(39.15-99.54)          
N=52 
58.28±14.64       
(29.63-87.39)        
N=47 
67.55±9.53           
(52.9-83.91)          
N=15 
 
Table 30: Health-related quality of life scores for adolescents and 
parents (Mean plus/minus SD and range) 
Measure  Adolescent Mothers Adolescent Fathers Adolescent 
HRQoL 69.73±14.24       
(29.09-99.28)      
N=148 
57.35±17.19         
(7.48-99.09)         
N=89 
64.61±17.04         
(7.48-92.86)         
N=37 
 
 
6.5 Relationship between quality of life and demographic data 
6.5.1 CYP 
There was a significant negative correlation between HbA1c and QoL (r=-0.186, p=0.008) 
as measured by Spearman’s rho,  suggesting that those with high HbA1c levels report 
lower quality of life, and vice versa (Figure 10).  This suggests that those with lower HbA1c 
levels and potentially better control of blood glucose, report a better quality of life. 
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Figure 10:  Scatter graph to illustrate relationship between QoL 
and HbA1c. 
 
 
Mann-Whitney tests revealed that there were no significant differences between QoL 
scores of males vs females, under 11 year olds vs adolescents and those on intensive 
insulin regimens vs conventional insulin regimens. 
 
6.6 Relationship between quality of life and fear of 
hypoglycaemia  
6.6.1 CYP 
In CYP greater fear of hypoglycaemia correlated with poorer quality of life with significant 
negative correlations between all three HFS (Behaviour, Worry and Total) scales and the 
PedsQL (r=-0.197, p=0.005; r=-0.585, p=0.000; r=-0.525, p= <0.001).   Investigating the 
relationship a little further by looking at each of the domains for the PedsQL also showed 
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significant negative relationships between each of the PedsQL domains and CHFS Worry 
and Total scores.  This suggests that a greater fear of hypoglycaemia is associated with 
poorer quality of life in CYP.  
 
6.6.2 Under 11 
In the under 11 group a greater fear of hypoglycaemia correlated with poorer quality of 
life with significant negative correlations between CHFS-W and CHFS-T scales and PedsQL 
(r=-0.679, p= <0.001; r=-0.572, p= <0.001).  There was a non-significant relationship 
between PedsQL and CHFS-B.  This suggests that in children, a greater worry and overall 
fear of hypoglycaemia might lead to poorer quality of life (83), although causality cannot 
be inferred from cross-sectional data. 
 
6.6.3 Adolescent 
Greater fear of hypoglycaemia correlated with poorer quality of life in adolescents.  There 
were significant negative correlations between all three HFS scales (Behaviour, Worry and 
Total) and PedsQL (r=-0.241, p=0.003; r=-0.545, p= <0.001; r=-0.507, p= <0.001).   
Significant negative correlations were also found between the each of the domains on the 
PedsQL and CHFS Worry and Total scores, in the adolescent group.  Again, suggesting a 
link between fear of hypoglycaemia and quality of life, although causality cannot be 
inferred directly from correlational analyses (83). 
 
6.6.4 Parents 
All PHFS scores were negatively correlated with parents’ PedsQL scores. These data 
suggest that for parents, higher parental fear of hypoglycaemia is related to a lower 
perception of their child’s quality of life (83). 
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All analyses of the PedsQL scores with HFS scores for parents and children suggest a 
relationship between these two variables.  This suggests that a greater fear of 
hypoglycaemia correlates with a lower quality of life/perceived quality of life, in CYP with 
T1DM. Fear of hypoglycaemia could be a predictor of poor quality of life in this population 
and further exploration of this might allow inferences about causality, to be made.   
 
6.7 Self –care and fear of hypoglycaemia 
The Self-Care Inventory (SCI-R) (138) was used to elicit scores on CYPs’ self-care 
behaviours in relation to their diabetes diagnosis.  It can also be used to get parental views 
of their child’s self-care behaviours, so is a proxy measure for pre-adolescent children.  
High self-care scores indicate high levels of self-care behaviours specific to diabetes care.  
Self-care scores can be found below.  Scores are presented for adolescents only as the self-
care inventory is recommended for use with this age group. 
 
Table 31:  Self-Care scores for adolescents and parents (Mean 
plus/minus SD and range) 
Measure  Adolescent Mother Adolescent Father Adolescent 
Self Care 66.27±13.86     
(18.3-96.7)       
N=150 
66.08±17.37     
(13.5-96.67)       
N=90 
58.31±23.79   
(13.30-91.67)    
N=37 
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Table 32: Parental proxy reports of self-care (Mean plus/minus SD 
and range) 
Self-care Mother CYP Father CYP Mother U11 Father U11 
 69.64±15.84 
(13.5-96.7) 
N=136 
62.05±21.76 
(13.5-91.7) 
N=52 
76.61±9.03 
(58.3-96.7) 
N=46 
71.29±11.87 
(51.7-88.3) 
N=15 
 
6.8 Relationship between self-care and demographic data 
Correlational analyses showed a significant negative relationship between HbA1c and self-
care scores (r=-0.215, p=0.002) which, not surprisingly, suggests that those with lower 
HbA1c levels (and potentially better metabolic control) also report higher levels of self-
care (Figure 11). 
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Figure 11:  Scatter graph to illustrate relationship between self-
care and HbA1c. 
 
 
 
There were no significant differences in self-care scores between males and females, or 
between those on conventional vs intensive insulin regimens. 
  
6.9 Relationship between self-care and fear of hypoglycaemia  
Correlational analysis revealed that the relationship between CHFS scores and self-care for 
adolescents was not significant.  This suggests that there is no link between fear of 
hypoglycaemia and self-care behaviours.  It was expected that there might be some link 
between fear of hypoglycaemia and self-care, considering the CHFS-B subscale measures 
behaviours (some of which are linked to self-care).  So potentially lower self-care 
behaviours could be evident in those with a higher FoH, to reflect behaviours that 
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potentially help prevent hypoglycaemia, but might not be the best behaviours in terms of 
diabetes management. 
 
A breakdown of parental proxy scores of self-care can be found in Appendix 26. The 
relationship between parental FoH and self-care (proxy reports) was also found not to be 
statistically significant.  This suggests that there is no link between FoH and self-care 
behaviours. 
 
6.10 Multivariate analysis of fear of hypoglycaemia 
In order to understand fear of hypoglycaemia further, initial exploration, of significant 
relationships between CHFS scores and other investigated variables, was followed up with 
multivariate analyses.  These analyses were carried out in order to identify whether any 
conclusions could be drawn regarding risk factors of or contributory factors to the 
presence of FoH in CYP and their parents. 
 
For each age category, a step-wise multiple regression analysis was performed using two 
of the variables that showed a significant relationship with FoH.  Trait anxiety and number 
of episodes of severe hypoglycaemia were entered as predictor variables, with HFS-T 
scores as the dependent variable.  Previous research also suggests a significant 
relationship between trait anxiety and FoH and previous experience of severe 
hypoglycaemia and FoH (72, 74, 91). 
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6.11 Multivariate analysis of CHFS-Total in Under 11 group 
Table 33: Regression analyses to identify significant predictors of FoH 
in Under 11 group (N=41) 
Significant variables B R2 Adjusted R2 β 
Step 1 
   Trait anxiety 
 
9.662 
 
0.366 
 
0.349 
 
0.605** 
Step 2 
   Trait anxiety 
   Severe hypoglycaemia 
 
9.598 
0.804 
 
0.369 
 
0.336 
 
0.601** 
0.057 
Dependent variable: CHFS-T 
**p<0.01 
 
The table above shows that both trait anxiety and severe hypoglycaemia have a positive 
relationship with CHFS-T scores in the under 11 group.  However, trait anxiety is the only 
variable which significantly predicts higher CHFS-T scores.  Trait anxiety scores account for 
36.6% variance in Under 11’s CHFS-T scores.  Although the addition of severe 
hypoglycaemia increases the variance it does so very slightly (∆R2=0.003).  The addition of 
severe hypoglycaemia in Step 2 does not significantly contribute to the predictability of 
Model 1.  It seems then for this group, trait anxiety is likely to be associated with a higher 
fear of hypoglycaemia.  The number of episodes of severe hypoglycaemia, however, does 
not add to the model’s ability to predict FoH.  It could be that in the younger group, 
children are less aware of the perceived danger of an episode of hypoglycaemia, and 
therefore having experienced severe hypoglycaemia in the past is less likely to impact on 
their fear of hypoglycaemia.  For under 11 year olds, having high trait anxiety suggests a 
higher fear of hypoglycaemia.  These results could have implications for the treatment and 
management of diabetes for this age group. 
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6.12 Multivariate analysis of CHFS-Total in adolescent group 
Table 34: Regression analyses to identify significant predictors of FoH 
in adolescent group (N=145) 
Significant variables B R2 Adjusted R2 β 
Step 1 
   Trait anxiety 
 
6.43 
 
0.20 
 
0.19 
 
0.45** 
Step 2 
   Trait anxiety 
   Severe 
hypoglycaemia 
 
6.08 
2.30 
 
0.23 
 
0.22 
 
0.42** 
0.18* 
Dependent variable: CHFS-T 
**p<0.01 
*p<0.05 
 
Multivariate analysis of adolescent scores also show that Trait anxiety can significantly 
predict CHFS-T scores in this group (Table 34).  Trait anxiety accounts for 20% of the 
variance in CHFS-T scores.  The addition of severe hypoglycaemia at Step 2 increases this 
variance to 23% and for the adolescent group, the addition of this predictor variable 
significantly adds to the model’s ability to predict fear of hypoglycaemia.  So even though 
the variance is small, it seems here that both trait anxiety and severe hypoglycaemia 
together make a significant contribution to the model.  In adolescents, it seems that 
severe hypoglycaemia does impact on CHFS-T scores probably because this age group is 
more likely to be aware of the dangers associated with hypoglycaemia and also potentially 
have memories of their experience.  Therefore, it is likely that adolescents with a history of 
severe hypoglycaemia and high trait anxiety scores are likely to have a high fear of 
hypoglycaemia.  In practice, these results could have implications for paediatric diabetes 
clinicians, in supporting adolescents with diabetes management.  
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6.13 Multivariate analysis of PHFS-Total in mothers 
Table 35: Regression analyses to identify significant predictors of FoH 
in mothers of CYP with T1DM 
Significant variables B R2 Adjusted R2 β 
Mothers of U11 (N=27) 
Step 1  
   Trait anxiety 
 
5.99 
 
0.18 
 
0.14 
 
0.42* 
Step 2 
   Trait anxiety 
   Severe hypoglycaemia 
 
6.53 
3.78 
 
0.25 
 
0.19 
 
0.46* 
0.27 
Mothers of adolescents (N=76) 
Step 1 
   Trait anxiety 
 
4.63 
 
0.06 
 
0.04 
 
0.24* 
Step 2 
   Trait anxiety 
   Severe hypoglycaemia 
 
5.08 
3.35 
 
0.09 
 
0.07 
 
0.26* 
0.19 
 Dependent variable: PHFS-T 
*p<0.05 
 
In mothers of both the under 11 group and the adolescent group it seems that trait 
anxiety was the strongest predictor of FoH (Table 35).  Although, as previously seen, 
severe hypoglycaemia did add to the variance in PHFS-T scores, the addition of this 
variable did not significantly add to the ability of the initial model to predict PHFS-T scores.  
This regression shows that mothers’ trait anxiety scores are significant predictors of FoH 
(accounting for 18% (under 11) and 6% (adolescent) of the variance) and the addition of 
previous severe hypoglycaemia does not significantly contribute to this relationship.  In 
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order to identify mothers who are likely to have a fear of hypoglycaemia, looking at trait 
anxiety scores might give an indication to who these might be.  The fact that trait anxiety 
potentially contributes to the level of FoH may have implications for reducing FoH by 
managing mothers’ anxiety. 
 
6.14 Multivariate analysis of PHFS-T in fathers 
Table 36: Regression analyses to identify significant predictors of FoH 
in fathers of adolescents with T1DM 
Significant variables B R2 Adjusted R2 β 
Fathers of adolescents (N=35) 
Step 1 
   Trait anxiety 
 
6.70 
 
0.13 
 
0.11 
 
0.36* 
Step 2 
   Trait anxiety 
   Severe hypoglycaemia 
 
5.97 
7.80 
 
0.30 
 
0.26 
 
0.32* 
0.41** 
Dependent variable: PHFS-T 
*p<0.05 
**p<0.01 
Multivariate analyses were not carried out for fathers of under 11 year olds due to the 
small sample size.   For fathers of the adolescent group (Table 36), however, trait anxiety 
accounted for 13% variance in their PHFS-T scores.  However the addition of severe 
hypoglycaemia in Step 2 shows an increase in variance, to 30% (∆R2=0.168), indicating that 
the addition of severe hypoglycaemia significantly increases the model’s ability to predict 
FoH in this group. It seems that fathers of adolescents are likely to have increased PHFS-T 
scores if they have higher trait anxiety and if their son/daughter has experienced severe 
hypoglycaemia.  This finding slightly differs to that of the mothers of adolescents in that 
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for mothers, severe hypoglycaemia did not significantly add to the predictability of the 
original model (with only trait anxiety as a predictor variable) of PHFS-T scores.  This 
difference could be explained by the fact that, in general, mothers are the main carers of 
CYP with T1DM and therefore have more experience of episodes of hypoglycaemia and 
severe hypoglycaemia.  Previous experience of severe hypoglycaemia might not have as 
much impact on mothers as it might do on fathers, who potentially have less exposure to 
these episodes and therefore might have more of an influence on PHFS scores (and FoH 
levels).  As with the under 11, adolescent and mother group analyses, these findings could 
help address FoH in fathers of adolescents by identifying those most at risk of high fear of 
hypoglycaemia. 
 
6.15 Summary of Chapter 6 
Fear of hypoglycaemia, for this sample of CYP and their parents, is significantly associated 
with factors such as state anxiety, trait anxiety and quality of life.   Fear of hypoglycaemia 
correlated positively with both state anxiety and trait anxiety across all groups.  This 
suggests that those with higher anxiety (including anxiety which remains relatively stable 
across time) are also likely to have higher fear of hypoglycaemia.  Potentially, anxiety may 
contribute to a higher FoH or inversely, for state anxiety at least, FoH might be the 
contributing factor.  For trait anxiety, however, it seems that those scoring higher on this 
scale also report higher CHFS scores (therefore higher FoH).  Trait anxiety could, therefore, 
be a contributory factor to the presence of FoH (72, 74, 159).  Potentially those individuals 
who have a tendency to worry might score higher on the Worry scale of the HFS and 
therefore are possibly likely to have higher FoH.  Another explanation for the relationship 
between anxiety and FoH could be that the HFS is actually measuring diabetes-related 
anxiety.  If this is the case then inevitably those CYP with higher anxiety levels are also 
likely to score higher on the HFS scale.  It will be interesting to explore this relationship 
further through qualitative analysis. 
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Quality of life (QoL) of children and adolescents, participating in the study, was 
investigated.  Statistically significant, negative correlations were found between the fear of 
hypoglycaemia and QoL.  This suggests that lower reported QoL is linked to a higher FoH.  
So those under 11 year olds and adolescents analyses could be interpreted to suggest that 
higher fear of hypoglycaemia might lead to poorer quality of life.  It could also be 
suggested that this association suggests that those personalities who report a lower QoL 
are also more likely to report a higher FoH. 
 
Parents’ PedsQL scores reflected parents’ perception of their child’s quality of life.  All 
PHFS scores had statistically significant, negative correlations with parental PedsQL scores.  
The data suggest that for parents, the higher parental fear of hypoglycaemia is, the lower 
the perception of their child’s quality of life is.  Fear of hypoglycaemia and QoL are 
associated with one another.  Although causality cannot be inferred from correlational 
data, fear of hypoglycaemia could potentially contribute to children and adolescents’ QoL 
and also parents’ perception of their son/daughters’ QoL. 
 
Unexpectedly, self-care was not found to have a significant relationship with fear of 
hypoglycaemia for adolescents or their parents.  Some relationship might have been 
expected considering that self-care behaviours reflect the HFS behaviour scales, to an 
extent. 
 
Multivariate analyses of fear of hypoglycaemia showed that trait anxiety was a significant 
predictor for FoH for under 11 year olds, adolescents, mothers of under 11s, mothers of 
adolescents and fathers of adolescents.  This suggests that those with higher trait anxiety 
are also likely to have higher fear of hypoglycaemia.  This is probably due to the fact that 
individuals who are more likely to worry will also score higher on the Worry scale of the 
HFS and therefore have a higher FoH.  The addition of severe hypoglycaemia to the model 
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added to the predictability of models for adolescents, and fathers of adolescents, 
suggesting that severe hypoglycaemia is a precursor to FoH in these groups.  
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Chapter 7: Discussion (Quantitative phase) 
7.1 Prevalence of hypoglycaemia 
Analysis of the data indicated that the prevalence of hypoglycaemia is high in this 
particular sample of CYP with Type 1 Diabetes Mellitus.    Although this study appears to 
be one of only a few to report on the prevalence of hypoglycaemia in the U.K. (27), Ly and 
Jones’ (48) comprehensive article on hypoglycaemia in CYP highlights worldwide research 
on hypoglycaemia and reports that hypoglycaemia is an issue in diabetes management.   
For this UK sample, the majority of CYP reported experiencing hypoglycaemia at least once 
per month with only a small percentage of the group stating that they had never 
experienced an episode of hypoglycaemia (9/193).    
 
Severe hypoglycaemia is defined as an episode of hypoglycaemia where the patient 
requires assistance of another person in order to treat the episode.  Only 62 CYP out of the 
sample of 193 reported never experiencing an episode of severe hypoglycaemia, with the 
majority reporting that they had experienced this at least once in their lives.  A number of 
studies reporting on the prevalence of severe hypoglycaemia in paediatric populations (26, 
38), also indicate that this is a problem in diabetes management.   Johansen et al. (39) 
carried out a large (n=3320) observational study of data collected for CYP in Denmark with 
diabetes between 1996 and 2009.  Severe hypoglycaemia was defined as an event leading 
to loss of consciousness and/or seizure (34). Their results showed that despite advances in 
diabetes care during this time period the incidence of severe hypoglycaemia did not 
change (15.1 per 100 patient years).  Authors concluded that severe hypoglycaemia was a 
problem for paediatric diabetes patients and further research to assess risk factors for 
severe hypoglycaemia are needed.   In an earlier study Katz et al. (25) also carried out an 
observational study to establish prevalence rates of severe hypoglycaemia in CYP with 
T1DM, in the US.  They used the DCCT definition (40) of severe hypoglycaemia which 
includes both a hypoglycaemic event requiring assistance from another; and an event with 
seizure/coma.  Overall, the reported incidence of severe hypoglycaemia in Katz et al.’s (25) 
study was 37.6/100 patient years.  This is much higher than reports from Johansen et al.’s 
 148 
 
(39) study, however, this could be due to the difference in the definition of severe 
hypoglycaemia between the two studies.  Katz et al. (25) also refined reports of incident 
rates and found that the incidence of severe hypoglycaemia (as characterised by 
seizure/coma) was 9.6/100 patient years, which is comparable to Johansen et al.’s (39) 
findings.  Although the reports of incidence of severe hypoglycaemia differ between 
reports from these two studies, authors concur that severe hypoglycaemia is a problem in 
paediatric groups.  This may have implications for the management of diabetes and 
clinicians should be aware of the frequency of hypoglycaemia amongst their patients in 
order to help manage any difficulties they have controlling their diabetes. 
 
Paternal participation in this type of research tends to be limited, so it was interesting to 
investigate fathers’ perceptions of their child’s diabetes and compare these to mothers’ 
perceptions.  Parental reports of hypoglycaemia for their children showed significant 
differences in reports of frequency of hypoglycaemia and severe hypoglycaemia between 
mothers and fathers.  Few studies have discussed parental reports of hypoglycaemia in 
their child per se, which could be due to the unreliability of parental reports.  Studies are 
generally focused on parents’ abilities and accuracy in identifying hypoglycaemia in their 
child (157, 160, 161).   
 
In the current study, fathers tended to report that their sons/daughters experienced more 
episodes of hypoglycaemia than the mothers did.  This could be explained by the fact that 
mothers are often the primary carers of children with T1DM and so might have been more 
aware of the actual frequency of these episodes than fathers were.  No differences were 
found in parental reports of severe hypoglycaemia and further analyses indicate reports of 
severe hypoglycaemia between parents and CYP were also consistent with one another. 
This suggests that parents seem to be able recognise when their child is experiencing 
hypoglycaemia however, this was not tested objectively in this study.  Confirming parental 
recognition of hypoglycaemia would involve CYP checking their blood glucose at the time 
and proving that they were experiencing hypoglycaemia when parents suspected it (157). 
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Experience of hypoglycaemia can eventually lead to impaired awareness of 
hypoglycaemia, as reported by Geddes et al. (45).  Impaired awareness of hypoglycaemia 
often occurs as a result of repeated episodes of hypoglycaemia and is characterised by a 
loss of warning symptoms usually associated with hypoglycaemia (45).  Adolescents in the 
current study completed the hypoglycaemia unawareness measure, adding to limited 
awareness research in UK samples.  Recently, Graveling et al. (161) attempted to measure 
IAH in children and adolescents in a UK study using both the Clarke (49) and Gold (47) 
methods (as was reported for the current study).  Their findings suggested that the 
methods for assessing IAH in CYP are better placed for older children aged 9 or older 
which supports the procedures undertaken for the current study only investigating IAH in 
adolescents.  Not surprisingly, adolescents with impaired awareness were shown to have a 
longer duration of T1DM than those with normal awareness.  This supports the idea that 
awareness of hypoglycaemia can become impaired after experiencing frequent episodes 
of hypoglycaemia.  Those adolescents with a longer duration of diabetes would have 
inevitably experienced a higher number of episodes of hypoglycaemia leading to impaired 
awareness.  No other differences between groups were found for impaired awareness.  
 
Impaired awareness of hypoglycaemia scores were correlated with free recall of severe 
hypoglycaemia in the past year and preceding year.  Results showed a significant positive 
relationship between the two indicating that those likely to have impaired awareness 
(higher score) reported higher incidences of severe hypoglycaemia.  This is in line with 
results of Gold et al.’s (47) study which reported a six-fold increase in the incidence of 
severe hypoglycaemia in those with impaired awareness, albeit in adult patients.  
Paediatric research in IAH revealed similar results.  In Ly et al.’s (48) cohort study, 29% of 
656 participating CYP reported IAH.  The overall incidence of severe hypoglycaemia was 
significantly higher for CYP with impaired awareness (37.1 vs 19.3 per 100 patient years).  
This is in agreement with the results of the current study which revealed that reports of 
severe hypoglycaemia were higher for those with impaired awareness when compared to 
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those with normal awareness.  This highlights the problem of IAH in diabetes care and 
could have further implications for those at risk, of a higher frequency of severe 
hypoglycaemia.  These findings support the suggestion that awareness of hypoglycaemia 
can be impaired in those who report frequent episodes of hypoglycaemia or severe 
hypoglycaemia.  This is an important factor to consider when supporting CYP in managing 
their BG levels.  If CYP are unable to identify that they are experiencing hypoglycaemia this 
can lead to more frequent episodes of hypoglycaemia or severe hypoglycaemia.  
Adolescents might benefit from learning about and recognising all possible symptoms of 
hypoglycaemia that they might otherwise be unaware of in an attempt to identify the 
onset of an episode before it becomes more serious. It should be noted that the effects of 
IAH can be reversed by consistent avoidance of hypoglycaemia over several weeks (29), 
however, clinical support to achieve this is likely to be needed.  
 
7.2 Fear of hypoglycaemia  
Fear of hypoglycaemia (FoH) was evident in children, adolescents and their parents. This 
does not seem to have been reported previously for a UK sample, although limited studies 
overseas report the presence of FoH for paediatric samples (74, 81). The results of the 
Hypoglycaemia Fear survey (HFS) indicate that CYP and their parents do experience fear of 
hypoglycaemia to varying extents.  Marrero et al. (91) investigated FoH in CYP and parents 
using the HFS.  They reported that FoH was apparent in these groups, although the level of 
fear was dependent on factors such as previous experience of severe hypoglycaemia 
(discussed later). Later studies have investigated parental FoH further.  Hawkes et al. (84) 
assessed FoH in 106 parents of CYP.  Their results suggest that parents do experience FoH, 
however more so for younger children (aged 6 to 11 years) than other age groups.  The 
current study revealed no such differences in FoH reports between parents of different 
age groups.   
 
Previous research studies report conflicting data on the link between FoH and CYP HbA1c 
(86, 89, 92).  Pate et al.’s (87) cross-sectional study looked at parental FoH again using the 
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HFS.  They reported that higher FoH scores were associated with higher HbA1c levels in 
children, suggesting an impact of FoH on diabetes management.   This is supported by 
previous research conducted by Patton et al. (76) who, although used reports of average 
daily blood glucose levels rather than HbA1c as indicators of glycaemic control, also found 
higher parental FoH was associated with higher blood glucose levels.  Johnson et al. (83) 
found slightly different results.  Although they reported no link between parental FoH and 
CYP HbA1c, they did report that CYP with higher FoH also had higher HbA1c levels.  For the 
current study there was no significant link between FoH (parental or CYP) and HbA1c 
levels.  Gonder-Frederick et al.’s 2006 (72) study, amongst others (80, 89, 162) supports 
this finding.  Gonder-Frederick et al. (72) investigated predictors of FoH with 39 
adolescent-parent pairs and found no relationship between FoH and HbA1c levels. The 
association between HbA1c and FoH is complex, especially in the CYP group, therefore 
subtle, yet significant links may go undetected.  Changes in hormone levels and onset of 
puberty are just two factors which might impact and mediate the relationship between 
HbA1c and FoH.  It is also important to note that the majority of studies that have 
previously reported a link seem to do so based on parental FoH rather than CYP FoH.   
 
HFS scores were higher in parents, both mothers and fathers, than in either children or 
adolescents indicating that parents have higher FoH for their children, than CYP have for 
themselves.  Specifically, comparison of scores across groups showed that mothers 
reported a greater fear of hypoglycaemia (all HFS subscales) for their children than their 
children did themselves.  This was a statistically significant result and although is in 
keeping with previous studies which report that mothers of children with T1DM have 
higher FoH than adult patients have for themselves (75), does not appear to have been 
reported before in FoH research.  Fathers were also found to report higher fear of 
hypoglycaemia than their children did for themselves, although the results were only 
statistically significant for the Worry scale and Total score, this again seems to be a unique 
finding in FoH research.  Similar findings for mothers and fathers were reported when the 
CYP group was split into under 11 year olds and adolescent age groups, although fathers 
reported lower FoH for the adolescent group than mothers did.  Haugstvedt et al. (86) also 
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found lower FoH in fathers (than mothers) but did not differentiate between parents of 
children and adolescents. This study appears to be the first study to highlight that parents 
report higher FoH than their children do.  This could have implications for parental 
management of their child’s diabetes, as well as parental well-being.  Mothers and fathers 
report a greater fear of hypoglycaemia (and often greater worry for their child) however, it 
is difficult to ascertain the best way to meet the needs of parents of children with T1DM 
who are often already burdened with the responsibility of caring for a child with a chronic 
illness and even more so for those individuals who are less likely to come to clinic 
appointments with their children (i.e. fathers).  Assessing FoH in parents might alert 
clinicians of the fact that parents may be struggling with the diabetes care for their child 
however, there currently does not seem to be any useful intervention that could address 
FoH in these parents.   
 
7.2.1 Fear of hypoglycaemia and severe hypoglycaemia  
Data from previous studies across Europe, the US and Australia suggest a considerable 
level of fear among children with Type 1 diabetes and their families. Like others we found 
a link between prior experience of severe hypoglycaemia and FoH in adolescents (72, 76, 
91).  One study found that it was only those adolescents experiencing severe 
hypoglycaemia in the recent 12 months who reported greater fear of hypoglycaemia (91).  
These authors suggested that FoH might be a transitory event in the life of an adolescent 
as a response to a specific stimulus. Interestingly, we found no link with prior experience 
of severe hypoglycaemia and fear in younger children. This may be due to differences in 
developmental stage and perspectives on the frightening nature of severe episodes of 
hypoglycaemia. Johnson et al. (83) suggest that the nature of severe hypoglycaemia 
resulting in a seizure or loss of consciousness might mean that younger children have less 
recollections of the event and so may not worry about it as much as their parents who are 
likely to be witnesses. The absence of a significant link between severe hypoglycaemia and 
FoH in this younger group could also be related to younger children’s reliance on and trust 
in their parents’/adult carers’ ability to manage episodes of hypoglycaemia on their behalf. 
This may lead to a greater burden on parents, particularly mothers (primary caregivers), 
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with increased stress and anxiety which has been shown to impact on diabetes care (95, 
97, 103, 163).  
 
In line with previous studies parental fear was linked to prior experience of severe 
hypoglycaemia for mothers in younger children and fathers in adolescents (72, 91). 
Marrero et al. (91)  explored the relationship between severe hypoglycaemia and FoH in 
parents and their children.  They found that parents whose children had a history of 
severe hypoglycaemia (seizure or sudden loss of consciousness), had higher levels of FoH.  
Moreover, parents whose children had experienced an episode of severe hypoglycaemia in 
the past year exhibited the greatest levels of FoH.  Looking at parents separately, Pate et 
al. (87) reported higher worry scores on the HFS for mothers, whilst highlighting higher 
behaviour scores (i.e. behaviours to avoid hypoglycaemia) for fathers of younger children.  
The small number of fathers of under 11 year olds participating in the current study, might 
have had an impact on the analysis for this particular group.  In the current study, mothers 
seemed to be more concerned about hypoglycaemia if their child was younger whereas 
fathers reported more worry for their adolescent children.  This could suggest that 
mothers, who are usually the main caregivers, are aware of the difficulty in detecting 
hypoglycaemia in younger children who themselves might be slow to recognise or react to 
the symptoms, however they have more confidence in their older children to recognise 
and treat an episode of hypoglycaemia before it becomes severe.  Fathers then may be 
less worried about their younger children, believing that they are under their mothers’ 
care (in most instances) and so may have more worries about whether their adolescent 
children can in fact treat an episode of severe hypoglycaemia independently.  The findings 
suggest that for parents, their child’s experience of severe hypoglycaemia can contribute 
to their own fear of hypoglycaemia (91).   
 
7.2.2 Fear of hypoglycaemia and anxiety  
An increasing number of studies have examined the relationship between trait anxiety and 
FoH in adolescents and parents, (72, 87, 89). This is perhaps due to the fact that the HFS 
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measure includes a Worry subscale which could in fact reflect a person’s tendency to 
exhibit general anxiety.  Therefore it is important to investigate any relationship between 
these two variables.  Gonder-Frederick et al. (72) explored the link between FoH and trait 
anxiety in adolescents and their parents.  Analyses of parent scores on both the HFS scale 
and trait anxiety measures indicated no relationship between parental FoH and trait 
anxiety.  However analyses of adolescent scores showed a significant positive correlation 
between their HFS total scores and trait anxiety score, as well as between their HFS worry 
scores and trait anxiety scores.   Considering that the HFS scale measures both worry and 
avoidance behaviour associated with hypoglycaemia it is possible that those with higher 
trait anxiety may be prone to generalised worry/anxiety and therefore have a tendency to 
report higher FoH levels than those with lower trait anxiety levels. Gonder-Frederick et al. 
(72) however, argued that there is ultimately a very real difference between trait anxiety 
(which may be predisposed according to genetics) and maternal diabetes-related worry 
(which varies according to the confidence mothers have in their child’s ability to manage 
their diabetes).  Therefore the relationship between the two variables may not be so 
obvious and might benefit from further exploration.   
 
Univariate analyses for the current study suggest that trait anxiety in all participants was 
independently associated with FoH in all groups. The association between high trait 
anxiety and high FoH may be a reflection of the higher hypoglycaemia worry scores for 
those with a tendency towards general anxiety.  The worry scale on the HFS then may just 
be another measure of anxiety albeit with a diabetes slant.  Nevertheless, increased FoH is 
evident in those with higher trait anxiety therefore attempts to relieve anxiety might also 
contribute to reducing FoH.  A significant positive correlation between maternal trait 
anxiety and FoH in younger children was also observed, which may be bi-directional. This 
loosely supports the findings for Gonder-Frederick et al.’s (72) study which found a 
moderate positive correlation between parental trait anxiety and adolescent (rather than 
younger children’s) HFS worry scores.  This could suggest that a more anxious mother 
contributes to more generalised worry in their child, particularly in relation to diabetes.  It 
was not possible to examine the temporal relationship between anxiety and fear, 
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however, so it is difficult to report whether anxiety precipitates FoH or vice versa.  
Research is still limited in this area which might benefit from further investigation. 
 
7.2.3 Fear of hypoglycaemia and CYP health-related quality of life  
Fear of hypoglycaemia has been recognised as an issue for CYP (72, 81). Therefore it is 
possible that FoH will have an impact on CYPs’ lives.  The impact of FoH on quality of life 
was reported by Johnson et al. (83) who concluded that FoH is associated with reduced 
CYP QoL as reported by both CYP and their parents.  This is true for the current study.  
Higher fear scores were related to poorer health related quality of life in both children and 
adolescents, and were also related to parents’ poorer perception of their child’s quality of 
life. The data indicate that children and adolescents who have a greater FoH also have 
poorer diabetes-related quality of life. Although the direction of the relationship between 
FoH and QoL cannot be confirmed, managing and improving QoL in CYP with T1DM is vital.  
A review by Cameron (108) concluded that health-related quality of life was key to 
improving diabetes-related outcomes.  Those parents who worry more about 
hypoglycaemia also perceive their offspring to have a poorer quality of life.  These findings 
highlight the impact of T1DM not only on children but on their parents too.  Parents’ FoH 
may impact their judgment of their child’s QoL and could potentially cause parents distress 
or further worry as a result.  It would be interesting to explore the association between 
FoH and parental QoL, given the large role parents play in diabetes management.   
 
7.2.4 Multivariate analysis of hypoglycaemia fear survey 
Multivariate analyses were conducted in order to examine the significant independent 
correlates of fear of hypoglycaemia.  Gonder-Frederick et al. (72) found that both trait 
anxiety and severe hypoglycaemia were important predictors of FoH in adolescents only.  
Results from the current study however, indicated that trait anxiety was associated with 
FoH in all groups except fathers of under 11 year olds (although this might be a reflection 
of the low number of fathers of under year 11 olds participating in the study).  Those with 
higher trait anxiety were also likely to have higher FoH.  This is not surprising considering 
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that it is probable that those with higher anxiety will tend to worry more as reflected in 
their worry scores on the HFS.  Another explanation for this relationship is that the HFS 
worry subscale is actually a diabetes-related anxiety scale and so will inevitably be related 
to a measure exploring general anxiety.  Previous experience of severe hypoglycaemia was 
also found to add to the predictability of FoH in adolescents and fathers of adolescents, 
which suggests that it is the combination of trait anxiety and previous experience of severe 
hypoglycaemia which is important.  It would be interesting to understand the link between 
severe hypoglycaemia and trait anxiety to determine whether increased severe 
hypoglycaemia contributes to increased general anxiety.   The reduction of severe 
hypoglycaemia in CYP and management of anxiety might be important factors in managing 
both fear of hypoglycaemia and quality of life.  Due to the limited evidence base of this 
topic, in the target population, further investigation of the direction of causality between 
the aforementioned variables should be carried out in order to decide the best method of 
intervention. 
 
7.3 Challenges in this research  
Looking back at the study, a number of challenges in the research are apparent.  A number 
of difficulties regarding research with children were encountered.  However, research with 
children is important so solutions to these difficulties were sought.  In order to obtain 
informed consent/assent from CYP the aims of the study had to be explained to potential 
participants in a way that would be understood by different age groups.  The information 
sheets used for this study were aimed at different groups (e.g. parents and CYP) and age 
groups of participants to help ensure that the information that they received was clear and 
coherent to them.   
 
In order to address the issue of completing lengthy questionnaires that can be tiring and 
difficult for young children, age appropriate questionnaire packs were produced for 5-7 
year olds, 8-10 year olds and 11+year olds; the younger 2-4 year olds were represented 
through parent by proxy reports.  Although for the older age groups there were a number 
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of questionnaires which needed to be completed, younger children were asked to 
complete a smaller battery of assessments. Using questionnaires was essential to allow 
data from a large number of participants to be collected with limited resources. 
 
There are methodological limitations to the study which was cross sectional and included 
participants with a wide range of diabetes duration and experience of hypoglycaemia. The 
definition of hypoglycaemia and severe hypoglycaemia might have not been clear enough 
and interpreted differently amongst CYP and parents who took part in the study.  The 
frequency measure included the DCCT definition (40) of severe hypoglycaemia which 
includes all episode requiring assistance for treatment, as well as those resulting in seizure 
or coma.  In hindsight, this definition of severe hypoglycaemia in paediatric studies, is 
unsuitable.  When this is taken in the context of younger children, the majority of episodes 
of hypoglycaemia could be interpreted as severe episodes, even when they are not 
because the child will require assistance.  Participants in paediatric studies should be 
provided with a stricter definition of severe hypoglycaemia (an event resulting in loss of 
consciousness or seizure) as recommended by ISPAD (34). Retrospective assessment of the 
frequency of hypoglycaemia is generally inaccurate, and previous authors have found that 
asking patients about absolute numbers of severe events is only accurate for the 
preceding year (164).  In adolescents, recall of the episodes of hypoglycaemia they 
experienced might also have been affected by impaired awareness.  A more reliable way 
of reporting the prevalence of hypoglycaemia might be to wear a device measuring 
physiological changes in the body in order to detect and consequently record 
hypoglycaemia. However, this type of method would need to be done over a long period 
of time which might be difficult to achieve for a large cohort of CYP over an extended 
period.  Therefore we have to accept that self-report, retrospective reports are the next 
best way of obtaining information relating to past episodes of hypoglycaemia in CYP 
participants, over a long period of time and in large cohort studies. 
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Participants in this study were a self-selected group who may either over-represent those 
who worry about hypoglycaemia and might be more interested in a study of this nature, or 
may have excluded those who were too anxious to participate.  Unfortunately these 
shortcomings may be difficult to overcome, participants have to be willing to participate in 
research and cannot be compelled to take part. Those CYP or parents who were unable to 
participate in the study due to language/reading difficulties might also contribute to a 
potentially biased view, as reflected by the predominantly white sample of CYP and 
parents.  The National Paediatric Diabetes Audit (NPDA) 2013-2014 (154) shows a 
population make up of 72% Type 1 Diabetes patients who were White, therefore this 
sample is over-representative of white ethnicity.  Future research might utilise 
questionnaires in languages other than English to be more inclusive of participants.  This 
study was able to report paternal data, which is otherwise limited in FoH research; 
however, the small numbers may have impacted the results and their generalisability. 
 
7.4 Implications 
The results of this study add to the growing body of quantitative literature on CYP with 
T1DM and their families. Understanding that there is an association between trait anxiety, 
severe hypoglycaemia and fear of hypoglycaemia may have clinical implications not only 
for diabetes management in this age group but patient-reported outcomes too (165).  
Managing and reducing severe hypoglycaemia may contribute to less anxiety/worry about 
experiencing hypoglycaemia.  Similarly, managing the fear associated with hypoglycaemia 
could contribute to improving outcomes for CYP and their parents.  Interventions aimed at 
reducing severe hypoglycaemia and/or managing anxiety might contribute to reducing 
FoH in CYP.  Severe hypoglycaemia may be the result of impaired awareness of 
hypoglycaemia, for some CYP. Therefore, teaching CYP to recognise the early signs of 
hypoglycaemia could contribute to a reduction in overall severe hypoglycaemia.   The 
relationship between FoH and quality of life provides further motive for reducing FoH in 
order to improve outcomes for CYP living with a chronic condition.  Identifying ways to 
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reduce FoH may help CYP better manage their condition without it impacting too 
negatively on their lives.   
 
Acknowledging the strength of parental FoH has implications for mothers and fathers of 
CYP with T1DM. Results of the current study show that parents experience higher FoH 
than CYP with T1DM do for themselves.  This suggests a necessity to find ways to manage 
parental anxiety and worry in order to better help them cope with their child’s illness and 
potentially promote optimal diabetes management in their CYP.  The data indicate that 
CYPs’ diabetes does have a negative effect on parents so it is important to try to find ways 
to support parents in their role as caregivers.  Such interventions could also be extended 
to supporting CYP/parents in the management of other chronic conditions.  These results 
encourage researchers and clinicians to think about and acknowledge the impact that 
CYPs’ diabetes has on parents.  Although there is some focus on supporting parents/carers 
of children with long-term conditions within research, this does not translate into support 
available to them in practice.  Parents often have little time, with conflicting 
responsibilities (166) therefore many interventions are not practical or suitable for them.  
Further investigation should be done to find out what parents think would work for them 
in terms of being supported in their role as carers, both practically and psychologically. 
 
The data suggest that parental FoH is related to parental anxiety.  In a review of parental 
FoH, Barnard et al. (77) concluded interventions to address anxiety in parents were 
needed in order to help parents optimally manage their child’s diabetes.  The impact of 
FoH on parental quality of life has received some attention (167) however, the benefits of 
additional support for parents of children with T1DM, to manage anxiety should be 
explored further.  For the current study, the qualitative analyses should clarify what 
parents think might help them to cope with the daily diabetes care they are required to 
provide to their child.  This will be discussed in later chapters.  Clinically significant FoH 
cut-off points might make it easier for clinicians to identify those CYP and parents who are 
struggling.  However, in the absence of a cut-off score, clinicians should at least be aware 
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of FoH and its impact on both CYP and parents, especially in the UK where limited research 
has been published.    
 
7.5 Future research  
Further research into the lives of CYP with T1DM and their parents needs to be carried out 
in order to develop a greater understanding of these experiences.  Phase two of this study 
aims to uncover the experience of living with diabetes at a deeper level.  These results will 
be presented and discussed in the next two chapters. A longitudinal study examining FoH 
and anxiety in children, young people and their parents from diagnosis could provide more 
informative data about the emergence of fear of hypoglycaemia and related variables, 
such as the experience of hypoglycaemia/severe hypoglycaemia, which may underpin and 
explain its development.   
 
Given that FoH is present in this cohort of CYP and parents, future research should address 
reducing this FoH, which, as previously suggested may impact on CYP QoL.  There is a clear 
link between severe hypoglycaemia, anxiety and FoH, although the direction of this 
relationship cannot be inferred from this cross-sectional study.  As the present study has 
highlighted that CYP and parents suffer from anxiety about hypoglycaemia, future 
research should concentrate on developing interventions that help reduce FoH, or at least 
anxiety and worry (which may contribute to FoH) in both CYP and their parents, in order to 
improve their well-being.  The results confirm a link between severe hypoglycaemia and 
FoH which suggests that those with a history of episodes of severe hypoglycaemia present 
higher levels of FoH.  Therefore, reducing the number of episodes of severe 
hypoglycaemia might help to reduce the associated fear and anxiety.  Hermanns et al. 
(168) have already devised an education programme aimed at informing patients about 
the problem of recurrent hypoglycaemia, recognising symptoms of hypoglycaemia using a 
combination of methods and teaching them these techniques.  Results for Hermanns et 
al.’s (168) study were promising and suggest that the HyPOS educational programme helps 
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to reduce severe hypoglycaemia.  Researchers also reported improvements in anxiety and 
quality of life related variables, although these findings were not significant.  The impact of 
HyPOS on the fear of hypoglycaemia, however, has not been investigated.  It would be 
interesting to see whether the reduction in severe hypoglycaemia had an impact on FoH 
levels in CYP and their parents.  A longitudinal study, using the HyPOS intervention could 
be conducted to assess the impact of this intervention on patient and carer FoH, which 
might also impact on QoL.     
 
The development of an educational intervention aimed at reducing FoH in CYP and 
parents, could be another way of managing FoH.  This might include education on diabetes 
management, hypoglycaemia, implications of hypoglycaemia/hyperglycaemia and the 
impact of hypoglycaemia avoidance, delivered in a group setting based in clinic.  
Educational programmes for adults (DAFNE; (169)) and children (KICk-OFF; (170)) have 
reported improvements in glycaemic control and quality of life respectively, but did not 
address FoH.  Recently, a pilot study testing a glucose management programme with a 
specific focus on FoH was carried out at University College London by Cai et al. (171).  
Although results have yet to be published, early analyses indicate a reduction in 
hypoglycaemic events with no increase in HbA1c.  Those parents and CYP who attended 
the sessions reported enjoyment, increased confidence and feeling connected to others in 
the same situation. Unfortunately attendance at the clinic-based educational groups was 
not as good as hoped.  Parents reported other commitments, unwillingness to miss school 
and transport issues as reasons for non-attendance.  This may have impacted on the 
feasibility of this type of intervention.   
 
Educational interventions aside, another way to help reduce FoH in CYP and parents might 
be to address anxiety levels in these groups.  The burden of caring for a child with diabetes 
might also contribute to parents exhibiting depressive symptoms.  Future research could 
further explore the impact of CYP T1DM on parental well-being by measuring anxiety, 
depression and stress in this group.  The current study focused quality of life of CYP.  Given 
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that parents reported higher levels of FoH, this fear could impact on parental QoL.  
Research investigating parental FoH and parental QoL is limited and therefore would 
benefit from further exploration.  Future research focusing on parental QoL alongside 
parental anxiety, depression and stress could add to data regarding parental experience of 
living with a child with diabetes. Such a study could also add to the limited information 
regarding the psychosocial factors associated with this group.    
 
Mindfulness is thought to help improve mental health and refers to paying attention to 
the present moment; being more aware of your present thoughts, feelings and the world 
around you (172).  The principles of mindfulness were used to develop mindfulness-based 
stress reduction (MBSR) by Dr Kabat-Zinn (173). MBSR combines mindfulness meditation 
with Hatha yoga as methods to help individuals to pay attention to their thoughts but let 
them pass without judgment, thereby reducing the impact these thoughts may have.  
MBSR techniques have been used with patients living with long-term conditions including 
T1DM (174, 175), however research with paediatric groups is limited (176).  Results 
indicate that MBSR techniques are successful in reducing depression, anxiety and distress, 
which in turn may improve management of long term conditions.  However, many of the 
paediatric studies in this field have been disadvantaged by poor methodologies in addition 
to the difficulties in practicing mindfulness with younger age groups (177). Future research 
should take these factors into account to ensure collection of empirically sound data.  
 
MBSR has also been used to reduce stress and distress in care-givers of chronic disease.  
Much of this research has been carried out in families of dementia patients.  Whitebird et 
al. (178) compared an MBSR intervention with a standard education and support 
intervention aimed at family caregivers.  Results indicated that MBSR was a much more 
effective at reducing stress and depression and improving mental health in caregivers than 
the educational intervention.  Although both MBSR and the educational intervention were 
successful in improving anxiety, MBSR does seem to have more strength than educational 
interventions do.  This supports the idea of using mindfulness as a method of reducing 
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stress and anxiety.  A five-component intervention incorporating mindfulness was also 
used with hospital workers who provide continuous care to patients (179). This model 
helped to significantly reduce stress in participants compared to controls.  The results of 
these studies are promising, and provide support for using MBSR on parental carers, 
despite the paucity of research looking at the impact of MBSR on parents of CYP with 
T1DM.  As the results of the current study have shown, parents (both mothers and fathers) 
exhibit a higher fear of hypoglycaemia than their children do.  Therefore it is as important 
to consider parental outcomes, as carers of CYP with T1DM and ways of improving these 
outcomes.  An MBSR intervention aimed at parents of CYP with T1DM is needed to help 
address the FoH and anxiety reported by these parents.  This would also address the lack 
of interventions aimed at this population. MBSR techniques might be more useful for 
those parents whose child has lived with diabetes for approximately one year, thus giving 
them some time to become accustomed to their child’s condition.  The MBSR programme 
could then address the worries, fears and anxieties that emerge through caring for their 
child, via a short course of sessions. 
 
As mentioned previously, research in MBSR programmes for CYP is relatively limited; 
however, future research could also look at developing MBSR programmes specifically for 
CYP, potentially by age group, in order to address fears and anxieties and potentially 
impact on self-management, care and QoL.  As suggested for the parents of CYP, this 
intervention would be best prescribed once the child/young person has lived with the daily 
demands of T1DM in order to address emerging anxieties.  Interventions incorporating 
mindfulness will add to existing research in both diabetes research and MBSR research.  
For this intervention to have value it should be properly developed to ensure data is 
collected robustly.  Future studies should include both experimental and control groups in 
order to assess the impact of the intervention on the target group.   
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7.6 Summary of Chapter 7 
In summary, FoH is a complex construct that may be impacted by both genetic disposition 
(trait anxiety) and external cues (episodes of severe hypoglycaemia).  Both CYP and 
parental FoH were evident in this sample highlighting it as a problem in diabetes 
management. Although a link with glycaemic control was not found, the significant impact 
on the quality of life of the entire family is demonstrated (74) as well as the impact of trait 
anxiety and previous experience of severe hypoglycaemia on FoH.   
 
Implications of the findings of the current study point towards increased awareness of the 
presence of and impact of FoH on CYP and their parents.  There is a clear link between 
severe hypoglycaemia and FoH which indicates that managing these episodes of severe 
hypoglycaemia could help to manage the associated fear.  Clinical staff should be aware of 
the FoH and its prevalence in CYP and parents.  Beneficial interventions are needed to help 
CYP and parents to cope with the daily demands of diabetes management and to also 
improve outcomes for both of these groups. 
 
Interventions should aim to manage and reduce FoH, although it is not clear what the best 
method to do this is.  Reducing severe hypoglycaemia using educational programmes has 
shown to be successful however the impact of these programmes on FoH should also be 
explored.   Interventions aimed at reducing the risk of hypoglycaemia may not be effective 
for all, given the contribution of personality factors such as trait anxiety. Instead 
interventions that consider the psychological well-being of patients and their families that 
provide strategies to reduce fear and anxiety need to be considered.  MBSR has shown to 
be effective in reducing anxiety and having a positive impact on well-being.  Incorporating 
the principles of MBSR and focusing them on CYP and perhaps more crucially on parents of 
CYP could contribute to managing anxiety and FoH in addition to other psychosocial 
outcomes. 
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Chapter 8: Qualitative analysis 
This chapter will report on the qualitative analysis of Phase Two of the study, looking in 
more detail at living with diabetes through the eyes of children, young people and their 
mothers.  The methods employed to analyse the qualitative data will be described briefly, 
as they have already been described fully in a previous chapter (Chapter 2, 2.12), followed 
by a description of the sample study population.  The aim of this chapter is to describe the 
main themes arising from analysis of interviews conducted with children, young people 
and their mothers. 
 
8.1 Summary of method 
The aim of Phase Two of the study was to get more in depth, detailed accounts of living 
with diabetes, from the perspective of children and young people with Type 1 diabetes, 
and their mothers.  Semi-structured interviews were conducted with a subset of 
participants who had already taken part in Phase one of the study.  Thematic analysis was 
conducted on the interview transcripts and took a theoretical approach (153).  Full details 
of the analysis can be found in (Chapter 2, 2.12 onwards) 
 
8.2 Demographics 
Children, young people and parents who had already taken part in Phase one of the study 
were invited, by letter, to take part in Phase two interviews.  Thirteen children and young 
people aged 7-17 years took part in Phase two of the study. The sample was made up of 
three under 11 year olds and the rest of the sample was classed as adolescents, as in the 
quantitative phase of the study.  The sample consisted of eight girls and five boys.  
Thirteen mothers also took part.  The sample was predominantly white, with the exception 
of one mother and son pair who identified as Asian (Pakistani).  Unfortunately no fathers 
took part in the qualitative phase of the study so the qualitative analysis refers to mothers 
of CYP with T1DM only, although some mothers did refer to the part that fathers play in 
their child’s care.   
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Interviews were semi-structured and followed a set of questions around living with 
diabetes, although there was flexibility to focus on certain topics if participants seemed to 
have more to say in those areas.  Where appropriate children, young people and mothers 
were interviewed separately, however, all participants were given the option of being 
interviewed with their mother present.  This was requested only by two of the younger 
members of the group.  In total 24 interviews were conducted, ranging from 8 minutes, 46 
seconds to 63 minutes, 3 seconds.  Data collection for Phase two was completed at the 
point of data saturation where the interviews ceased to elicit any new topics.  This is the 
point at which no new information seemed to emerge as the interviews were being 
conducted i.e. the responses did not add to data which had already been collected.  
 
8.3 Results of thematic analysis  
8.3.1 Burden 
After familiarisation with the interview transcripts, various themes and sub-themes were 
considered.  ‘Burden’ was identified as the overarching theme in this analysis.  CYP and 
mothers, especially, referenced negative emotions associated with T1DM and the 
responsibility of living with diabetes.  The themes ‘negative emotions’ and ‘living with 
diabetes’ emerged as key areas of the interviews. The majority of mothers and CYP relayed 
the ‘negative emotions’ they experienced as a result of living with T1DM. These emotions 
were examined in relation to topics including ‘feelings about T1DM’ and ‘fear of 
hypoglycaemia’; which were identified as sub-themes.  ‘Living with diabetes’ was 
particularly prominent in discussions about the early years of adjusting to living with 
diabetes.  However, changes and impact on life were also reported during later phases of 
CYPs’ and mother’s lives.  The emergent sub-themes here were the ‘positive impact,’ 
‘negative impact’ and ‘practical’ changes associated with CYP and mothers’ lives beyond 
diagnosis.  Figure 12 below illustrates these themes and sub-themes for CYP and mothers. 
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Figure 12: Thematic analysis  
 
 
Each theme and sub-theme will be discussed from the perspectives of both CYP and their 
mothers.  Initially, it was assumed that separating the analysis for these two groups would 
lead to more clarity, however, crossover between CYPs’ and mothers’ accounts made it 
difficult to present the data in this way.  The differences in the experience of diabetes 
between CYP and parents are apparent from the quantitative analysis.  The qualitative 
analysis also highlighted differences between these groups, these will be discussed 
further.    
 
8.3.2 Negative emotions 
Both mothers and CYP reported negative emotions during interviews about living with 
diabetes.  These emotions included feelings of distress, worry and guilt. 
 
8.3.2.1 Feelings about T1DM 
Recollections of diagnosis evoked memories of distress, worry and fear from mothers and 
CYP.  Children’s (and mothers’) accounts of diagnosis referred heavily to how they felt, 
emotionally, at the time.  This included indications of extreme distress and disbelief: 
I thought I was gonna die cause it said diabetes so I was like crying my eyes out and then 
mum was trying to like explain to me what it was. (14 year old CYP) 
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Many CYP were fearful that diabetes was life-threatening.  Often CYP had never heard of 
diabetes so this elicited fear in itself.  Reactions were unsurprisingly emotional.  This was 
CYPs’ first experience of living with diabetes, having been given an actual diagnosis.  Even 
following diagnosis, however and knowing that something was wrong, children and young 
people did not immediately fully understand their diagnosis and how it would affect them: 
She said “am I going to die?” and I said “no no you’re not going to die”. (Parent of 12 year 
old) 
This extract highlights the lack of knowledge CYP had regarding a diagnosis of T1DM.  This 
was to be expected considering that for most CYP, the point of diagnosis was usually a 
response to an unforeseen and urgent hospital admission.  The time from identifying 
extremely high blood sugars to having emergency treatment was swift with no time to 
think or process what was happening.  The first experiences of diabetes then were 
frightening for CYP.    As the extracts from the interviews above indicate, the diabetes 
diagnosis revealed feelings of anxiety, uncertainty and confusion from children and young 
people.   
 
Although CYP reported being fearful of being diagnosed with T1DM acknowledging that 
diabetes is a treatable condition and that it could be worse, helped them to reach some 
acceptance: 
It’s like obviously it’s not the worst like thing you could have like when I think of people 
that have cancer and things. (14 year old CYP) 
This extract was reflected by this young person’s mother too, or perhaps this is a reflection 
of the mother’s perspective of the diagnosis.  Either way, being grateful that there were 
options for treatment and that diabetes is a manageable condition seemed to help CYP to 
accept their diagnosis and try to cope with it.   
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As many of the children and young people interviewed were diagnosed fairly early on in 
life, it was not surprising that their mothers would have a clearer recollection of diagnosis 
than the CYP themselves.  Similar to CYP, mothers gave factual reports of events leading to 
diagnosis.  However, in addition to this mothers also gave vivid and emotional descriptions 
of what happened prior to diagnosis: 
They said sit in the waiting room. I said I’ve got a poorly child.  She was lying across my 
arms like a rag doll….She’d lost so much weight, and all of a sudden the room was full of 
doctors and they’d done the blood test and she was off scale. They couldn’t even measure 
her blood, it was too much. (Mother of 8 year old) 
As this extract shows, descriptions of the events leading to diagnosis were often frantic, 
unexpected and met with a great deal of urgency by medical staff.  For parents, this was a 
frightening experience and for most it was totally unexpected. 
 
Maternal reports of diagnosis suggest an even more distressing reaction to their child’s 
diagnosis than children and young people had for themselves, “I was just a gibbering wreck 
crying most the time” (mother of 14 year old).  Initial maternal responses included reports of 
tearfulness at what their child was going through, and being “in shock.”  Mothers’ initial 
experiences of diabetes then were not dissimilar to those of their children.  They too felt 
anxious, scared and unprepared for such a diagnosis.  Perhaps, being responsible for their 
child’s healthcare it is likely that mothers were more aware than CYP of the implications 
diabetes would have and therefore the diagnosis potentially impacted them a lot harder 
than it did their children.   There was also an element of guilt that mothers had not noticed 
that their child was unwell: 
It’s like Oh my God, how did I not notice.  But you just don’t because you’re with them all 
day every day. (Mother of 8 year old) 
This added to the distress mothers experienced.  In hindsight mothers could see the signs 
were there but had not noticed them before diagnosis.  Mothers felt guilty about not 
spotting the early symptoms and reported anxiety about what might have happened had 
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they not have got their child the medical attention they had needed, sooner.  So the guilt 
resulting from their child’s diagnosis was apparent in mothers very early on. 
 
In comparison to CYP, many mothers’ accounts of diagnosis were extremely poignant.  
They seemed to understand the wider implications of having a lifelong condition, whereas 
perhaps CYP were more focussed on the present: 
I just thought our world had ended you know and I just thought she’s ill. (Mother of 9 year 
old) 
For their child to be diagnosed with a lifelong chronic condition was devastating for 
parents; what they once knew had changed forever.  It was almost in the same way a 
death might have an impact, it was like a period of bereavement.  One parent described 
the diagnosis as a real loss, and referred to her young daughter’s life being cut short as a 
result of the diagnosis: 
I think I supposedly went through a period of bereavement…she was diagnosed umm on 
my son’s 1st birthday so that I think was quite hard because I’ll remember the date until 
the day I die…so I suppose I did find it quite hard I did, because my perfect daughter now 
had 10 years wiped off her life. (Mother of 11 year old) 
The references to death here illustrate the strong reactions mothers, unsurprisingly, had 
towards the diagnosis given to their child.  It seems that the diagnosis of diabetes signalled 
the end of the life they knew.  There was also acknowledgement that this diagnosis could 
impact on the lifespan of their child.  No parent wants to think that their child will not live 
a long and healthy life and when faced with such a revelation, mothers were 
understandably distraught. 
 
Following the comparison of the diagnosis to death, mothers also reported initial feelings 
of denial: 
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We came home and drove to the Leicester Royal and even that point I was thinking no it’s 
not going to be and even doing my job [paramedic] I was thinking no, no, no. It was at the 
point where they actually injected her with insulin and it was at that point where I had to 
leave the room and I thought oh God yes she is. (Mother of 12 year old) 
Again, this links back to the experience of something ending, and in this case it was a life 
without diabetes.  Life had changed for CYP and their parents after being given a diagnosis.  
Initial reports of denial certainly were apparent for mothers, but not for CYP in this 
sample, who, although distressed by the diagnosis did not refute the fact that they had 
diabetes.  
 
Mothers expressed a real sense of regret for their child, in response to their diagnosis: 
And why did it happen and why did it happen to him…Why was it [child], my youngest, and 
my baby. (Mother of 15 year old) 
The feeling of injustice and guilt about why their child was suffering was common amongst 
many of the mothers: 
You feel guilty a lot of the time. (Mother of 15 year old) 
They did not want their child to have to go through life with an illness, for the illness to 
impact on them every day and to potentially lead to future complications and possibly a 
shorter lifespan.  Interestingly, none of the CYP interviewed for this study reported feeling 
this way which may or may not be a true reflection of how they felt at the time.  It is 
possible that mothers were more open in terms of discussing their feelings than CYP were.  
Although mothers experienced a high level of distress and upset they had to remain strong 
for their child’s sake and so outwardly presented a very different response to the diagnosis 
in comparison to how they actually reported feeling inside. 
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For mothers especially then, the impact of diagnosis was great and it stirred many 
emotional reactions: denial, fear, distress and heartbreak, perhaps greater than children 
expressed for themselves.  In some cases the diagnosis of diabetes took over: 
A friend of mine said that it, it probably took me about 3 years to stop talking about it 
[diagnosis]. (Mother of 11 year old) 
The diagnosis had a real impact on the lives of not only CYP but their parents and families 
too. 
 
Following discussions about diagnosis, the interview transcripts returned more reports of 
negative experiences of diabetes, than positive ones.  This could be due to the fact that 
especially for the more extreme events, mothers and CYP found these episodes difficult to 
forget: 
She umm was fine talking she walked down the stairs and just collapsed and fitted at the 
bottom of the stairs. (Mother of 14 year old) 
Witnessing your child experience a seizure, especially unexpectedly is likely to have been a 
key memory for mothers of CYP with diabetes.  Perhaps, more so for mothers than their 
children as they would be more likely to remember details of the event than CYP 
themselves.  
 
Diabetes regimen was often difficult for CYP but mothers also felt their child’s pain: 
Some days she cries a lot cos her fingers hurt, that’s the big thing at the moment. (Mother 
of 11 year old) 
Mothers found it hard to watch their children go through the constant regimen of blood 
testing and insulin injections.  It is not surprising then that mothers reported that CYP 
struggled with the constant demands of dealing with diabetes: 
We do get tears and she doesn’t wanna be diabetic anymore and that makes me sad. 
(Mother of 9 year old) 
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This mother expressed both sadness and helplessness at her daughter’s situation.  The 
CYP’s obvious sadness was reflected by her mother.  
 
Although mothers reported having faith that their child could treat hypoglycaemia if they 
needed to, one area of concern was whether or not their child was able actually able to 
recognise an episode of hypoglycaemia.  While rare, there were some maternal reports of 
CYP suffering from impaired awareness of hypoglycaemia: 
We went through a phase when he was losing his awareness, quite often, I mean even now 
I’m not sure it’s great. (Mother of 15 year old) 
A lack of awareness meant that it would be difficult for a child to detect and treat 
hypoglycaemia quickly enough, which increased the likelihood of an episode of severe 
hypoglycaemia.  This also contributed to mothers’ anxiety about whether or not CYP were 
able to manage their diabetes on a daily basis. 
 
Evidently, there was a great impact of diabetes on mothers however mothers also 
described the impact it had on CYP’s fathers, which gives a little more insight to fathers’ 
experiences of having a child with diabetes:  
 
Her dad found it more distressing…her dad was worried about day to day. (Mother of 12 
year old) 
 
Some fathers might not have coped with their child’s diagnosis as well as mothers who 
tended to be the main caregivers, although later sections highlight the supportive role 
fathers take in caring for their child.  This is interesting in terms of learning more about 
paternal roles in the care of children with T1DM. 
 
It seems that both CYP and mothers reported fear and worry about living with T1DM.  
However, mothers reported many more negative emotions than their children did.  They 
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experienced periods of denial, following diagnosis; regret for their child and also reported 
feeling bereaved.  Interestingly, these feelings were not reported by CYP which suggests 
that the impact of diabetes could be greater for mothers than it is for their children.  CYP 
seemed to report negative emotions associated with immediate consequences of their 
diagnosis and did not talk about worries of or fears about the future, whereas mothers 
reported fear, grief and worry about the diagnosis, coping with diabetes and also the long 
term implications.  This will be discussed further in subsequent themes. 
 
Negative emotions stemming from the overarching theme of burden were reflected in 
interviews in various ways.  Considering diabetes management does impact on everyday 
life to a large extent, with checking blood sugars and having to inject insulin, it is not 
surprising that, over time, CYP reported that they did not want to be seen as different 
from their peers and at times tried to hide the fact that they had diabetes, especially as 
they got older.   This highlights the ongoing impact diabetes has on CYP’s lives.  Even those 
CYP who had moved to pump therapy had issues about their condition being too obvious:  
Though she’s got the pump, having something and having to carry something, you know, is 
a bit of a bind. (Mother of 16 year old) 
The fact that the pump was something that CYP would have to wear most of the time did 
actually discourage some CYP from agreeing to move to this intensive therapy.  It was 
almost like having the pump attached was a constant reminder of having diabetes and for 
many CYP, they already had plenty of reminders of their condition: 
It’s just having it in my mind whole time. (15 year old CYP) 
The endless management and daily treatment meant that CYP became tired and reported 
feeling like they needed a break from their diabetes.  There was often little respite from 
the condition. 
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CYP difficulties in managing diabetes in the long-term were acknowledged by mothers.  
One mother spoke about how her 9 year old daughter coped with diabetes:  
She does want more things, she does want what her friends have got, she does want to eat 
what they’re eating….She really broke down the last time we was at the hospital…she’d 
said she’d love just for one day not to have any injections and to be like everybody else. 
(Mother of 9 year old) 
It seems that for some CYP, as they got older and started to notice how they differed from 
other children their age, they experienced feeling unhappy about their condition.  Mothers 
reported where CYP might have accepted their diagnosis and embraced diabetes 
management routines in the short-term, as they entered new phases and became more 
independent they became more aware of the impact diabetes had on their lives.  One 
young person’s report of breaking away from her diabetes routine was verified by her 
mother’s account, which highlighted the CYPs’ mental health in relation to coping with her 
illness:  
 [My child] had told this [other] child that she had considered it [self-harming] because of 
her diabetes. (Mother of 12 year old) 
As CYP approach adolescence and conflicting demands and pressures are placed upon 
them, it is no wonder that the constant management of diabetes might become more 
burdensome than it previously had.  The constant demands of managing diabetes certainly 
impacted on how well CYP were able to cope with living with diabetes. One young person 
reported breaking away from the recommended treatment, indicating problems in coping 
with her condition: 
After a while I got really annoyed with it cos at one point I stopped doing my injections and 
stuff. (12 year old CYP) 
This illustrates the issues that some CYP have with coping with chronic illness, especially 
when there is a constant need to monitor and manage it.  It is not only the physical impact 
of living with diabetes but also the mental and psychological effect it can have on CYP (this 
is reflected in the maternal reports of this young person’s ability to cope with her 
condition).  During adolescence, when there are already many changes that a young 
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person might be experiencing, even for those CYP who have previously managed their 
condition well, living with a lifelong condition can become burdensome and CYP might 
rebel against their daily regimen.  Girls (and some boys) during this time are also becoming 
more aware of their body and may experience issues with body image.  Having to inject 
insulin then, which can cause weight gain, might be at odds with trying to portray the 
‘perfect’ body (180).  Although there were no reports of eating disorders from CYP, 
changes in motivation to manage their diabetes could stem from psychological issues. 
 
CYP reported feeling more self-conscious about their diabetes as they got older, often as 
they entered high school or period of adolescence: 
I think it’s that move to high school. A lot of her friends she’s made at High School, don’t 
know she’s diabetic. She hasn’t told them. (Mother of 12 year old) 
Some CYP reports indicated that having to manage their diabetes at times made them feel 
like they were different and they did not want to feel this way all of the time.   
 
CYP found other people’s perception of diabetes frustrating.  Even after having lived with 
diabetes in the long-term often other children did not believe that the child had diabetes 
because there were no obvious signs of illness.  This was upsetting: 
I don’t like having diabetes because people come up to me and say “you don’t have 
diabetes” and I say “yes I do” and they say “how come I can’t see it” because most things 
you can see. (8 year old CYP) 
The fact that diabetes is an ‘invisible’ illness can put additional pressure on those CYP who 
are trying to manage their diabetes whilst not showing signs of being ill. 
 
Interestingly, one child reported the guilt she felt and the impact she felt her diabetes had 
on the rest of her family: 
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like Taybarns [restaurant], like even though they’re having a good time and I act like I am 
and I think in a way deep down they’re thinking ‘I bet [child’s name] would’ve been having 
a good time without diabetes.’ (9 year old CYP) 
It’s thought-provoking to learn that CYP with diabetes report feelings of guilt about the 
impact their illness has had on their parents and rest of the family. This guilt could impact 
on CYP well-being and quality of life. CYP guilt has otherwise received very little attention 
in previous research and highlights a problem that previously does not appear to have 
been reported in this group. 
 
Although CYP reported the burden of diabetes management there were mixed feeling with 
regards to additional support, outside of the family unit, with most CYP saying they had 
enough support: 
Too much support, stops being support. That’s being over the top.  I think what we’ve got 
is good. (15 year old CYP) 
Most CYP felt that they knew how to manage their condition, what they needed to do to 
control blood sugars and how to deal with episodes of hypoglycaemia.   
 
The burden that CYP felt as a result of living with diabetes was evident from the interview 
transcripts.  The constant management and diabetes regimen were reported to impact on 
CYP over time and especially, as they approached adolescence, already a time of many 
changes.  Most CYP reported that familial support helped to relieve the burden of their 
condition. 
 
There were many references to the responsibility mothers felt for their child.  This 
included the day to day responsibility of diabetes care and the responsibility of avoiding 
long-term health problems.  As well as coming to terms with their child’s diagnosis, 
mothers reported feeling that there was a lot to learn about the practicalities of living with 
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diabetes and how stressful and overwhelming it was.  There was also the feeling of having 
a lot of responsibility on their shoulders, for their child and their child’s well-being.   
That responsibility was overwhelming. (Mother of 12 year old) 
Mothers spoke about how they would check on their children throughout the night to 
make sure that their blood sugars were not too low.  This was another added responsibility 
and pressure on mothers (and fathers) in the management of their child’s diabetes. 
 
As well as struggles to grasp the new demands that the diabetes diagnosis brought there 
were also maternal reports of feeling unsure and unsupported by clinical staff about how 
to manage their child’s diabetes.  Mothers felt conflicted at times between what the 
doctors and nurses were advising and what they felt was best for their child.  This type of 
struggle was often difficult for mothers (and fathers) who were already going through a 
stressful period and no doubt added to any anxiety they were already experiencing.  
Mothers reported being made to feel guilty by some clinical staff, which added to the 
pressure placed on them: 
Sometimes, they do have a way of making you feel as though you’re not trying hard. 
You’re not doing enough… I actually had a doctor that told me that when [child] went on 
the multiple injections, he said that perhaps it would be an idea, if I looked for a job that 
meant I could be around [child’s] school at lunch time.  I said I can’t afford to leave my job! 
He said you got to decide what and I thought, I’m very respectful of people, but I was 
getting more and more irate and sometimes the doctors don’t get their heads out of the 
book and you sort of say right, come and live my life, for one week. (Mother of 12 year old) 
So for mothers then, the pressure and responsibility of supporting and looking after a child 
with diabetes was enormous but eventually became a part of their daily lives.  By 
accepting the fact that they/their child now had to live with diabetes, CYP and their 
mothers could now focus their energy on managing the condition and adjusting their lives 
to living with diabetes. 
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Mothers were helpless in relieving their children of the one thing that they wanted.  This 
resulted in mothers harbouring feelings of guilt and dismay and feeling redundant in their 
role as protector:  
I get quite tearful with it really really cos I say to her I’d love to take it away from you and 
sometimes I feel guilty because I didn’t have [child] ‘til I was 31. (Mother of 9 year old) 
Mothers hoped they were doing the right thing and there was a lot of guilt about the 
things they could not do (however unrealistic), including making it so their child didn’t 
have diabetes. 
 
Unsurprisingly there were a number of references to the pressure that mothers felt under: 
It’s just a constant battle I, I, I just never know what I’m doing. (Mother of 14 year old) 
Mothers felt that there was no break from the regimen and they were unsure of whether 
they were doing all they could to help their child.  The constant burden of their child’s 
illness was described by many of the mothers interviewed: 
It’s like, it’s like being a gerbil on a cage. (Mother of 16 year old) 
Having a child with diabetes meant that mothers had to provide never-ending support and 
care often with no respite.  Although they tried to be strong and “go with the flow” (mother 
of 14 year old), mothers reported feeling like “a complete failure” (mother of 14 year old).  
 
There were references to other family members as a source of support and coping.  
Mothers spoke about the support and help fathers and siblings provided in caring for their 
children: 
We all know dad’s brilliant I’ll quite happily come to work or do a night shift or whatever 
and he just she goes and wakes him up and he knows and even big sister brilliant. (Mother 
of 14 year old) 
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This seemed to help ease the pressure that a lot of mothers felt they were under.  When 
mothers couldn’t cope with certain aspects of their child’s condition having a supportive 
partner helped to relieve some anxiety: 
I suppose being a nurse I should have been [able] felt better about doing her injections but 
out of the two of us my husband was better. (Mother of 11 year old) 
Where mothers felt they had shortcomings in the management of their child’s diabetes, 
they reported the ways in which CYPs’ fathers provided help.  These reports add to small 
body of research with fathers of CYP with diabetes.  They also help to illustrate how 
fathers are involved in helping CYP (and mothers) cope with the day to day management 
of diabetes.  Ultimately, the primary care of CYP was the responsibility of mothers. 
 
Considering all the pressure mothers felt under and the responsibility of providing 
optimum care for their children there were reflections about the lack of support made 
available to parents to help them and their children cope with the chronic condition:  
There was never an opportunity or never a question asked to see how we were coping 
mentally or psychologically and whether we needed support. (Mother of 16 year old) 
The constant management, stress and responsibility of managing diabetes had an impact 
on mothers, psychologically.  Struggles in coping may benefit from psychological support 
for parents, to help them deal with the day to day stresses.  Thinking about additional 
support in the long term, some mothers reported that they did not feel comfortable going 
to diabetes parents groups to talk about diabetes, as they might hear stories about the 
frightening things that could happen to their child.  These parents preferred the support of 
the family unit, close friends and CYPs’ clinicians, suggesting that there are different types 
of support that parents benefit from. 
 
Those parents who did feel additional support might be beneficial however, suggested 
that parent groups would be helpful, in addition to knowing about what the more serious 
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consequences were from the beginning so that if they did experience them they would 
already have an inclination that this could possibly happen: 
That you know it will be alright you may they may I know it’s frightening to say they may 
have a fit or whatever but you know it is part of it. (Mother of 14 year old) 
This refers to feeling confident and prepared for certain eventualities associated with 
having a child with diabetes, so that mothers did not feel unprepared in the event of, for 
example, an episode of severe hypoglycaemia leading to a seizure. 
 
Mothers reported enormous pressure and responsibility for their child’s day to day 
diabetes care and also for their long-term health.  This was often overwhelming and 
incessant, putting pressure on mothers and impacting on their quality of life.  Mothers 
benefitted from support from their partners in managing their child’s diabetes but 
ultimately were the primary caregivers and assumed the majority of responsibility of care.  
 
8.3.2.2 Fear of hypoglycaemia 
Fear of hypoglycaemia was evident in CYP and maternal reports of living with diabetes.  
CYP reported feeling scared and worried about severe hypoglycaemia.  CYP fears also 
extended to having an episode of hypoglycaemia in their sleep.  One young person 
reported actively avoiding nocturnal hypoglycaemia as a reaction to a period of night-time 
episodes of hypoglycaemia.  She was so afraid about having an episode of severe 
hypoglycaemia in her sleep, she stopped taking her insulin injections: 
There was a period where I tried not to have any injections but I got seriously told off for 
that. (12 year old CYP) 
Fear of hypoglycaemia for this young person had serious implications for her diabetes 
care. Children worried that they might go into a coma as a result of severe hypoglycaemia: 
I think that I can go into a coma. (9 year old CYP) 
 182 
 
It was something that they were genuinely scared and worried about at least for one of 
the CYP interviewed, impacted adversely on their motivation to achieve optimum 
glycaemic control.  
 
CYP also reported keeping blood sugar levels a little higher, during exam times, where 
having an episode of hypoglycaemia might impact on their performance: 
It’s just like the last exam I had, I didn’t have, I had, I didn’t have as much insulin just in 
case. (14 year old CYP) 
The worry about the impact of hypoglycaemia on performance in an exam contributed to 
hypoglycaemia avoidance behaviours, although reports of intentional avoidance were not 
common practice.  It seems that CYP really tried to manage blood sugars as well as they 
could. 
 
Fear of hypoglycaemia was apparent in this group of mothers.  Mothers were not only 
worried about CYP having an episode of hypoglycaemia on their own; they also worried 
about the symptoms of hypoglycaemia and severe hypoglycaemia, in general: 
When they were little and she used to go it’s frightening for anybody to watch. (Mother of 
14 year old) 
Mothers feared the worst for their child in terms of severe hypoglycaemia and the 
implications of a severe episode. 
I’ve got that orange thing [glucagon injection] in my fridge and I just dread that, panic 
really. (Mother of 14 year old) 
A number of parents spoke of their fear of administering a glucagon injection in an 
emergency, although no-one reported having to use it (with only one parent reporting that 
the paramedics had used it during one incident) and most being assured by the nurses that 
very often they wouldn’t have to.  Nevertheless, the fact that it was a possibility was a 
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distressing prospect for mothers.  This reflects another negative emotion as a result of 
T1DM.   
 
Experience of severe hypoglycaemia was traumatic and episodes were obviously 
distressing and frightening for mothers.  CYP did not report on these incidents in as much 
detail as their mothers did, perhaps because they did not remember as vividly/were not 
aware of the episode: 
They were bad hypos where she’d she wouldn’t even let you give her a drink she would 
refuse to swallow so I’d have to put the gel in her cheeks and rub and we’d pin her down 
cos she’d fight and become really angry. (Mother of 12 year old) 
Mothers described genuine difficulties in treating their child’s episodes of severe 
hypoglycaemia.  One account was obviously extremely upsetting for a mother but 
highlights why perhaps parents and CYP struggle with the prospect of severe 
hypoglycaemia and develop related fears and anxieties: 
That was our worst hypo, she did {starts to get upset] uh, … he [father] just poured orange 
juice down … I went ‘she’s dead!’ and she was by all attempts and purposes she’d got the 
thick skin, she’d got blue lips umm she just slumped forward yeh so being, being a nurse I 
just smacked her [to stop child choking] … her behaviour was just outrageous, I said just 
call 999 I can’t deal with this. (Mother of 11 year old) 
There were more than a few reports of cases where severe hypoglycaemia had led to 
emergency treatment, which in itself is an ordeal for both parent and child.  It is no 
wonder then that mothers reported worry and fear of hypoglycaemia, especially severe 
hypoglycaemia.  
 
Not surprisingly mothers described worries about their child having an episode of 
hypoglycaemia whilst asleep: 
I did not sleep particularly well for probably the first 4 months because I was terrified she’d 
have a hypo during the night and not wake up … I just couldn’t sleep I had to go in and 
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keep checking on her and my, my husband was not as bad as me but he was you know 
he’d go in, we, we were performing blood tests on her while she was asleep. (Mother of 12 
year old) 
The fear of nocturnal hypoglycaemia compelled mothers (and fathers) to monitor blood 
sugar levels throughout the night.  For some families this process continued long after 
their child had been diagnosed.  Mothers reported that CYP would inform them if their 
sugars were low during the night however, the majority continued to carry out their own 
nightly checks, often supported by CYPs’ fathers: 
What we do, do as well, religiously, is we do check her through the night…so between 2.30 
and 3am … we do a check… you know once you start … my husband and I, he’s very good, 
he works and I don’t and he still alternates. Yay! (Mother of 16 year old) 
This mother (and father) had been carrying out nightly checks since their daughter was 
diagnosed at 18 months old.  This highlights the impact of diabetes on parents’ lives.  Most 
of the references to sleep reflected the impact on parental sleep rather than on CYP sleep.  
CYP seemed to allow their (usually) mothers take responsibility for monitoring them after 
experiencing hypoglycaemia in the night.  This maternal responsibility will be discussed 
further. One of the main reasons for mothers’ worry regarding nocturnal hypoglycaemia 
was that their child might not wake up to alert them or treat themselves, which could have 
devastating consequences: 
As a parent that’s our biggest fear would be that she doesn’t wake up so yeh it is always 
there… yeh your hypo’s your biggest enemy and constant highs are you biggest enemy but 
hypos will cause death, instantly. (Mother of 16 year old) 
Many of the mothers reported fears that their child would not wake up following a drop in 
blood sugars while they slept.  However, it is worth noting here that hyperglycaemia 
(dangerously high blood sugars), while typically more insidious, is more likely than 
hypoglycaemia to result in serious harm to the child, including coma and death, so these 
reports reflect that mothers do not completely understand and perhaps overestimate the 
dangers of nocturnal hypoglycaemia.  When CYP had low blood sugar during the night 
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mothers reported keeping their child with them for the remainder of the night and so 
often had disturbed periods of sleep: 
I do go in and check on her then to make sure nothing has happened you know if she’s 
gone into the deep sleep coma or anything like that cos I do panic. (Mother of 9 year old) 
The impact of diabetes was not only during the waking hours, for some mothers it really 
was incessant.   The constant diabetes-related fear and anxiety and impact on parental 
sleep for some of the mothers interviewed suggest a major impact on mothers’ (and 
fathers’) lives, as well as on their quality of life. This reflects findings reported on the link 
between fear of hypoglycaemia and anxiety for the quantitative data, although the link 
with parental quality of life could be explored further in future studies. 
 
Fear of hypoglycaemia was evident in both CYP and mothers.  This fear stemmed from 
negative experiences associated with hypoglycaemia and severe hypoglycaemia.  The 
trauma seemed to be greater for mothers who often witnessed episodes of severe 
hypoglycaemia.  Mothers and CYP also expressed fear of nocturnal hypoglycaemia, 
however, it was mothers (and fathers) who seemed most affected by this.  Maternal 
reports of nocturnal hypoglycaemia indicated that mothers regularly monitored their 
child’s blood sugar levels throughout the night to make sure their child’s BG levels had not 
suddenly dropped.  Mothers’ accounts also highlighted issues with regards their 
understanding of the dangers of hypoglycaemia. 
 
Hypoglycaemia-avoidance behaviours were reported by both CYP and mothers, only in 
specific situations.  However, neither group admitted to deliberately maintaining high BG 
levels on a regular basis which suggests that CYP and their mothers do try to achieve good 
glycaemic control.  
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8.3.2.3 Summary of ‘Negative emotions’ theme 
Mothers and CYP used a number of negative emotions to report their experience of 
diabetes.  This included fear, anxiety, distress and guilt.  Both CYP and mothers reported 
distress and worry at diagnosis.  However, it was mothers who seemed to continue to feel 
anxious about their child’s diabetes, both in terms of day to day management and future 
impact of the illness. 
 
Guilt was apparent in CYP and mothers, but for different reasons.  Mothers reported 
feeling guilty that they had not recognised the symptoms their child had exhibited prior to 
diagnosis.  Mothers also felt guilty that their child had to live with a long-term condition 
and that they could do nothing to help them.  One child reported the guilt she felt 
regarding the impact diabetes had on her family, highlighting yet another example of the 
effect diabetes can have on CYP and their families.   
 
The responsibility and burden of managing diabetes was evident from CYP and maternal 
reports.  CYP reported that self-care could be relentless and mothers were overwhelmed 
by the daily management.  Mothers tried to support their children with day to day 
diabetes care and although they themselves benefitted from the support provided to 
them by their partners, they felt that they had ultimate responsibility for their children’s 
care.  
 
Reports of hypoglycaemia and severe hypoglycaemia revealed associated anxiety and fear, 
especially from mothers.  Although there were few reports of maintaining high BG levels 
to avoid hypoglycaemia, mothers did report monitoring their child’s BG levels through the 
night because they worried about nocturnal hypoglycaemia. 
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8.3.3 Living with diabetes  
Inevitably, a diagnosis of T1DM meant that there would be changes to both CYP and their 
mothers’ lives.  The majority of reports on living with diabetes from both CYP and mothers 
were negative although some did try to acknowledge the positives. CYP and parents also 
acknowledged the practical changes associated with a T1DM diagnosis. 
 
8.3.3.1 Negative impact  
CYP reported the initial difficulties of diabetes management: 
I mean the thought of injecting was, was really hard. (16 year old CYP) 
CYP mentioned that certain things had to change as a result of their diagnosis, such as the 
types of food they could eat, being prepared for episodes of hypoglycaemia, being 
organised at school and remembering to check blood sugar levels regularly.  Although CYP 
seemed to adapt well in the early days to the new routine and responsibility their 
diagnosis brought, the regimen of daily injections, checking blood sugars and monitoring 
meals were difficult to accept. 
   
Generally, the effects of trying to manage diabetes and maintain optimum blood sugar 
levels resulted in embarrassing and sometimes distressing experiences for CYP.  This was 
due in part to CYP-reported symptoms associated with hypoglycaemia: feeling “wobbly,” 
“dizziness” and “feeling sick,” but also the experience of severe hypoglycaemia.  As 
hypoglycaemia was often flagged as a problem for CYP, they appeared to be very well 
prepared when it came to treating hypoglycaemia.  In general, CYP reported having access 
to glucose tablets, Lucozade or chocolate to counteract hypoglycaemia.   
 
Although some CYP reported that coping with diabetes was, “Just routine” (14 year old CYP) 
and wanted to try to resume life as normal to make it easier to cope with, others reported 
 188 
 
the difficulties in everyday management of diabetes.  CYP found injections and blood sugar 
testing painful and unpleasant:  
It’s just that it’s not very fun sticking needles in yourself. (12 year old CYP) 
Not surprisingly then, day to day management of diabetes was often flagged as a negative 
experience by CYP. 
 
Mothers were aware that a diabetes diagnosis was the beginning of a lot of changes to the 
way to life as they knew it: 
Because we’d always been quite relaxed about eating, what they wanted when they 
wanted.  To then, not to do, we never had a regimen with our lifestyle at all. That was 
quite hard. (Mother of 17 year old) 
So, in addition to adjusting to the diagnosis mothers reported struggling to help manage 
their child’s diabetes.  The impact of diabetes was not just on care for their child, but 
everyday tasks such as shopping, cooking meals; essentially most aspects of their lives. 
 
Mothers reported the impact their child’s diabetes had on their marital relationships.  
Mothers often being the primary caregiver had a lot of responsibility and pressure placed 
on them.  It is hardly surprising that there might be some disagreements in how best to 
manage CYPs’ diagnosis: 
I suppose it put pressure on our marriage for a while… there were slight differences where 
I was happy to let her go to birthday parties and sleepover and my husband was ‘oh no, 
no, no, no.’ (Mother of 12 year old) 
The constant management of their child’s diabetes did seem to put additional pressures 
on parents’ marriages.  Parents expectedly had disagreements about the best way to 
manage the diabetes and about how much independence to afford their child.   
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In addition to the more frightening aspects of managing diabetes, there were also reports 
of CYP feeling self-conscious as a result of their diagnosis: 
He’s shy to do his injections in from of people so he always finds another room wherever 
we are. (Mother of 15 year old) 
However, as CYP tended to be quite young at point of diagnosis (primary school age) this 
meant that the diagnosis was perhaps more visible to others, because their age meant 
that adult caregivers often had to take some responsibility for their diabetes care.  Many 
CYP then reported that in the early days/years, their diabetes was not a secret and friends 
and family were all aware of the condition and what it meant for the child.   
 
The reports of impact on school and learning were mixed.  Some mothers reported that 
there was minimal impact of diabetes on learning.  Others suggested that there was an 
impact: 
I think it did affect her in primary school I think there are chunks of learning that she’s not 
got. (Mother of 11 year old) 
Clearly some parents did feel there was a negative impact of diabetes on learning, 
whether that was due to living with diabetes itself or due to poor attendance at school. 
 
Mothers hoped that their care and support of their child’s diabetes management meant 
that CYP would see diabetes as being part of everyday life.  Depending on the age of the 
child it seems that at some point the daily management of diabetes wasn’t constantly seen 
as a negative, rather a way of life.  However, the period of adolescence often resulted in a 
shift in diabetes experience, whether that be the social impact or the impact puberty had 
on managing blood glucose levels.  Mothers had to deal with these changes and help CYP 
accept their condition again.   
But first probably, six months, she didn’t inject herself at school. We had all sorts of 
problems. I was just keeping on at her.  We made an appointment at the hospital and I said 
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right, and I said right, we’re going to tell the doctor.  And I sent Tina [diabetes nurse] up 
and Tina came and basically sort of said, ‘you’ve got to sort it out.’ (Mother of 12 year old) 
This mother reported that her daughter’s transition to high school resulted in a shift in 
diabetes management.  Her daughter, who previously had been very open about her 
condition, now felt self-conscious and didn’t want her peers to know about her diabetes.  
Clinically this could have had serious implications for her health.  
 
For mothers, there were obvious anxieties about their child’s future, living with diabetes.  
Mothers’ concerns related to the long-term impact of suboptimal diabetes care, on their 
child’s health in the future: 
It’s if you don’t look after yourself and do it all properly and you know as a parent I, I dread 
the future really. (Mother of 14 year old) 
In order to manage their child’s diabetes, mothers had to control blood sugars enough so 
that CYP were not constantly experiencing hypoglycaemia, but also so that their blood 
sugars didn’t run too high for fear of the consequences.  It was a real balancing act: 
So learning about the implications on her healthcare now having on her body in later life as 
far as, you know, her internal organs and her eyesight and you know all of those things was 
hideously scary to know that you are responsible for practic- that she in 20 years’ time 
could turn around and just say ‘well the pair of you didn’t do a very good job did you.’ 
(Mother of 12 year old) 
This highlights the anxiety mothers felt for the future health of their children and the 
responsibility they carried.  No doubt this kind of constant worry is likely to impact on 
maternal well-being and illustrates how mothers not only worried about the present 
impact of diabetes but also what it meant for their child in the future.  
 
A couple of mothers had real life experience of the risk diabetes posed to their child, both 
in the short and long-term: 
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I had a friend, growing up, who completely abused his diabetes and went blind so that was 
a, that was a thought…and also my sister-in-law umm at 19, her daughter died, of a 
diabetic coma. (Mother of 16 year old) 
Having had such negative first hand experiences of diabetes seemed to add to the worry 
that this mother felt for her daughter.  This mother expressed her worry at her daughter 
getting older and becoming more independent and being responsible for making critical 
decisions, such as drinking alcohol.   
 
A number of mothers reported feeling worried about their child’s increasing independence 
and were aware that they, themselves, needed to trust their child to be able to manage 
their own condition.   Mothers made more references to their worries about their 
children’s diabetes than children and young people did themselves.  Many fears and 
anxieties reflected separation anxiety mothers felt being away from their children and the 
lack of control they had over their child’s diabetes management.  They especially worried 
about how their child would cope with hypoglycaemia without a parent present: 
You know when she’s off out with her friends, even when she’s at school, you know I’m 
still kind of a little bit on alert. (Mother of 12 year old) 
There was also worry about the impact diabetes might have on other aspects of the young 
person’s life, for example at school or later in life: 
Yes something I think of all the time.  How he’ll manage when he leaves home. (Mother of 
15 year old) 
Mothers worried about the reduced control they had as their children moved from 
primary to secondary school, college, university and beyond.  This meant that having 
accepted their child’s diagnosis and being in a position to feel confident in their own and in 
their child’s abilities to manage diabetes (to an extent) now mothers were again 
experiencing anxiety and doubts about their child’s ability to manage their condition 
completely independently.   
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The negative impact of diabetes on day to day life revolved mainly around diabetes 
management, from the tasks associated with diabetes care to feeling self-conscious about 
carrying out self-care behaviours.  Mothers also reported the impact diabetes had on 
otherwise normal day to day tasks, such as shopping and cooking for CYP and their 
families.  They discussed the impact on their marital relationships and spoke about their 
worries about the future. 
 
8.3.3.2 Positive impact 
In spite of such a life changing diagnosis there were some positive responses.  CYP and 
mothers reported that CYP felt special as they were given special attention as a result of 
their diagnosis, which in some ways, at times, helped to compensate for the fact that they 
now had to live with this chronic illness: 
Well when she was first diagnosed it was umm she didn’t mind it was almost like star 
status at school because she was having this extra sort of care. (Mother of 14 year old) 
Mothers acknowledged the extra care that they and others gave to their child after a 
diagnosis of T1DM, which seemed to help accept the diagnosis; that their child would at 
least receive special attention and care. There was also a sense of relief from mothers that 
the diagnosis was treatable and that things could be worse: 
Also I’m relieved it’s something that can be treated because there are so many horrible 
things when you get down you have to sort of think thank goodness it is that and nothing 
worse. (Mother of 14 year old) 
This mother had the view that she and her child should count themselves lucky, although 
the diagnosis was initially seen as a negative she tried to see the positive side of things.  
This could be a seen as a move to acceptance of the diagnosis.   
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Other instances of special attention at home and at school included being allowed to treat 
hypoglycaemia with sugar, “I can have sweeties” (7 year old CYP) and at school being able to, 
“get out of lessons when you’re ill” (12 year old CYP).  It should be noted here that positive 
experiences in the short-term were reported by younger children, older CYP tended to 
report on more of the negatives or else were reported diabetes as neither positive nor 
negative, but just something that they had to live with. 
 
Some mothers reported relief that there seemed to be an explanation for particular 
behaviours and phases that children had gone through such as bed wetting and mood 
changes.  Thinking about the diabetes diagnosis differently helped to almost bring a sense 
of acceptance following the initial distress and anxiety.   
 
Another positive reflection made by CYP was that they felt that having the T1DM diagnosis 
made them more aware of the lifestyle choices they made: 
I kind of like it, because I don’t eat all the sugary stuff which makes me fat and I don’t eat 
chocolate which has sugar in it. (8 year old CYP) 
In some cases the diagnosis seemed to motivate CYP to be healthier which in turn helped 
them to feel better about living with diabetes. 
 
Some mothers were full of praise for their children’s coping skills: 
He never cried for an injection.  He never cried when we tested him.  Not once has he 
ever!  And I think that made it a lot more easier.  Yes it’s a blessing really.  He’s been 
brilliant. (Mother of 15 year old, son diagnosed at age 3) 
They were proud of their children’s ability to adjust, manage and cope with their illness as 
well as all the responsibility it brought, for their child.   
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One parent also reported how the family benefitted on a trip to Disneyland:  
In Disneyland we got fast passes, that was brilliant so 'yay' so it's the one thing that's 
beneficial.  That was good so we all appreciated that. (Mother of 16 year old) 
So despite the many difficulties and constant pressure of living with diabetes, mothers 
(and CYP) did try to see the positives where they could, which might have helped them to 
accept that T1DM was now a part of all of their lives.   
 
8.3.3.3 Practical changes  
Mothers spoke about their practical reactions to diagnosis: 
We [parents] went to Sainsbury’s we were in there for two hours reading absolutely 
everything [both laugh] because you’re looking for sugar content within that and keeping it 
within certain, you know the, the percentages of everything you’re looking at. (Mother of 
12 year old) 
Mothers reported receiving copious amounts of information at diagnosis which they felt 
was overwhelming and also signalled the changes to the way that families would now have 
to function in order to manage their child’s diabetes.  Mothers’ initial responses seemed to 
be a reflection of their lack of knowledge and understanding about living with diabetes. 
 
As CYP had been diagnosed at quite a young age, they were able to adapt and accept the 
new demands of having diabetes.  They ‘never knew any different’ (mother of 15 year old) and 
so were better able to deal with the practical changes to daily life.    Nevertheless, mothers 
reported initially trying to help CYP accept their diabetes and focus on managing their 
condition, rather than dwelling on the negatives: 
You just need to accept it and, and get on so that was our attitude and it seems to have 
worked.  And we made a big point immediately as well of having her do everything 
publicly… we didn’t ever want it to be something that caused embarrassment or shame. 
(Mother of 12 year old) 
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Mothers hoped that by encouraging their child to be open about their diabetes would help 
them to accept their diagnosis and feel comfortable and confident managing their 
condition.  For some families, especially in the first few years, this way of thinking 
continued once diabetes had been established and was reported as a positive coping 
strategy. 
 
In order to manage the burden of T1DM mothers had to feel confident that their CYP knew 
how and were able to treat an episode of hypoglycaemia:  
If he’s low he knows he needs to go and get Lucozade and a biscuit and he, he near enough 
does it all himself. (Mother of 7 year old) 
This gave mothers the assurance that their child could manage their diabetes, and perhaps 
took some of the responsibility and burden away from themselves.  This is a key 
development from the time of diagnosis to a point where mothers had adjusted to their 
child living with diabetes. School staff were generally reported to know how to 
treat/recognise hypoglycaemia which again helped mothers to feel able to let go a little in 
terms of their child’s diabetes management. 
 
Siblings often were given extra responsibilities and had to help with household chores and 
do more than their share if CYP had an episode of hypoglycaemia or if CYP had to have 
their injections.  In the main, however, mothers reported that siblings did look out for 
their siblings and contributed to managing CYP diabetes: 
In the beginning we relied on the boys a lot more to look out for signs, whether we were in 
or out.  You can’t constantly be in the same room.  He’s got to play with his friends, he’s 
got to play with his brothers.  You got to let go. They’ve had a huge role. (Mother of 15 
year old) 
The impact of diabetes and changes to family life were evident in the role siblings took, 
who provided an extra source of support for parents and CYP.  Day to day support in 
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diabetes management seemed necessary in order to manage the demands of the 
condition. 
 
Considering the impact of hypoglycaemia it is not surprising that there were some reports 
of avoiding hypoglycaemia.  Mothers made it clear that this avoidance was not to make life 
in the short term easier but more for peace of mind if CYP were going to be away from 
parents overnight, for example (for practical reasons): 
I’d rather him be a little bit higher than a little bit lower just because it’s somebody else’s 
house. (Mother of 7 year old) 
Maintaining higher than optimum blood sugar levels allowed mothers to give their child 
the freedom they might have ordinarily not had to think twice about.  In the main, 
however, mothers did not engage in hypoglycaemia-avoidance behaviours to avoid low 
blood sugar.  Mothers were determined to help CYP manage their diabetes the best they 
could. 
 
Mothers made references to the way in which diabetes affected leisure time/activities for 
CYP but in the main they were about adjustments CYP had to make rather than missing 
out as such: 
For [child] it’s that she can’t just go out for the day with her friends and not have to plan it 
in advance. (Mother of 12 year old) 
This was a promising outcome in terms of the impact diabetes had on CYP’s leisure time.   
 
CYP reported that in time, management of diabetes became routine: 
Well it’s kind of normal for me now, like I don’t know any different. (16 year old CYP) 
 197 
 
This report came from a 16 year old girl who had lived with diabetes all her life (from 18 
months old) who had experienced feeling frustrated about her condition during early 
adolescence but had now come to accept it again.  This is encouraging and reflects the fact 
that managing diabetes over time does get easier.  There were also positive and hopeful 
comments about diabetes management: 
We thought that it [the pump] would give best control of blood sugars, I suppose so 
diabetes didn’t control me.  (15 year old CYP) 
CYP wanted to be in control of their condition, to feel that they had a grasp on their illness.  
They were optimistic that they were at a point where they felt in control of their diabetes 
and could manage it in a way that did not impact on day to day life as much as it might 
have previously. 
 
The practical impact and changes T1DM brought were evident for CYP, mothers and their 
families.  CYP had to adjust to the daily regimen of diabetes care and had to be vigilant 
with regards to treating hypoglycaemia and being prepared for such a situation every time 
they left the house.  This was reflected by mothers’ reports too which described the 
practicalities of giving their child the freedom to do the things that other children their age 
were able to do, such as leisure activities and sleepovers.   
 
8.3.3.4 Summary of ‘Living with diabetes’ theme 
This theme highlighted the numerous examples of the negative impact of diabetes.  This 
included injecting insulin, experiencing hypoglycaemia and the change in lifestyle.  Impact 
was also discussed with regards to the effect diabetes had on school and learning, moving 
towards independence (CYP) and marital relationship (mothers).  Mothers also spoke at 
some length, about the future impact of diabetes on their child’s health and worried about 
relinquishing the responsibility they had for their child’s care, as their child became more 
independent. 
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There were some references to the positive impact of a diabetes diagnosis.  CYP and 
parents spoke about the special care and attention they/their child received as a result of 
the diagnosis.  CYP also mentioned the positive impact that diabetes had on the lifestyle 
choices they made. 
 
The practical changes had a noticeable impact on CYP and their mothers.  CYP and their 
mothers had to adjust to the daily management of T1DM and ensure that they were 
prepared to treat episodes of hypoglycaemia.  Over time, these changes became a way of 
life and both CYP and parents seemed to accept this. 
 
8.4 Summary of Chapter 8 
Thematic analysis of interviews carried out with CYP and their mothers illustrates the 
experience of living with diabetes and the emotions and pressure associated with this.  
Not surprisingly, a diabetes diagnosis was met by fear, uncertainty and worry in both 
mothers and CYP.  Mothers felt the added pressure and burden of helping their child to 
adjust to the diagnosis as well as taking charge of diabetes management, at least in the 
early days, if not beyond.  Mothers reported more distress regarding their child’s diagnosis 
than children did themselves.  CYP burden was highlighted in interviews and emphasises 
the difficulties they faced as a result of their diabetes.  CYP guilt also emerged as an impact 
of diabetes management, which had not been explored previously. 
 
Hypoglycaemia and severe hypoglycaemia were reported as the most negative aspect of 
having diabetes.  The symptoms of hypoglycaemia made CYP feel unwell, however, severe 
hypoglycaemia was often extremely frightening for CYP and mothers.  There were reports 
of events that led to emergency treatment.  Mothers exhibited much worry about their 
child having an episode of severe hypoglycaemia and were especially fearful of their child 
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experiencing nocturnal hypoglycaemia.  As a result, many mothers reported night time BG 
monitoring which also reflected the constant management of their child’s condition.  The 
reported impact on mothers’ lives then seemed to be as great if not greater than impact 
on CYP. 
 
Long-term effects of diabetes were also a source of worry for mothers.  They worried 
about future complications and grieved for their child’s shortened lifespan.  Mothers also 
reported the added burden of trying to manage their child’s blood sugars at the optimum 
levels to prevent long term health problems but also to try to control hypoglycaemia. 
 
Impact of diabetes was evident in multiple areas, from marital relationships and family life 
to leisure time and school.  Promisingly, the impact of diabetes seemed to be controlled by 
adjustments to insulin and regular routines and being prepared.  The main impact seemed 
to be on making preparations when going out or before exams, for example, which might 
not have been necessary if CYP were not diabetic.  Throughout the interviews however, it 
is obvious that diabetes has a genuine impact on the quality of life of both CYP and 
mothers considering the reports of fear, worry and pressure. 
 
Mothers described the practical changes they had to make to accommodate the diabetes 
diagnosis.  CYP spoke about the daily demands of diabetes management from injections to 
monitoring blood sugar levels.  The majority of mothers and CYP said that eventually they 
managed to get into a routine so that diabetes management just became part of life.  
 
The interviews gave a richer and deeper insight into life with diabetes.  This allowed 
further understanding of the similarities and differences in CYP and mothers’ experience 
of living with diabetes and the kind of impact this has on their lives.       
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Chapter 9: Discussion (Qualitative phase) 
Qualitative research allows a deeper understanding of health-related topics which 
otherwise might not be so accessible when using structured questionnaires.  Qualitative 
data also allow researchers to delve further into the experiences of participants in order to 
get a richer insight into their emotions, experiences and stories.  
 
For the current study, results of the qualitative analysis add to the small body of research 
(65, 104, 120, 123, 124) carried out with CYP (not just adolescents) with T1DM and their 
families.  This phase also allowed the researcher to gain further understanding of the 
findings that emerged from the quantitative analyses.  The interviews and subsequent 
analysis addressed one of the key aims of this study; to collect data on the impact of 
episodes of hypoglycaemia.  They also allowed further understanding of living with 
diabetes and the impact that that has on CYP and their mothers.   
 
Thematic analyses conducted on the interview data with both CYP and their mothers (no 
fathers consented to take part in this phase of the study) led to the emergence of two 
main themes: negative emotions and living with diabetes.  Sub-themes were also apparent 
for each of these themes after further analysis of the interview transcripts.  Negative 
emotions were described with reference to ‘feelings about T1DM’ and ‘fear of 
hypoglycaemia.’  Living with diabetes was made up of three sub-themes: ‘negative 
impact,’ ‘positive impact’ and ‘practical changes.’   ‘Burden’ was identified as an over-
arching theme and was evident in each of the interviews with CYP and their mothers.  
Mothers and CYP discussed the impact of diabetes on their lives with reference to the 
constant management and responsibility of the necessary daily care. 
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9.1 Burden 
Type 1 diabetes mellitus places much pressure and responsibility on CYP to manage their 
condition but more so on mothers of these children and young people.  Several subthemes 
emerged within the overarching theme of ‘Burden;’ exploring the negative emotions 
associated with diabetes and the impact of living with diabetes. Mothers took 
responsibility for helping their children firstly accept their diabetes diagnosis, learn how to 
manage their condition and also took responsibility for supporting that management to 
varying degrees throughout CYPs’ lives.  Mothers expressed the burden they felt, of the 
worry of the long term health implications resulting from diabetes which lead to 
considerable anguish and fear for their child’s future.  
 
Worry, anxiety and feelings of burden were some of the key topics that emerged regarding 
living with diabetes. Interviews illustrated the ways in which diabetes impacted on CYP 
and mothers’ lives, and potentially their quality of life too (105, 167).  This supports the 
findings of the quantitative analysis which identified links between anxiety, fear of 
hypoglycaemia and quality of life.  The qualitative data allow further understanding of the 
ways in which anxiety presents itself and the impact that it has on CYP and mothers.  CYPs’ 
and mothers’ accounts of the impact that hypoglycaemia, diabetes management and 
thoughts about the future can have, help to explain why there is a prevalence of fear and 
anxiety and also how that might impact on the quality of life in these individuals.  Both 
CYPs’ and mothers’ accounts of living with diabetes suggested that diabetes is a burden 
(101, 122, 124, 125).   
 
9.2 Negative emotions  
Discussions about T1DM evoked negative emotions in both CYP and their mothers.  The 
way in which this group spoke about their experience of diabetes is particularly poignant, 
especially in terms of mothers’ reports.  Although the CYP did demonstrate distress and 
worry about living with diabetes and also indicated anxieties concerned with fear of 
hypoglycaemia, mothers seemed to experience these emotions to a greater extent. 
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In the days and months following diagnosis especially, mothers went through a period 
similar to bereavement and expressed feelings of grief in response to their child’s 
diagnosis.  This goes some way in showing the magnitude of the impact this diagnosis had 
on mothers.  In their qualitative study of living with diabetes, Marshall et al. (124) found 
that parents especially, spoke about ‘loss’ in terms of their child’s diagnosis.  They also 
reported that parents went through a grieving process in response to the diagnosis.  These 
reports, in addition to maternal reports for the current study, show how deeply parents 
are affected by T1DM in their child, from the point of diagnosis.  This seems to be more 
evident in parents than it does in CYP themselves.  Bowes et al. (105) also support the idea 
that parents of CYP diagnosed with T1DM go through a period of grief.  They go further by 
suggesting that these parents experience ‘chronic sorrow’ (181) which reflects the 
ongoing, although not constant, sadness felt by parents when their child is diagnosed with 
a lifelong condition.  Certain triggers can cause a resurgence of these feelings of grief such 
as an episode of severe hypoglycaemia or recollection of previous events such as 
diagnosis.  Indeed mothers interviewed for the current study showed instances of distress 
when talking about their child’s diagnosis.  These reports are vital in understanding the 
huge impact that caring for a child with a lifelong condition can have.    
 
Distress, fear and worry were the initial key emotions experienced by CYP and their 
mothers at diagnosis.  This is similar to other qualitative studies exploring living with 
diabetes within similar groups.  Spencer et al. (123) conducted interviews with adolescents 
and parents in order to discover more about their experiences of diabetes.  As with the 
current study, they found distress and worry to be part of the initial experience of 
diabetes.  Researchers reported that mothers often had a better recollection of events 
around diagnosis and that many did not attribute the symptoms their child was 
experiencing to T1DM.  The worry and anxiety experienced by CYP and their mothers was 
obvious from the point of diagnosis to present day, albeit varying in nature.  The CYP who 
were old enough to remember reported that initial diagnosis was distressing and they 
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worried about the implications of diabetes.  Similarly mothers also reported feelings of 
upset, worry and sorrow that this was happening to their child (104, 124), possibly to a 
greater extent than children felt, although this may reflect reporting differences.   
 
Whilst coming to terms with their child’s diagnosis, mothers, simultaneously, tried to 
support their children by keeping life as normal as possible and incorporating diabetes 
care, as well as they could, into everyday life.  Privately though, mothers struggled to 
accept the diagnosis that their child had been given.  Although the impact of diagnosis was 
difficult for CYP, it seemed to have a profound effect on mothers’ lives.  The diabetes care 
was constant, often with no break.  Although the majority of mothers benefitted from 
support from fathers of the CYP, mothers bore most of the burden.  Smaldone et al. (125) 
found that parents of CYP diagnosed at an early age felt completely overwhelmed at 
diagnosis.  They worried that they would not be able to provide the care that their child 
needed. Feeling overwhelmed was also reflected in the accounts of parents interviewed by 
Spencer et al. (123).  Their study investigated the experiences of adolescents with T1DM 
and their parents. Parents felt that they had a lot of responsibility to bear and again this 
was reflected in the current study by mothers. 
 
Mothers reported feeling the pressure of having to care for a child with diabetes.  This is a 
common finding as reported in Sullivan-Bolyai et al.’s (101) paper on constant vigilance.  
They found that mothers of CYP with T1DM expressed the constant care they had to 
provide their child in managing diabetes. This included day to day responsibilities, 
managing hypoglycaemia and worrying about future complications.  The current study also 
highlighted that the care that mothers provided was constant and often there was little 
respite.  As mentioned previously, mothers even continued to provide care throughout the 
night and this is reflected in previous research (65, 128).  It is likely that this type of 
responsibility and never-ending care could result in negative health outcomes for mothers 
of children with T1DM.  Although, like other reports, mothers in this study benefited from 
spousal support (101, 125) other mothers spoke of the pressure it put on marital 
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relationships often due to disagreements about diabetes management.  Smaldone et al.’s 
(125) study reflects both of these findings.  They found that fathers could be a source of 
great support for mothers, if they were able to work as a team.  When this was not 
possible, however, the pressure of their child’s condition had a negative impact on their 
relationship with one another. 
 
Guilt was evidently experienced by mothers and to a lesser extent, though not less 
significantly, by CYP.  Mothers’ distress was exacerbated by their guilt at not noticing the 
symptoms of T1DM pre-diagnosis, often leading to a distressing series of events before 
diagnosis.  Their guilt also resulted from worry that they were somehow to blame for their 
child’s condition.  For example one mother felt that perhaps the diagnosis was due to her 
having her daughter later in life.  This feeling of guilt was not uncommon.  Mothers taking 
part in Spencer et al.’s study (123) also reported factors linked to pregnancy such as diet 
and pre-eclampsia, as possible reasons that their child had developed diabetes.  These 
mothers blamed themselves and in doing so demonstrated that they took responsibility 
for their child’s illness, adding further to the burden they experienced.   
 
It was affecting to note the guilt that one child expressed about the impact she felt that 
her diabetes had on her family.  Her revelations seemed to reflect thoughts about her 
condition that she perhaps had not discussed before as her mother made no reference to 
this in her interview (which was conducted separately from her daughter).  CYP guilt in this 
study seems to be a unique finding.  This child felt guilty that her family could not enjoy 
themselves when they all went out for a meal because they would be worrying about her.  
This finding may be important in understanding the way in which diabetes can impact on 
CYPs’ psychological outcomes such as well-being and quality of life.  Further exploration is 
needed. 
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As CYP approached adolescence, even for those who had lived with T1DM since they were 
toddlers, the diagnosis seemed to become a source of embarrassment.  CYP were 
reluctant for their condition to be revealed and were selective in who they disclosed this 
information to.  To keep a large part of themselves hidden from others is likely to have 
been difficult and burdensome.  This again demonstrates the negative emotions 
associated with T1DM.  A review of qualitative studies in adolescents with T1DM (120) 
highlighted the move towards adolescence, for some CYP, becoming a barrier to self-
management.  As highlighted in the current study, some CYP seemed to struggle with 
diabetes during adolescence as it was usually a time when many changes were taking 
place, such as moving to secondary school where inevitably new friendships would be 
formed.  Whereas, it is likely that many friends and teachers would have been aware of 
CYPs’ diabetes in primary school (where perhaps teachers may have had some 
responsibility for supporting diabetes care) secondary school provided a new start 
therefore, CYP may not have been comfortable about revealing the condition they were 
living with.  One mother in Spencer et al.’s (123) study revealed that her son avoided 
certain social situations if they clashed with his diabetes care, although he did not tell his 
friends that this was the reason and seemed to hide the fact from them. However, other 
reports from the same paper suggest that friends can play an important role in supporting 
CYP with their diabetes management.  This was also reflected in the current research 
study.  Clinicians should be aware of the changes in motivation and self-care that the 
period of adolescence may bring in order to ensure CYP are managing their condition 
optimally. 
 
Considering the burden and responsibility placed on mothers of CYP with T1DM, there was 
a distinct lack of psychological support offered to mothers.  Mothers in the current study 
were surprised by the lack of psychological/emotional support for carers, considering that 
having a child with diabetes was overwhelming.  Although other types of support were 
available (support groups), albeit to varying degrees, mothers felt that specific 
psychological support would have been beneficial to help them to cope with the daily 
demands of diabetes care.  Bowes et al. (105) reported a genuine need for psychological 
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support as expressed by parents of CYP with T1DM.  They felt that as parents, they were 
often overlooked and perceived to be coping when in fact they were struggling.  There 
were differences regarding when parents felt psychological support would be most 
appropriate, varying from at the time of diagnosis, a later time point and also the 
suggestions that support should be ongoing.  Future studies may benefit from exploring 
the most effective method of delivering such support.  Parents in Rankin et al.’s (128) 
study also conveyed the need for psychological support.  They felt that although clinical 
staff empathised with their situation they did not fully understand the impact it had.  
These parents also worried that if they voiced their true feelings then the doctors and 
nurses might judge them negatively and perhaps assume that they were not coping.  The 
current study, as supported by previous findings, supports the need for psychological 
support for mothers of CYP T1DM in order to better help them cope with the daily burden 
and stresses. 
 
Fear of hypoglycaemia was identified as a subtheme due to CYPs’ and mothers’ associated 
worries.  Hypoglycaemia and severe hypoglycaemia were reported as amongst the most 
negative experiences of living with diabetes by the majority of CYP and mothers 
interviewed.  Although prevalence of hypoglycaemia cannot be inferred from the small 
sample, these reports do indicate that hypoglycaemia and severe hypoglycaemia are a 
problem for this group.  This supports findings of the quantitative phase of this study 
which also highlighted that hypoglycaemia was an issue for CYP and their parents.  
Mothers tended to report the most distress regarding severe hypoglycaemia because they 
had witnessed these frightening events, and their accounts indicated that their memories 
of the events were vivid and evoked emotions such as sadness and distress.  CYP reports of 
fear of hypoglycaemia were mainly related to nocturnal hypoglycaemia with one report of 
avoiding night-time hypoglycaemia by missing insulin injections.  This shows that some CYP 
were more concerned with the more immediate impact of severe hypoglycaemia than the 
long-term problems that chronic hyperglycaemia might lead to. 
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Both mothers and CYP reported anxieties about hypoglycaemia, severe hypoglycaemia and 
nocturnal hypoglycaemia (65, 120, 123, 128).  Mothers were equally, if not more, 
concerned about nocturnal hypoglycaemia.  Although they did not report avoiding 
hypoglycaemia by maintaining higher blood glucose levels, possibly due to anxiety 
regarding future health complications, there were many reports of night-time monitoring 
of CYPs’ blood glucose levels.  Using Interpretative Phenomenological Analysis, Scott (65) 
reported that mothers described the constant worry that they felt in terms of 
hypoglycaemia.  Mothers were worried for their children day and night and feared that 
they might find their child unconscious.  Mothers in the current study similarly reported a 
fear of nocturnal hypoglycaemia and reported diabetes fear-related behaviours such as 
checking their child’s blood sugar levels throughout the night.  Rankin et al.’s (128) study 
also found that parents of children with T1DM struggled to sleep amid fears that they 
would have an episode of hypoglycaemia during the night, although most reports reflected 
that this was most common in the early days after diagnosis.  The current study however, 
highlighted how such practices may continue for years after diagnosis with one parent still 
checking their child’s night-time blood glucose levels 16 years later.  
 
These reports add to research which is focussed on the worries and fears associated with 
hypoglycaemia.  Interestingly, CYPs’ fears of nocturnal hypoglycaemia do not seem to have 
been reported in the majority of previous studies.  For parents, however, this topic is 
evident time and time again.   These data also reflect the higher maternal fear of 
hypoglycaemia levels reported in the quantitative analysis, reinforcing the idea that 
mothers’ anxieties and fear of hypoglycaemia for their child are often greater than their 
child experiences themselves.  These findings have clinical implications for the 
management of psychosocial factors in mothers.    
 
9.3 Living with diabetes 
This theme explored how living with diabetes impacted on the lives of CYP and their 
mothers, in terms of the negative impact, positive impact and practical changes. 
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The negative impact, as with the negative emotions discussed earlier, was great.  CYP 
struggled with the diabetes regimen, especially the daily injections required to manage 
their blood glucose levels.  Many of the CYPs’ worries were related to diabetes 
management, namely, injections and blood glucose testing (and hypoglycaemia, as 
previously mentioned).  CYPs’ worries ranged from worry about the pain of diabetes 
management, to worry about peer reactions, especially as they got older and approached 
adolescence (as discussed earlier in this chapter) (120, 126).  Some CYP experienced 
periods of wishing that they did not have diabetes and described wanting a break from the 
daily diabetes management.  Wennick et al. (122) reported the difficulties some CYP had 
managing the daily regimen; eating properly, taking insulin and always being prepared.  
This responsibility was often difficult for CYP whose peers did not have the same amount 
of duty placed on them.   
 
Mothers illustrated that diabetes not only contributed to the pressure they felt as care-
givers, but also added to the difficulties in carrying out daily tasks, such as shopping and 
cooking. The pressure of looking after a child with T1DM also had a detrimental effect on 
some marital relationships, which added to maternal struggles.  
 
Anxiety and worry about the future were again mainly reported by mothers.  The 
responsibility they felt around their child’s care was reflected in their anxieties about long-
term diabetes complications.  Parents in Ivey et al.’s (121) study communicated the fear 
they had of future complications if they did not support their child with their diabetes 
care.  Mothers in the current study also worried that if they did not manage their child’s 
diabetes properly now then their child might develop additional health problems later on.  
This was again common across previous research, for both mothers and fathers.  Bowes et 
al. (105) reported that parents worried about the future implications of diabetes.  It was 
something that parents were concerned about and was upsetting.  Similarly, Spencer et al. 
 209 
 
(123) reported the fear of future health complications which made it difficult for one 
mother to give up the responsibility she had taken on for the management of her son’s 
diabetes.  These interviews highlighted why mothers experienced so much worry and 
anxiety in relation to their child’s diabetes whether their child was recently diagnosed or 
whether they had lived with diabetes over a number of years.  Day to day, the anxieties 
revolved around diabetes care and management but there were also worries about what 
the future might bring. 
 
Not surprisingly, given the numerous references to the negative implications of diabetes, 
there were very few reports on the positive impact of diabetes from CYP and mothers.  
CYP reported the ‘star status’ they experienced as a result of their diagnosis, citing the 
special attention they received. There was also mention of the diabetes regimen leading to 
CYP making healthy choices, which they thought was a good thing.    
 
Mothers were thankful that diabetes was treatable and tried to see the positive in that.  
However, in essence, CYP and mothers struggled to identify the positive impact diabetes 
had on their lives, which supports the idea that living with diabetes is a struggle for CYP 
and their mothers. 
 
The practical challenges of living with diabetes were initially described as overwhelming, 
however, promisingly, both CYP and mothers reported that the practical changes became 
routine over time and so the impact was less significant than it had previously been.      
 
9.4 Challenges in this research 
There were some limitations identified with conducting qualitative research, especially 
with CYP.  To ensure that younger children felt confident and understood what they were 
being asked to do, pictures and gestures were used within the information sheet 
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(Appendix 27). Interviews with CYP may not always be productive and elicit as much 
information as required.  CYP might not feel confident in giving their views fully, and this is 
often due to the issue of power and dynamics of an adult/child interview setting (132, 
133). There was potentially some experience of this with one particular interview with a 
14 year old lasting only 8 minutes, 46 seconds.  However, the researcher appreciated that 
this CYP had taken their time and wanted to give their views, whether or not they were 
able to articulate those views fully.  For this particular young person, one extract was 
included in the analysis, so even though the interview was short, it still contributed to the 
overall findings.  Although difficult, qualitative research with CYP can help researchers to 
understand the stories of these individuals at a more in depth level, which might afford a 
more useful analysis of the data.  
 
In terms of the data, another limiting factor was that fathers did not consent to participate 
in this phase of the study.  There is paucity of qualitative research with fathers of CYP with 
T1DM and it would have been interesting to get a more in depth view of their feelings and 
the impact their child’s condition has on them.  Quantitative data already highlighted that 
fathers have a higher fear of hypoglycaemia than their children have for themselves, so 
this could have been an area for further exploration.  Mothers were, however, able to give 
some indication of how fathers reacted/dealt with their child’s diabetes, so their accounts 
provided some indirect detail of what fathers’ perspectives may be.    
 
With the exception of one mother and son pair (Pakistani), participants in Phase Two were 
white.  Results might not be generalisable as ethnic minorities might have reported 
different experiences of diabetes although, previous qualitative research suggests CYP and 
families with experience of T1DM have similar experiences of living with diabetes despite 
differences in background culture (124). 
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9.5 Implications 
The findings of the qualitative phase allow deeper understanding of the ways in which 
T1DM impacts on both CYP and their mothers.  The data also add to the limited but 
growing amount of qualitative research looking at the impact of diabetes on CYP and their 
mothers.  These data acknowledge the impact that diabetes has.  It is therefore important 
to try to formulate ways to overcome any negative impact of T1DM on CYP and mothers.  
As with the quantitative findings, it seems that worry (anxiety) and fear, as well as burden, 
are key issues and play a big role in living with diabetes.   
 
Acknowledging the pressure on both CYP and mothers is important.  CYP report negative 
feelings associated with daily management of diabetes.  However, it seems that mothers 
often support their children both emotionally and practically.  Therefore, importance 
should be placed on developing supportive/psychological interventions for mothers.  
Mothers in this study have already expressed a need for psychological support.  In 
previous studies there were often worries, however, that asking for this support might 
suggest that they were not able to cope with their child’s illness.  Often this was not the 
case however, psychological support could help mothers cope more effectively and not to 
the detriment of their own mental health and well-being.  It is well documented that 
caring for a child with a chronic illness can often trigger anxiety or depressive symptoms in 
parents (182), therefore, more needs to be done to support these parents.  Clinicians 
should be aware that mothers might be struggling to cope even if they do not admit to it.  
Mothers may be managing their child’s diabetes optimally, however, this does not 
necessarily mean that the constant management is not having a negative effect on these 
mothers.  Mothers would benefit from a non-judgemental, supportive arena where they 
felt comfortable discussing their worries or concerns.  This may or may not be directly 
linked to their child’s diabetes care provider.  Providing techniques to reduce this worry 
might help mothers cope better with diabetes and could potentially impact on well-being 
by helping to manage the stress and anxiety that they experience. 
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As children approach adolescence it is important that clinical staff are aware of the 
negative impact this stage in life might have on diabetes management and should 
incorporate techniques that might alleviate these new found worries, into regular clinic 
appointments.  This could help to manage any difficulties with diabetes care as CYP move 
through new phases of their lives and towards independence.    
 
9.6 Future research 
A key area of future research would be to conduct qualitative research with fathers of CYP 
with T1DM to explore and understand the impact their child’s diabetes has on them.  
Previous research which suggests that fathers might encourage optimal diabetes 
management, in comparison to mothers (87) could be investigated further to identify if 
there are any differences and if so, how and why.  This would also add to the limited 
research with this group. 
 
Further research could also explore CYP guilt.  As discussed, maternal guilt was evident in 
more than one interview transcript.  CYP guilt, however, was a more unique finding and 
could be an area worth exploring further to identify whether it is something that other CYP 
experience.  This would allow further understanding of the impact of diabetes on CYP. 
 
Additionally, whilst many CYP and mothers did not necessarily feel that they would benefit 
from additional help, they did report that psychological support might be useful.  The 
qualitative data indicate that CYP and mothers do struggle with diabetes, both in the 
short-term and in the long-term.  There are reports of guilt, worry, stress, responsibility 
and being different.  The current study highlights the need to address the worry/anxiety 
experienced by CYP and perhaps more so, their mothers. Methods to manage these 
emotions on a daily basis might be beneficial to the well-being of both CYP and their 
mothers.  Therefore, development of a programme of care to address these concerns 
could help to improve the quality of life of these individuals.  
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Mothers could benefit from psychological support to address their anxieties and fears with 
regards their child’s condition.  They might also benefit from incorporating coping 
strategies to help them to deal with the multiple demands placed on them.  Future 
research should look at implementing a pilot counselling service to address mothers’ 
worries and give them a safe forum to talk about their concerns.  This should be a non-
judgemental setting with a trained counsellor or psychologist and can be separate from 
the diabetes service.  A programme of counselling sessions could be offered to 
mothers/parents of children potentially at various time-points from diagnosis and beyond 
in order to judge when the intervention might be most effective.  During these sessions 
researchers could evaluate mothers’ psychological state at the first session and then again 
at the last session to see whether the counselling sessions have helped and whether the 
time of delivery is also a factor in the intervention’s effectiveness.  Results of this study 
could provide evidence to support the provision of psychological support for parents who 
report a need for it. 
   
 As previously mentioned (Chapter 7, section 7.5) using a mobile application to address 
stress and worry, through mindfulness, might be an efficient and effective way of 
addressing some of the difficulties living with diabetes involves, especially as parents/CYP 
expressed more of a need for psychological support compared to the traditional diabetes 
education and support groups.  With parents and their children already burdened with 
hospital appointments, running educational interventions in clinic, in a group setting, 
might not be practical or realistic for CYP or their parents.  With the advent of mindfulness 
(173) to reduce anxiety, and constantly evolving technology, an intervention which 
combines the two might be more appropriate; a mindfulness mobile application aimed 
specifically at CYP with T1DM and their parents.  This type of mobile app would give users 
access to ‘mindful’ exercises and deliver ‘mindful’ and ‘positive’ quotes on a daily basis to 
participants’ mobile phones.  These short exercises and ‘messages’ remind CYP and 
mothers to be attentive to the present and could provide an easily accessible way of 
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practicing the principles of mindfulness without investing a large amount of time.  If 
effective, this could be an accessible, economical and convenient method to manage 
stress and anxiety. 
 
9.7 Summary of Chapter 9 
The qualitative analysis provided a richer set of data regarding living with diabetes for this 
cohort of CYP and mothers.  Thematic analysis reflected findings from the quantitative 
data and allowed further understanding of the issues that impact CYP living with diabetes 
and their families.  This research adds to the limited T1DM qualitative data for CYP and 
mothers and illustrates the experience of living with diabetes and the impact that it can 
have. The key areas linking qualitative with quantitative data were anxiety, fear of 
hypoglycaemia, quality of life and experience of hypoglycaemia.     
 
CYP and their mothers expressed the worry, anxiety, fear and burden of T1DM.  CYPs’ 
motivations to manage their diabetes changed with age and as they approached 
adolescence.  As with the quantitative results, the impact on mothers seemed to be 
greater than the impact on CYP.  Mothers took on much of the responsibility of diabetes 
care for their children in order to manage the burden and pressure for them.  However, 
support for mothers was limited.  Although fathers were reported to help with diabetes 
care, the main caregivers were mothers.  Constant worry about hypoglycaemia (severe 
and nocturnal) and worries about future implications of diabetes on their child’s health 
had a genuine impact on mothers.  There was also evidence of chronic sorrow in their 
reports of living with diabetes. 
 
The implications of these results suggest that clinical staff should be aware of the 
psychological impact diabetes can have on their paediatric patients and parents.  As CYP 
move towards adolescence, clinicians should be aware of possible changes in diabetes 
management.  Clinical staff also need to mindful of how mothers are coping with the daily 
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demands of managing their child’s diabetes.  Optimal management might not be an 
indicator that a parent is coping well.  Therefore, targeted psychological support for 
mothers should be offered in order to help them to manage and cope in their role as 
caregivers.  
 
Recommendations for future research relate to providing additional support to help CYP 
and mothers cope with living with diabetes.  This could be either be via a structured 
programme of psychological support or a more convenient, accessible way of managing 
stress.   
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10. Conclusions  
Research regarding the prevalence of hypoglycaemia and the fear of hypoglycaemia is 
relatively limited, especially for paediatric cohorts in the UK.  This study aimed to address 
this by collecting quantitative data in relation to the prevalence of hypoglycaemia, severe 
hypoglycaemia, hypoglycaemia unawareness and fear of hypoglycaemia amongst children, 
young people and their parents attending paediatric diabetes clinics in the West Midlands, 
UK.  The relationship between the aforementioned variables and psychosocial variables, 
such as anxiety, quality of life and self–care was also of interest to the researcher.  This 
study also aimed to explore the impact that living with diabetes had on this cohort by 
conducting semi-structured interviews. 
 
To conclude, this study reports some interesting and important findings.  The prevalence 
of hypoglycaemia, severe hypoglycaemia and fear of hypoglycaemia are all evident in this 
UK paediatric cohort and their parents.  Parental FoH was reported to be higher than the 
FoH CYP had for themselves.  This does not appear to have been reported in FoH studies, 
previously.  The qualitative data further supports higher reports of fear in parents, with 
mothers reporting a fear of nocturnal hypoglycaemia and admitting to monitoring their 
child’s blood glucose levels throughout the night.  These findings introduce more 
questions about the impact that T1DM has on parents of CYP.  Although this impact has 
been identified in past research, the current study recognises that parents may benefit 
from additional support to help them to cope with and support their children with 
managing their diabetes.  The current study also adds to the growing literature on FoH in 
CYP and parents. 
 
The links between FoH and anxiety illustrate the worry that many CYP and parents 
experience in relation to diabetes management.  This link could potentially be explained 
by the fact that the HFS Worry subscale is simply another measure of anxiety, with a 
diabetes slant.  Nevertheless, it seems that those individuals with a tendency to worry also 
exhibit higher FoH.  Therefore, reducing or managing anxiety may go some way to manage 
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FoH in CYP and parents.    Although anxiety and FoH were not shown to be linked to higher 
HbA1c this does not necessarily indicate that CYP and parents are coping with managing 
T1DM.  Those who appear to be managing their diabetes optimally could also be the group 
of patients/carers that are struggling with anxiety and FoH (as a result of the pressure of 
managing optimum BG levels).  When considering interventions to manage anxiety it is 
important not to restrict these to those with poor diabetes control.  
 
Higher FoH was associated with lower CYP/perceived CYP QoL, which again demonstrates 
the impact of T1DM on the psychosocial aspects of CYP and parents’ lives.  The qualitative 
reports also highlight the struggle of living with T1DM for both CYP and mothers.  The 
often negative impact of T1DM was reported by CYP and their mothers, which could be a 
reflection of their perception of their/their child’s QoL.  Again, this has previously received 
some attention in past research and the current study adds to this. 
 
Multivariate analyses suggest that higher trait anxiety adds to the predictability of FoH in 
all groups.  One of the key findings emerging from this study highlights anxiety as a 
predictor of FoH in CYP and parents.  Although clinically it is important to try to improve 
T1DM treatment to avoid hypoglycaemia, this study highlights the impact of T1DM on the 
psychological well-being of CYP and parents.  Future research should explore this impact 
further to help identify methods to help manage symptoms of anxiety and FoH.      
Increased understanding of predictability of FoH could allow clinicians/CYP/parents to 
manage these predictors and consequently manage levels of FoH. 
 
Overall, the findings of the current study highlight the issues that both CYP and parents 
face when living with diabetes.  In addition to original findings regarding parental FoH, the 
current study also supports previous studies in this area.  The gaps in addressing these 
issues, however, remain.  Therefore, the outcomes of this study have important 
implications for clinical practice.  Although clinicians will undoubtedly be aware of the 
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impact of diabetes on CYP and their parents, they should appreciate how this impact can 
affect these families’ lives.  Further thought should be given to offering/providing 
psychosocial support to all CYP and parents who have to manage diabetes care on a daily 
basis; even if the family seem to be coping.  Further research should investigate the 
predictors of FoH by conducting a more rigorous, longitudinal study.  This could be 
achieved by having a more robust method of collecting hypoglycaemia incidence data.  As 
we know, retrospective reports of hypoglycaemia are often inaccurate, however, in the 
absence of real time reports, are the next best way of obtaining such information.  With 
mobile applications evermore popular and more advanced blood monitoring technology it 
would be much easier to collect actual data on blood glucose levels over a specified 
period.  This would allow more accurate reporting on the frequency of hypoglycaemia and 
episodes of severe hypoglycaemia in CYP.  FoH and anxiety data could be collected at 
intervals to see whether any changes were linked to fluctuations in daily BG levels, for 
example in the previous 4 week period, rather than relying on HbA1c data, which is a more 
crude measure of blood glucose.        
 
Future research should also be carried out to test interventions that might reduce the 
stress and anxiety experienced by mothers (parents) of children with T1DM, and 
potentially help to manage FoH too.  As previously mentioned in both the quantitative and 
qualitative discussion chapters, MBSR has been found to be an effective method of 
reducing anxiety in both patients of long-term illnesses and their carers (174, 178).  MBSR 
might also be useful in reducing FoH, which itself incorporates a scale of worry (anxiety) 
about hypoglycaemia, especially in parents of children with T1DM, who seem to 
experience higher FoH than their children do.  A pilot study could be developed to test the 
impact that MBSR has when delivered to parents face to face or via mobile technology 
(mobile based applications) compared to no intervention.  The change in anxiety and FoH 
could be measured by comparing scores on the STAI state subscale (148, 149) and the HFS 
(72, 74, 147) at baseline and then 6 weeks later (after 6 sessions of MBSR have been 
delivered).  The pilot study could also include a debrief qualitative session to understand 
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how parents felt about using MBSR and whether they felt any differently after the 6 
session course. 
 
CYP with T1DM and the parents who care for them face many anxieties, responsibilities 
and pressures to manage the condition on a daily basis.  The results of this study have 
highlighted that hypoglycaemia and the fear of hypoglycaemia are a problem for 
paediatric diabetes patients and their parents, in the UK.  These groups should be 
supported not only in their pursuit of optimal glycaemic control, but also to improve their 
psychosocial outcomes so that the stress and anxiety that they report do not become 
problems in themselves.  By targeting FoH and anxiety (potentially by further education or 
reduction in the experience of hypoglycaemia) might help to improve QoL for CYP and 
reduce the burden experienced by mothers (parents).  This study contributes the wider 
body of research on FoH worldwide but also provides specific recommendations for the 
UK population for which there is limited research. 
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Appendices 
Appendix 1 – Frequency of hypoglycaemia survey 
 
 
 
 
 
 
 
To be completed by patient: 
 
This question is about frequency of hypoglycaemia.  This is not restricted to severe 
episodes, but includes any occasion when you feel that your blood sugar is low (or you 
get a low measurement) and take action to correct it, e.g. having a snack or an early 
meal. 
 
1. How often do you experience hypoglycaemia?  Please tick as appropriate: 
 Never     
 Less than once per year   
 1 to 3 times per year   
 4 to 12 times per year   
 More than once a month   
 More than once a week   
 
The following questions are about severe hypoglycaemia.  A severe episode is any 
occasion when you needed assistance to recover from a hypo.  Assistance may be 
Patient details:   Sex 
Name      Duration of diabetes 
DoB     Occupation 
Hospital number    
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medical (e.g. hospital admission, or treatment from an ambulance crew) or non-
medical (e.g. being given sweets by a relative or member of the public) 
 
2. How many episodes of severe hypoglycaemia have you had in your life? 
 
 None     
 1 or 2     
 3 to 5     
 More than 5    
 
3a. How many episodes of severe hypoglycaemia have you had in the last year? 
Estimate number __________ 
 
3b. How many episodes of severe hypoglycaemia did you have in the year before last? 
Estimate number __________ 
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Appendix 2 – Hypoglycaemia awareness survey 
 
Name……………………………… 
DOB………………………………. 
Address……………………………. 
…………………………………….. 
…………………………………….. 
 
Telephone number………………… 
 
Year of diagnosis of Diabetes (approximately)……………… 
 
Insulin types 1.………………… 2…………………………. 
 
Timing of insulin injections (pleas tick and fill in how many units of insulin you use): 
 
 Before breakfast  Units of insulin………………..   
 
Before lunch   Units of insulin……………….. 
      
 Before evening meal  Units of insulin……………….. 
 
Bed      Bedtime   Units of insulin……………….. 
 
 
Other medications (i.e. tablets etc)………………….. 
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1) Tick the category that best describes you (tick one only) 
I always have symptoms when my blood sugar is low   
I sometimes have symptoms when my blood sugar is low  
I no longer have symptoms when my blood sugar is low   
 
 
2) Have you lost some of the symptoms that used to occur when your blood sugar was 
low? 
Yes  
No  
 
 
3) In the past six months how often have you had moderate hypoglycaemia episodes? 
(episodes where you might feel confused, disorientated, or lethargic and were unable to 
treat yourself) 
Never     
Once or twice    
Every other month   
Once a month    
More than once a month  
 
 
4) How often in the past year how often have you had severe hypoglycaemic episodes ? 
(episodes where you were unconscious or had a seizure and needed glucagons or 
intravenous glucose) 
 
Never    4 times    9 times   
1 time    6 times    10 times  
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2 times    7 times    11 times  
3 times    8 times    12 or more times 
 
 
5) How often in the last month have you had readings less than 3.9mmol/L with 
symptoms? 
Never      2 to3 times/week  
1-3 times     4 to 5 times/week  
1 time/week     Almost daily   
 
 
6) How often in the last month have you had readings less than 3.9mmol/L without any 
symptoms? 
Never      2 to3 times/week  
1-3 times     4 to 5 times/week  
1 time/week     Almost daily   
 
7) How low does your blood sugar need to go before you feel symptoms? 
3.3-3.8 mmol/L     2.2-2.7mmol/L  
2.8-3.3 mmol/L       <2.2mmol/L  
 
8) To what extent can you tell by your symptoms that your blood sugar is low? 
Never    Often   
Rarely    Always   
Sometime     
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9) Please score the extent to which you experience the following symptoms during a 
typical daytime hypoglycaemic episode (circle a number for each symptom) 
 
Not present    Present a great deal 
 
Confusion   1 2 3 4 5 6 7 
Sweating   1 2 3 4 5 6 7 
Drowsiness   1 2 3 4 5 6 7 
Weakness   1 2 3 4 5 6 7 
Dizziness   1 2 3 4 5 6 7 
Warmth   1 2 3 4 5 6 7 
Difficulty Speaking  1 2 3 4 5 6 7 
Pounding heart   1 2 3 4 5 6 7 
Inability to concentrate  1 2 3 4 5 6 7 
Blurred vision   1 2 3 4 5 6 7 
Hunger    1 2 3 4 5 6 7 
Nausea    1 2 3 4 5 6 7 
Anxiety    1 2 3 4 5 6 7 
Tiredness   1 2 3 4 5 6 7 
Tingling lips   1 2 3 4 5 6 7 
Trembling   1 2 3 4 5 6 7 
Headache   1 2 3 4 5 6 7 
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10. Do you know when your hypos are commencing?  Please circle a number: 
 
   Always aware     Never aware 
 
Awareness   1 2 3 4 5 6 7 
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Appendix 3 – Self-care inventory (revised)  
ID#________          Date: 
Month___Day___Year_____ 
Self-Care Inventory 
Part 2 – Children’s Form 
 
This survey measures what you actually do, not what you are advised to do.  How 
have you followed your diabetes treatment plan in the past 1-2 months?       
                                      
 
  1. Check blood glucose with a 
monitor 
Never 
1 
Rarely 
2 
Sometimes 
3 
Usually 
4 
Always 
5 
  
 
 
  2.  Record blood glucose 
results 
 
1 
 
2 
 
3 
 
4 
 
5 
  
   
  3. Check ketones when glucose 
level is high 
 
1 
 
2 
 
3 
 
4 
 
5 
  
 
   
  4. Take the correct dose of 
insulin 
 
1 
 
2 
 
3 
 
4 
 
5 
  
   
  5. Take insulin at the right time 
 
1 
 
2 
 
3 
 
4 
 
5 
  
 
  6. Eat the correct food portions 
 
1 
 
2 
 
3 
 
4 
 
5 
  
 
  7. Eat meals/snacks on time 
 
1 
 
2 
 
3 
 
4 
 
5 
  
 
  8. Keep food records 
 
1 
 
2 
 
3 
 
4 
 
5 
  
 
 
  9. Read food labels 1 2 3 4 5  
 240 
 
 
   
  10. Treat low blood glucose 
with just the recommended 
amount of carbohydrate 
 
1 
 
2 
 
3 
 
4 
 
5 
Never 
had  
low 
blood  
glucose 
   
  11. Carry quick acting sugar to 
treat low blood glucose 
 
1 
 
2 
 
3 
 
4 
 
5 
 
 
  12. Come in for clinic 
appointments   
 
1 
 
2 
 
3 
 
4 
 
5 
 
 
  13. Wear a Medic Alert ID 
 
1 
 
2 
 
3 
 
4 
 
5 
 
 
  14. Exercise  
 
1 
 
2 
 
3 
 
4 
 
5 
 
   
  15. Adjust insulin dosage based 
on    glucose values, food, and 
exercise 
 
1 
 
2 
 
3 
 
4 
 
5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 241 
 
Appendix 4 – Pediatric quality of life inventory (CYP)- example 
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Appendix 5 - Pediatric quality of life inventory (Parent) - 
example 
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Appendix 6 – Hypoglycemia Fear Survey (CYP) 
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Appendix 7 – Hypoglycemia Fear Survey (Parent) 
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Appendix 8 – STAI 
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Appendix 9 – STAICH 
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Appendix 10 – Ethics approval 
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Appendix 11 – Substantial amendment number 1 
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Appendix 12 – Substantial amendment number 2 
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Appendix 13 – Substantial amendment number 3 
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Appendix 14 – Substantial amendment number 4 
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Appendix 15 – Information sheet (CYP) 
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Appendix 16 – Information sheet (Parent) 
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 272 
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Appendix 17 – Consent form CYP aged 16+ 
 
 
 275 
 
Appendix 18 – Assent form 
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Appendix 19 – Parent consent on behalf of child 
 
 
 277 
 
Appendix 20 – Parent consent form  
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Appendix 21 – Letter of invitation (interview) 
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Appendix 22 – Participant information sheet (interview) 
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 283 
 
Appendix 23 – Consent form CYP aged 16+ (interviews) 
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Appendix 24 – Participant information sheet for younger 
children (interviews) 
 
